<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=Windows-1254">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="basagrisi_dosyalar/filelist.xml">
<title>BAÞAÐRISI</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>userE</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bono</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>16</o:TotalTime>
  <o:Created>2019-01-01T17:53:00Z</o:Created>
  <o:LastSaved>2019-01-01T18:40:00Z</o:LastSaved>
  <o:Pages>22</o:Pages>
  <o:Words>19743</o:Words>
  <o:Characters>112536</o:Characters>
  <o:Company>UNUN</o:Company>
  <o:Lines>937</o:Lines>
  <o:Paragraphs>264</o:Paragraphs>
  <o:CharactersWithSpaces>132015</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:TargetScreenSize>800x600</o:TargetScreenSize>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=dataStoreItem href="basagrisi_dosyalar/item0006.xml"
target="basagrisi_dosyalar/props007.xml">
<link rel=themeData href="basagrisi_dosyalar/themedata.thmx">
<link rel=colorSchemeMapping href="basagrisi_dosyalar/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>120</w:Zoom>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>TR</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:SplitPgBreakAndParaMark/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:__Grammarly_42____i>H4sIAAAAAAAEAKtWckksSQxILCpxzi/NK1GyMqwFAAEhoTITAAAA</w:__Grammarly_42____i>
   <w:__Grammarly_42___1>H4sIAAAAAAAEAKtWcslP9kxRslIyNDa0NDAwtTQzMjMyNgMyLJR0lIJTi4sz8/NACkxqAWWnULAsAAAA</w:__Grammarly_42___1>
  </w:DocumentVariables>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"MS Gothic";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:0 134676480 16 0 131072 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"MS Gothic";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:0 134676480 16 0 131072 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:162;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:162;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073732485 9 0 511 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:162;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:162;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536858881 -1073711013 9 0 511 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:0 134676480 16 0 131072 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Baþlýk 1 Char";
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:24.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
h2
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Baþlýk 2 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
h3
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Baþlýk 3 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:10.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Açýklama Metni Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Gövde Metni Girintisi Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Gövde Metni Girintisi 2 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
pre
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"HTML Önceden Biçimlendirilmiþ Char";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Açýklama Metni";
	mso-style-link:"Açýklama Konusu Char";
	mso-style-next:"Açýklama Metni";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balon Metni Char";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.Balk1Char
	{mso-style-name:"Baþlýk 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Baþlýk 1";
	mso-ansi-font-size:24.0pt;
	mso-bidi-font-size:24.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:18.0pt;
	font-weight:bold;}
span.Balk2Char
	{mso-style-name:"Baþlýk 2 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Baþlýk 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Cambria","serif";
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	font-weight:bold;}
span.Balk3Char
	{mso-style-name:"Baþlýk 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Baþlýk 3";
	font-family:"Cambria","serif";
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	font-weight:bold;}
span.HTMLncedenBiimlendirilmiChar
	{mso-style-name:"HTML Önceden Biçimlendirilmiþ Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"HTML Önceden Biçimlendirilmiþ";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-fareast-language:TR;}
span.AklamaMetniChar
	{mso-style-name:"Açýklama Metni Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Açýklama Metni";
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
span.GvdeMetniGirintisiChar
	{mso-style-name:"Gövde Metni Girintisi Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Gövde Metni Girintisi";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.msobodytextindent, li.msobodytextindent, div.msobodytextindent
	{mso-style-name:msobodytextindent;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.GvdeMetniGirintisi2Char
	{mso-style-name:"Gövde Metni Girintisi 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Gövde Metni Girintisi 2";}
p.msobodytextindent2, li.msobodytextindent2, div.msobodytextindent2
	{mso-style-name:msobodytextindent2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:18.0pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.AklamaKonusuChar
	{mso-style-name:"Açýklama Konusu Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Açýklama Konusu";
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.BalonMetniChar
	{mso-style-name:"Balon Metni Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Balon Metni";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.ListeParagraf1, li.ListeParagraf1, div.ListeParagraf1
	{mso-style-name:"Liste Paragraf1";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ListeParagraf1CxSpFirst, li.ListeParagraf1CxSpFirst, div.ListeParagraf1CxSpFirst
	{mso-style-name:"Liste Paragraf1CxSpFirst";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ListeParagraf1CxSpMiddle, li.ListeParagraf1CxSpMiddle, div.ListeParagraf1CxSpMiddle
	{mso-style-name:"Liste Paragraf1CxSpMiddle";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ListeParagraf1CxSpLast, li.ListeParagraf1CxSpLast, div.ListeParagraf1CxSpLast
	{mso-style-name:"Liste Paragraf1CxSpLast";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11, li.ColorfulList-Accent11, div.ColorfulList-Accent11
	{mso-style-name:"Colorful List - Accent 11";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11CxSpFirst, li.ColorfulList-Accent11CxSpFirst, div.ColorfulList-Accent11CxSpFirst
	{mso-style-name:"Colorful List - Accent 11CxSpFirst";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11CxSpMiddle, li.ColorfulList-Accent11CxSpMiddle, div.ColorfulList-Accent11CxSpMiddle
	{mso-style-name:"Colorful List - Accent 11CxSpMiddle";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11CxSpLast, li.ColorfulList-Accent11CxSpLast, div.ColorfulList-Accent11CxSpLast
	{mso-style-name:"Colorful List - Accent 11CxSpLast";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.GvdeMetniGirintisiChar1
	{mso-style-name:"Gövde Metni Girintisi Char1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.GvdeMetniGirintisi2Char1
	{mso-style-name:"Gövde Metni Girintisi 2 Char1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Calibri;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:20323243;
	mso-list-type:hybrid;
	mso-list-template-ids:-1597314306 1598988842 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l0:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l0:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l0:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l0:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l0:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l0:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l0:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l0:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
@list l1
	{mso-list-id:77870187;
	mso-list-type:hybrid;
	mso-list-template-ids:1102468456 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l1:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l1:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l1:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l2
	{mso-list-id:343215408;
	mso-list-template-ids:1228431502;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3
	{mso-list-id:362364138;
	mso-list-type:hybrid;
	mso-list-template-ids:1419536154 -839598368 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l3:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
@list l3:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l3:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l3:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l3:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l3:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l3:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l3:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l3:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l4
	{mso-list-id:383984971;
	mso-list-type:hybrid;
	mso-list-template-ids:-1778858946 -1794100168 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l4:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l4:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l4:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l4:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l4:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l4:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l4:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l4:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l4:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l5
	{mso-list-id:597250372;
	mso-list-template-ids:1339819034;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level3
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l6
	{mso-list-id:603147894;
	mso-list-type:hybrid;
	mso-list-template-ids:-441815946 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l6:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7
	{mso-list-id:720636337;
	mso-list-type:hybrid;
	mso-list-template-ids:-1007506136 -2137236968 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l7:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l7:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l7:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l7:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l7:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l7:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l7:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l7:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l7:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
@list l8
	{mso-list-id:751391266;
	mso-list-template-ids:1059850566;}
@list l8:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l8:level2
	{mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:36.0pt;
	text-indent:-18.0pt;}
@list l8:level3
	{mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-36.0pt;}
@list l8:level4
	{mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l8:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-54.0pt;}
@list l8:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-54.0pt;}
@list l8:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-72.0pt;}
@list l8:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-72.0pt;}
@list l8:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-90.0pt;}
@list l9
	{mso-list-id:816386540;
	mso-list-type:hybrid;
	mso-list-template-ids:-1704145424 1941571700 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l9:level1
	{mso-level-start-at:2;
	mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-36.0pt;}
@list l9:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l9:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l9:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l9:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l9:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l9:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l9:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l9:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l10
	{mso-list-id:879823778;
	mso-list-type:hybrid;
	mso-list-template-ids:-921304488 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l10:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l11
	{mso-list-id:880240606;
	mso-list-type:hybrid;
	mso-list-template-ids:117496752 2133365444 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l11:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l11:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l11:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l11:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l11:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l11:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l11:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l11:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l11:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
@list l12
	{mso-list-id:1128086301;
	mso-list-type:hybrid;
	mso-list-template-ids:-1621061722 1417157292 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l12:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-36.0pt;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1231814688;
	mso-list-template-ids:-698158210;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l14
	{mso-list-id:1261177339;
	mso-list-template-ids:983366336;}
@list l14:level1
	{mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level2
	{mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level3
	{mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level4
	{mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level5
	{mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level6
	{mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level7
	{mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level8
	{mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level9
	{mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15
	{mso-list-id:1302921694;
	mso-list-template-ids:1913134126;}
@list l15:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l15:level2
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l15:level3
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l15:level4
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l15:level5
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l15:level6
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l15:level7
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l15:level8
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-90.0pt;}
@list l15:level9
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-90.0pt;}
@list l16
	{mso-list-id:1435128830;
	mso-list-type:hybrid;
	mso-list-template-ids:1411967202 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l16:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l16:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l16:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l17
	{mso-list-id:1453599040;
	mso-list-type:hybrid;
	mso-list-template-ids:567160966 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l17:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l17:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l17:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l18
	{mso-list-id:1714235132;
	mso-list-template-ids:-1125360740;}
@list l18:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level2
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:45.0pt;
	text-indent:-18.0pt;}
@list l18:level3
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l18:level4
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-36.0pt;}
@list l18:level5
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-54.0pt;}
@list l18:level6
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-54.0pt;}
@list l18:level7
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-72.0pt;}
@list l18:level8
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-72.0pt;}
@list l18:level9
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:252.0pt;
	text-indent:-90.0pt;}
@list l19
	{mso-list-id:1734965091;
	mso-list-template-ids:-900575658;}
@list l19:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l20
	{mso-list-id:1872841271;
	mso-list-template-ids:2054825488;}
@list l20:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l20:level2
	{mso-level-start-at:5;
	mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:102.0pt;
	text-indent:-48.0pt;}
@list l20:level3
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:102.0pt;
	text-indent:-48.0pt;}
@list l20:level4
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:102.0pt;
	text-indent:-48.0pt;}
@list l20:level5
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l20:level6
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l20:level7
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l20:level8
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l20:level9
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-90.0pt;}
@list l21
	{mso-list-id:1920869555;
	mso-list-type:hybrid;
	mso-list-template-ids:302678924 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l21:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l21:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l21:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l22
	{mso-list-id:2014800848;
	mso-list-template-ids:-1621210828;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l23
	{mso-list-id:2017884447;
	mso-list-type:hybrid;
	mso-list-template-ids:2001923486 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l23:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l23:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l23:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l24
	{mso-list-id:2045785680;
	mso-list-template-ids:-789964158;}
@list l24:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l25
	{mso-list-id:2082947439;
	mso-list-type:hybrid;
	mso-list-template-ids:-225042084 2803764 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l25:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Normal Tablo";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=TR link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:16.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<div style='mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:16.0pt;mso-bidi-font-size:11.0pt;
line-height:115%;font-family:"Tahoma","sans-serif"'>BAÞAÐRISI <o:p></o:p></span></b></p>

<p class=MsoNormal style='border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-family:"Tahoma","sans-serif"'>Yazanlar:
Esme Ekizoðlu, Elif Kocasoy-Orhan, Betül Baykan</span></b><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;mso-bidi-font-size:11.0pt;
line-height:115%;font-family:"Tahoma","sans-serif"'><o:p></o:p></span></b></p>

<p class=MsoNormal style='border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-family:"Tahoma","sans-serif"'>Son
güncelleþtirme tarihi: 01.01.2019<o:p></o:p></span></b></p>

</div>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>GÝRÝÞ ve SINIFLAMA<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br>
Ýnsanlarý etkileyen aðrýlý durumlardan en yaygýn olaný baþaðrýsýdýr. Baþaðrýsý
nörolojik hastalýklarýn yaný sýra sistemik hastalýklara&nbsp;da eþlik edebilen
bir <span class=GramE>semptomdur</span>. Baþaðrýsýyla hayatý boyunca tanýþmamýþ
insan yok gibidir ve toplumda en sýk görülen belirtilerden bir tanesidir. Bir
çalýþmamýza göre yurdumuzda nöroloji polikliniklerine baþvuran hastalarýn
toplam 2/3ünün baþaðrýsý vardýr ve 1/3ü sadece baþaðrýsý için baþvurmaktadýr.
Bu hastalarýn en az 1/4 kadarýnda þiddetli ve ciddi kýsýtlýlýk yapan migren
olduðu gösterilmiþtir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tanýyý
kolaylaþtýrmak için ve etyolojik yaklaþýmla baþaðrýsýný daha iyi ele almak için
deðiþik baþaðrýsý tiplerini sýnýflamak esastýr. Baþaðrýsýnýn etyolojisi,
sýklýðý, þiddeti ve yaþamsal sonuçlarý çok büyük farklýlýklar gösterebilir ve
baþarýlý bir tedavinin ilk basamaðý doðru ve özgül bir tanýdýr. Hastalarýn çoðu
baþaðrýlarýnýn ciddi bir sorunun belirtisi olduðundan korkar. Fakat çoðunda iyi
seyirli ancak uzun yýllar boyu ataklarla seyreden bir süreç söz konusudur.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tüm
dünyada kullanýlan ve genel kabul gören bir sýnýflamaya sahip olmak týbbýn her
dalý için önemlidir. Baþaðrýsý bozukluklarý hakkýnda çok fazla önyargý
olduðundan bu durum baþaðrýsý için özellikle doðrudur.&nbsp;<span
style='mso-bidi-font-style:italic'>Uluslararasý Baþaðrýsý&nbsp;</span>Derneði <span
style='mso-bidi-font-style:italic'>(International Headache Society (IHS))</span>&nbsp;ilk
olarak 1988 yýlýnda baþaðrýlarýný ayrýntýlý þekilde sýnýflamaya yönelik bir
çalýþma yapmýþtýr. Baþaðrýsý tanýsýnda standart oluþturan ve özellikle klinik
araþtýrmalarda kullanýlmasý amaçlanan bu ilk sýnýflama sistemi tüm dünyada
yaygýn bir kabul görmüþ, yeni bilimsel geliþmeler doðrultusunda 2004 ve 2013de
(IHS beta) <span class=GramE>revizyonlarý</span> yapýlmýþ ve son sýnýflama Ocak
2018de yayýnlanmýþtýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>IHS
sýnýflama sisteminde baþaðrýlarý baþlýca iki temel grupta ele alýnmaktadýr: <i
style='mso-bidi-font-style:normal'>primer baþaðrýsý bozukluklarý</i> (1.-4.
Kategoriler) ve <i style='mso-bidi-font-style:normal'>sekonder baþaðrýsý
bozukluklarý</i> (5.-12. Kategoriler) (<b>Tablo 1A ve B</b>). Sekonder
baþaðrýsý bozukluklarýnda baþaðrýsý beyin tümörü, inme veya metabolik bozukluk
gibi bir baþka hastalýða baðlýdýr ve IHS <span class=GramE>kriterleri</span> bu
grup baþaðrýlarýný etyolojik nedenlerine dayanarak sýnýflayan bir sistem
saðlamaktadýr. Primer baþaðrýsýnda ise altta saptanabilir baþka bir neden
yoktur ve IHS <span class=GramE>kriterleri</span> baþaðrýlarýný belli klinik
özelliklerine göre sýnýflayan tanýmlayýcý bir sistem ortaya koymuþtur. IHS <span
class=GramE>kriterleri</span> Dünya Saðlýk Örgütü (WHO) tarafýndan kabul görmüþ
ve bu sistemin ana hatlarý Uluslararasý Hastalýk Sýnýflamasýna da alýnmýþtýr.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>IHS
sýnýflamasýný bu bölümün sýnýrlarý içinde tümüyle ele almak mümkün olmadýðýndan
önce tanýsal yaklaþým, ardýndan bazý sýk karþýlaþýlan primer baþaðrýlarý bölüm içinde
kýsaca tartýþýlacaktýr; sekonder baþaðrýsýna neden olan nörolojik hastalýklar
için kitabýn ilgili bölümlerine bakýlmalýdýr.</span><span style='font-size:
13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all>
</span></b><b><span style='font-size:12.0pt;mso-bidi-font-size:14.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Tablo 1A</span></b><b><span style='font-size:
12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>.&nbsp;</span></b><span style='font-size:
12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Uluslararasý
Baþaðrýsý Derneði (IHS) 2018 Sýnýflama Sistemine Göre Primer Baþaðrýsý
Bozukluklarý (Bölüm 1)</span><span style='font-size:12.0pt;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='text-indent:-18.0pt;line-height:normal;
mso-list:l18 level1 lfo1'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Migren<o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='text-indent:0cm;line-height:normal;
mso-list:l18 level2 lfo1;tab-stops:58.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aurasýz migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='text-indent:0cm;line-height:normal;
mso-list:l18 level2 lfo1;tab-stops:58.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Auralý migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:18.0pt;mso-add-space:auto;
text-indent:36.0pt;line-height:normal'><span style='font-size:12.0pt;
mso-ansi-language:TR'>1.2.1. Tipik auralý migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>      </span>1.2.1.1. Baþaðrýlý tipik aura<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>      </span>1.2.1.2. Baþaðrýsýz tipik aura<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.2.
Beyinsapý auralý migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.3.
Hemiplejik migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>      </span>1.2.3.1. Ailesel hemiplejik migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>                  </span>1.2.3.1.1. Ailesel hemiplejik migren
(FHM1)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>                  </span>1.2.3.1.2. Ailesel hemiplejik
migren<span style='mso-spacerun:yes'>  </span>(FHM2)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>                  </span>1.2.3.1.3. Ailesel hemiplejik
migren<span style='mso-spacerun:yes'>  </span>(FHM3)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>                  </span>1.2.3.1.4. Ailesel hemiplejik
migren, diðer lokus<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>      </span>1.2.3.2. Sporadik hemiplejik migren (SHM)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.4.
Retinal migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>            </span>1.3. Kronik migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>            </span>1.4. Migren <span class=GramE>komplikasyonlarý</span>
<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>                  </span>1.4.1. Status migrenozus<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>                  </span>1.4.2. Ýnfarkt olmaksýzýn
kalýcý aura<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>                  </span>1.4.3. Migrenöz infarkt<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>                  </span>1.4.4. Migren aurasýyla
tetiklenen nöbet<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:1'>            </span>1.5. Olasý migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>                  </span>1.5.1. Aurasýz olasý
migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>                  </span>1.5.2. Auralý olasý
migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:1'>            </span>1.6. Migrenle iliþkili olabilecek
epizodik <span class=GramE>sendromlar</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>                  </span>1.6.1. Yineleyen
gastrointestinal rahatsýzlýk<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt 72.0pt'><span style='font-size:12.0pt;
mso-ansi-language:TR'><span style='mso-tab-count:3'>                        </span>1.6.1.1.
Siklik kusma <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:3'>                        </span>1.6.1.2.
Abdominal migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>                  </span>1.6.2. Selim
paroksizmal vertigo<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>                  </span>1.6.3. Selim
paroksizmal tortikollis<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l18 level1 lfo1;
tab-stops:18.0pt 36.0pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Gerilim tipi baþaðrýsý<span
style='mso-spacerun:yes'>  </span><o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1.2. Seyrek epizodik gerilim tipi
baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-spacerun:yes'> </span><span style='mso-tab-count:1'>     </span>1.2.1.
Perikranyal duyarlýlýðýn eþlik ettiði seyrek epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>1.2.2.
Perikranyal duyarlýlýðýn eþlik etmediði seyrek epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2.2. Sýk epizodik gerilim tipi
baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.2.1.
Perikranyal duyarlýlýðýn eþlik ettiði sýk epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.2.2.
Perikranyal duyarlýlýðýn eþlik etmediði sýk epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2.3. Kronik gerilim tipi
baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.3.1.
Perikranyal duyarlýlýðýn eþlik ettiði kronik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.3.2.
Perikranyal duyarlýlýðýn eþlik etmediði kronik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2.4. Olasý gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.4.1.
Olasý seyrek epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.4.2.
Olasý sýk epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>2.4.3.
Olasý kronik epizodik gerilim tipi baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l18 level1 lfo1;
tab-stops:18.0pt 36.0pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Trigeminal otonomik sefalaljiler
(TOS)<o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:36.0pt 58.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>3.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Küme baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:90.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik küme baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:85.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-31.5pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.1.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik küme baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.2.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.2.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kýsa süreli tek yanlý nevraljiform baþaðrýsý ataklarý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Konjunktival kanlanma ve yaþarmalý kýsa süreli tek yanlý nevraljiform
baþaðrýsý (SUNCT)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik SUNCT<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.1.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik SUNCT<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kranyal otonomik <span class=GramE>semptomlarýn</span> eþlik ettiði kýsa
süreli tek yanlý nevraljiform baþaðrýsý (SUNA)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.2.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik SUNA<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.2.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik SUNA<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hemikranya kontinua<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:90.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.4.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hemikranya kontinua, remisyonlu alt tip<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.4.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hemikranya kontinua, remisyonsuz alt tip<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olasý trigeminal otonomik baþaðrýlarý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olasý küme baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olasý paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olasý kýsa süreli tek yanlý nevraljiform baþaðrýsý ataklarý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olasý hemikranya kontinua<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:18.0pt 36.0pt 85.5pt'><span style='font-size:12.0pt;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l18 level1 lfo1;
tab-stops:18.0pt 36.0pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Diðer primer baþaðrýlarý<o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer öksürük baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer egzersiz baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Cinsel etkinliðe eþlik eden primer baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer gökgürültüsü baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Soðukla uyarýlan baþaðrýsý <o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Dýþ basýnçla iliþkili baþaðrýsý <o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer saplanýcý baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Numüler baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hipnik baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 63.0pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.10.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Yeni günlük ýsrarcý baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 36.0pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:14.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>BAÞAÐRILI
HASTAYA TANISAL YAKLAÞIM</span></b><span lang=EN-US style='font-size:13.5pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýsý
bulunan bir hasta deðerlendirilirken,&nbsp;<span style='mso-bidi-font-style:
italic'>ilk yapýlmasý gereken sekonder baþaðrýsýnýn dýþlanmasýdýr</span>. Bu
karar öyküye, genel týbbi ve nörolojik muayenelere dayandýrýlýr. Eðer kuþkulu
özellikler mevcutsa, taný için bazý testlerin yapýlmasý gerekli olabilir.&nbsp;<span
style='mso-bidi-font-style:italic'>Sekonder baþaðrýsý bozukluklarý dýþlandýðýnda,
yapýlmasý gereken primer baþaðrýsý bozukluðunun doðru tanýsýnýn konmasý</span>dýr.
Ayný hastada birden fazla baþaðrýsý varsa, her biri ayrý ayrý taný alýr.
Ülkemizde yapýlan prevalans çalýþmalarýnda migren için rastlanma sýklýðý %16,4
iken gerilim tipi baþaðrýsýnýn sýklýðý %31,7 olarak belirlenmiþtir. Bu denli
sýk görülen hastalýklara rastlantýsal olarak baþka hastalýklarýn da eþlik etme
olasýlýðý doðal olarak yüksektir. Bu nedenle, baþaðrýsý tanýmlayan bir hastada
daha önceden taný konmuþ bir primer baþaðrýsý olsa bile, yeni tanýmladýðý
baþaðrýsý hakkýnda, bu baþaðrýsý özelliklerinin önceki aðrýlarýyla uyumlu olup
olmadýðýný anlamaya yönelik olarak tekrar bilgi almak ve hastayý muayene etmek
gerekir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all style='mso-special-character:line-break'>
</span><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
1B.</span></b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararasý Baþaðrýsý
Derneði (IHS) 2018 Sýnýflama Sisteminde Sekonder Baþaðrýsý
Bozukluklarý&nbsp;(Bölüm 2) <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 31.5pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=ListeParagraf1 style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:
  -18.0pt;line-height:normal'><u><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.<span
  style='mso-spacerun:yes'>  </span>Baþ ve/veya boyun <span class=GramE>travmasý</span>
  ile iliþkili baþaðrýsý</span></u><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.1.&nbsp;Travma
  sonrasý akut baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.2.&nbsp;Travma
  sonrasý kronik baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.3.&nbsp;Kamçý
  darbesi tipi yaralanmaya baðlanan akut baþaðrýsý (whiplash: ani ivmelenme/
  yavaþlama <span class=GramE>travmasý</span>)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.4. Kamçý
  darbesi tipi&nbsp;yaralanmaya baðlanan kronik baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.5.
  Kranyotomi sonrasý akut baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.6.
  Kranyotomi sonrasý kronik baþaðrýsý<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>6.<span style='mso-spacerun:yes'> 
  </span><u>Kranyal ya da servikal damarsal hastalýklara baðlanan baþaðrýsý</u><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.1.&nbsp;Ýskemik
  inme ya da geçici iskemik ataða baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.2.
  Travmatik olmayan kafa içi kanamaya baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.3.
  Yýrtýlmamýþ damarsal malformasyona baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.4.&nbsp;Arterite
  baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.5.&nbsp;Karotis
  ya da vertebral arter aðrýsý (diseksiyon ve giriþim sonrasý)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.6.&nbsp;Beyin
  ven trombozuna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.7.&nbsp;Diðer
  kafaiçi akut damarsal bozukluða baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.8. Genetik
  vaskülopatiye baðlanan baþaðrýsý (CADASIL, MELAS vb)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'>6.9. Pituiter apopleksiye baðlanan
  baþaðrýsý <o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>7.&nbsp;<u>Damar-dýþý kafaiçi
  hastalýklarla iliþkili baþaðrýsý</u></span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.1.&nbsp;Beyin
  omurilik sývýsý (BOS) basýnç yüksekliðine baðlanan baþaðrýsý</span><span
  lang=EN-US style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.2.&nbsp;Düþük
  beyin omurilik sývýsý basýncýna baðlanan baþaðrýsý</span><span lang=EN-US
  style='font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.3.&nbsp;Ýnfeksiyon
  olmayan inflamatuar hastalýða baðlanan baþaðrýsý (aseptik menenjit, HaNDL vb)</span><span
  lang=EN-US style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.4. Kafaiçi
  neoplazmalara baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.5.&nbsp;Ýntratekal
  injeksiyonlara baðlý baþaðrýsý</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.6.&nbsp;Epileptik
  nöbetlere baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.7.&nbsp;Chiari
  malformasyon tip 1e baðlanan baþaðrýsý</span><span lang=EN-US
  style='font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'>7.8. Diðer vasküler olmayan
  kafaiçi hastalýklara baðlanan baþaðrýsý<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>8.&nbsp;<u>Madde kullanýmý veya
  yoksunluðu ile iliþkili baþaðrýsý</u></span><span lang=EN-US
  style='font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>8.1.&nbsp;Madde
  kullanýmý veya maddeye maruziyet ile iliþkili baþaðrýsý</span><span
  lang=EN-US style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>8.2.&nbsp;Ýlaç
  aþýrý kullanýmý baþaðrýsý (ÝAKB)</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>8.3. Madde
  kesilmesine baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>9.&nbsp;<u>Ýnfeksiyona baðlanan
  baþaðrýsý</u></span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>9.1.&nbsp;Kafaiçi
  infeksiyona baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>9.2.&nbsp;Sistemik
  infeksiyona baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>10.&nbsp;<u>Homeostaz bozukluðuna
  baðlanan baþaðrýsý</u></span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.1. Hipoksi
  ve/veya hiperkapniye baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.2.&nbsp;Diyaliz
  baþaðrýsý</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.3.&nbsp;Preeklampsi
  veya eklampsiye baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.4.&nbsp;Hipotiroidizme
  baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.5.&nbsp;Açlýða
  baðlanan baþaðrýsý</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.6.
  Kardiyak baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.7.Diðer homeostaz
  bozukluklarýna baðlanan baþaðrýsý<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>11.<u>Kafatasý, boyun, gözler,
  kulaklar, burun, sinüsler, diþler, aðýz veya diðer yüz ve kafa yapýlarýna
  baðlanan baþaðrýsý veya yüz aðrýsý</u><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.1.&nbsp;Kafa
  kemiði bozukluðuna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.2.&nbsp;Boyun
  hastalýklarýna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.3.&nbsp;Göz
  bozukluðuna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.4.&nbsp;Kulak
  bozukluðuna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.5.&nbsp;Rinosinüzite
  baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.6.&nbsp;Diþler,
  çene veya iliþkili yapýlarýn bozukluðuna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.7.&nbsp;Temporomandibüler
  eklem hastalýðýna baðlanan baþaðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.8.
  Stilohiyoid ligamanýn inflamasyonuna baðlanan baþaðrýsý veya yüz aðrýsý<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.9. Diðer
  kafatasý, boyun, gözler, kulaklar, burun, sinüsler, diþler, aðýz veya diðer
  yüz ve kafa yapýlarýna baðlanan baþaðrýsý veya yüz aðrýsý<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>12.&nbsp;<u>Psikiyatrik hastalýklara
  baðlanan baþaðrýsý (<span class=GramE>12.1</span> Somatizasyon bozukluðu ve
  12.2 Psikotik bozukluða baðlý)<o:p></o:p></u></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
1C.</span></b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararasý Baþaðrýsý
Derneði (IHS) 2018 Sýnýflama Sisteminde Aðrýlý Kranyal Nöropatiler, Diðer
Fasyal Aðrýlar ve Diðer Baþaðrýlarý (Bölüm 3)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'>13.&nbsp;<u>Kranyal nevraljiler ve yüz
aðrýsýnýn santral nedenleri</u><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.1.&nbsp;Trigeminal
nevralji<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.2.&nbsp;Glossofaringeal
nevralji<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.3.&nbsp;Nervus
intermedius nevraljisi<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.4.&nbsp;Oksipital
nevralji<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.5.&nbsp;Boyun
dil <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.6. Aðrýlý optik
nörit<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.7.&nbsp;Ýskemik
oküler motor sinir paralizisine baðlanan baþaðrýsý<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.8.
Tolosa-Hunt <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.9.
Paratrigeminal okülosempatetik <span class=GramE>sendrom</span> (Readers
sendromu)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.10.
Yineleyen aðrýlý oftalmoplejik nöropati<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.11. Yanan
aðýz <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.12. Kalýcý idyopatik
yüz aðrýsý<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.13. Yüz
aðrýsýnýn santral nedenleri<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'>14. Diðer baþaðrýsý bozukluklarý: Baþka
yerde sýnýflanamayan ya da tanýmlanamayan baþaðrýlarý<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýlý
Hastada Öykü Alýnmasý</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýlý
hastalarýn tanýsýnýn konulmasýnda en önemli nokta <span style='mso-bidi-font-style:
italic'>baþaðrýsý öyküsünün tam olarak alýnmasý</span>dýr. Baþaðrýsý
hastalarýnýn çoðunda týbbi ve nörolojik muayeneler normal bulunur. Bu nedenle,
doðru taný için elimizdeki en yararlý gereç ayrýntýlý öyküdür. Baþaðrýsý öyküsü
hastanýn baþaðrýlarýnýn ayrýntýlý bir tablosunu çizmeli, ayrýca varsa tanýyý
veya tedaviyi etkileyebilecek diðer týbbi durumlar hakkýnda da bilgi
saðlamalýdýr.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýsý
öyküsünde aþaðýdaki parametreler mutlaka sorulmalýdýr:</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Baþaðrýsýnýn tipi ve karakteri</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Baþlangýç þekli</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Sýklýðý</span><span lang=EN-US
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Yeri</span><span lang=EN-US
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Þiddeti</span><span lang=EN-US
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Aura ve prodromal belirtilerin
     olup olmamasý</span><span lang=EN-US style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Eþlik eden belirtilerin olup
     olmamasý (bulantý, kusma, foto-,fono-,osmofobi, allodini gibi)</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Presipite eden faktörlerin olup
     olmamasý</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Uyku düzeni</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Emosyonel faktörler</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Aile öyküsü</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Medikal, cerrahi veya doðum öyküsü</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Alerji, taþýt tutmasý vb. de
     içeren özgeçmiþ öyküsü</span><span lang=EN-US style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Önceki medikasyonlar ve tedaviler</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
</ul>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l2 level1 lfo3;tab-stops:list 36.0pt'><span
     lang=EN-US style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
     mso-fareast-font-family:"Times New Roman";mso-fareast-language:TR'>Madde
     kullanýmý</span><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
     mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR;mso-fareast-language:
     TR'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR;mso-fareast-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ýlk
deðerlendirme sýrasýnda, sekonder baþaðrýsý bozukluðu olasýlýðýný düþündüren, <b
style='mso-bidi-font-weight:normal'>Tablo 2</b>de ayrýntýlý olarak bildirilen
ve aþaðýda listelenen <b style='mso-bidi-font-weight:normal'>&nbsp;<span
style='mso-bidi-font-weight:bold'></span></b><i>baþaðrýsý alarm belirtileri</i><b></b><span
style='mso-bidi-font-weight:bold'>&nbsp;mutlaka<b> </b></span>gözden
geçirmelidir: <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Ýlk veya hayatýnýn en þiddetli
     baþaðrýsý</span><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Akut baþlangýç</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Sýklýðý veya þiddeti giderek artan
     baþaðrýsý</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Yeni baþlayan baþaðrýsý:</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
      line-height:normal;mso-list:l22 level2 lfo4;tab-stops:list 72.0pt'><span
      style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
      "Times New Roman";mso-ansi-language:TR'>Kanserli hastada</span><span
      lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
      mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
  <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
      line-height:normal;mso-list:l22 level2 lfo4;tab-stops:list 72.0pt'><span
      style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
      "Times New Roman";mso-ansi-language:TR'>50 yaþ üzerinde</span><span
      lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
      mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
  <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
      line-height:normal;mso-list:l22 level2 lfo4;tab-stops:list 72.0pt'><span
      style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
      "Times New Roman";mso-ansi-language:TR'>Kafa <span class=GramE>travmasýnýn</span>
      ardýndan</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
      mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 </ul>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Egzersizle birlikte ortaya çýkan
     baþaðrýsý (öksürük, <span class=GramE>efor</span>, cinsel aktivite gibi)</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Belirli bir þekle uymayan
     baþaðrýsý</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Tedaviye yanýt vermeyen baþaðrýsý</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Sabah olan veya uykudan uyandýran
     baþaðrýsý</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Hiç yer deðiþtirmeyen baþaðrýsý</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Alýþýlmadýk, uzun süren veya sebat
     eden aura</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Eski baþaðrýsý özelliklerinde
     açýklanamayan deðiþiklik</span><span lang=EN-US style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Nörolojik baþka yakýnmalarýn veya
     bulgularýn eþlik ettiði baþaðrýsý (ateþ, ense sertliði, papilödem, görme
     kaybý, epileptik nöbet, lateralizan bulgular, kafa karýþýklýðý-þaþkýnlýk,
     uyku hali gibi)</span><span lang=EN-US style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all>
Tablo 2. </span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-weight:bold'>Baþaðrýsýnýn deðerlendirilmesinde bazý uyarýcý
belirtiler ve bulgular ile inceleme þemalarý<b> </b></span><span lang=EN-US
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=695
 style='width:520.9pt;border-collapse:collapse;mso-yfti-tbllook:1184;
 mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;padding:
  0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>BAÞAÐRISI</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border:inset 1.0pt;border-left:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>AYIRICI TANI</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border:inset 1.0pt;border-left:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>ÖNERÝLEN ÝNCELEME</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>50 yaþýndan
  sonra ortaya çýkan baþaðrýsý</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Temporal
  arterit, YKL </span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sedimentasyon,
  nörolojik görüntüleme yöntemleri</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ani baþlayan
  baþaðrýsý</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Subaraknoid
  kanama, hipofiz apopleksisi, AVM ya da YKLnin içine kanama</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nörolojik
  görüntüleme yöntemleri,</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon (kontrendikasyon yoksa)</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Þiddeti
  giderek artan baþaðrýsý</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>YKL, subdural
  hematom,<span style='mso-spacerun:yes'>  </span>aþýrý ilaç kullanýmý</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nörolojik
  görüntüleme yöntemleri,</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>analjezik</span></span><span
  style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'> ilaçlarýn gözden geçirilmesi</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sistemik
  hastalýkla birlikte baþaðrýsý (ateþ, ense sertliði, döküntüler)</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Menenjit,
  ensefalit, sistemik infeksiyon, kollajen vasküler hastalýk</span><span
  lang=DE style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nörolojik
  görüntüleme yöntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon, ilgili serolojik ve biyokimyasal testler</span><span lang=DE
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Kanser ya da
  HIVli hastada yeni baþlayan baþaðrýsý</span><span lang=DE style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Menenjit
  (kronik ya da karsinomatöz), beyin abseleri (toksoplazma vb), metastazlar</span><span
  lang=DE style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nörolojik
  görüntüleme yöntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon (kontrendikasyon yoksa), ilgili serolojik testler</span><span
  lang=DE style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Lateralizan
  nörolojik <span class=GramE>semptomlar</span></span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>YKL, AVM,
  inme, kollajen vasküler hastalýk </span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nörolojik
  görüntüleme yöntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>kollajen
  vasküler hastalýklarýn araþtýrýlmasý </span><span lang=DE style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Papilödem</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>YKL,
  idyopatik intrakranyal hipertansiyon, menenjit</span><span lang=DE
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nörolojik
  görüntüleme yöntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon (kontrendikasyon yoksa)</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;text-indent:14.2pt;line-height:normal'><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>YKL: Yer kaplayýcý lezyon, AVM: Arterio-venöz
malformasyon, HIV: Human Immundeficiency Virus, &nbsp;</span><span lang=EN-US
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Bu tür kuþkulandýrýcý
durumlar yoksa normal nörolojik muayenesi olan ve öyküsü uyumlu bir hastada
primer baþaðrýsý tanýsý için güçlü bir izlenim oluþtuðunda görüntüleme
yöntemleri gibi yardýmcý inceleme yöntemleri çoðu kez gerekli deðildir, hatta
bazý sakýncalarý da olabilir. Örneðin rastlantýsal olarak saptanan araknoid
kist, nonspesifik beyaz madde lezyonlarý benzeri bulgular hastanýn yaklaþýmýný,
moralini ve hatta tedavi seçimini olumsuz yönde etkileyebilir <b
style='mso-bidi-font-weight:normal'>(Þekil1 A ve B</b>).</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:35.25pt;margin-bottom:.0001pt;line-height:normal'><b><u><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi1.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>Þekil 1A-B</span><span
style='mso-bidi-font-size:11.0pt;color:purple;font-weight:normal'>.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Her ikisi de aurasýz
migrenli olan ve nörolojik baþka bulgusu olmayan hastalarda yapýlan MRG ve BT
incelemelerinin sýrasýyla araknoid kist ve serebellar kalsifikasyon gibi
yakýnmalarý ile iliþkisiz bazý lezyonlarý göstermesi bu hastalarýn gereksiz
þekilde endiþelenmesine ve birçok ek inceleme yapýlmasýna neden olmuþtur.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Primer baþaðrýlarý içinde
en sýk karþýlaþýlanlar migren ve gerilim tipi baþaðrýlarýdýr. Bunlarla
karþýlaþtýrýldýðýnda çok daha seyrek olmakla birlikte (2000 kiþide bir veya
daha ender) çok þiddetli, sýk baþaðrýlarýna neden olmalarý, geleneksel aðrý
kesicilere yanýt vermemeleri ve farklý tedaviler gerektirmeleri
nedeniyle&nbsp;trigeminal <span style='mso-bidi-font-style:italic'>otonomik
sefalaljiler (küme baþaðrýsý, paroksizmal hemikranya</span>&nbsp;gibi) önemli
bir diðer primer baþaðrýsý grubunu oluþturmaktadýr. Çoðu kez bu hastalar doðru
taný alamamalarý nedeniyle yýllarca þiddetli aðrýlar çekebilmektedir. Þu an
için dünyada en sýk üçüncü baþaðrýsý tipi ise iyatrojenik bir tablo olan&nbsp;<span
style='mso-bidi-font-style:italic'>analjezik ilaç aþýrý kullaným baþaðrýsý</span>dýr
(ÝAKB). Bu nedenle, tedavi için kullanýlan analjeziklerin en az 3 ay boyunca
ayda 10 günden fazla alýnmasýnýn kendi baþýna kronik bir baþaðrýsý nedeni
olduðu konusunda hastalar mutlaka en baþtan uyarýlmalý ve dikkatli bir þekilde
takip edilmelidir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýlý hastaya
yaklaþýmda aþaðýdaki özellikler ayrýntýlý olarak ele alýnmalýdýr:</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<b><span
style='mso-bidi-font-style:italic'>1. Hastanýn özellikleri:</span></b>&nbsp;<span
style='mso-bidi-font-style:italic'>Baþaðrýsýnýn <i>baþlangýç yaþý</i></span><i
style='mso-bidi-font-style:normal'>&nbsp;</i>taný konulmasýnda önemli ipuçlarý
verir. Primer baþaðrýlarý genellikle çocukluk veya genç eriþkinlik yaþlarýnda
ortaya çýkar, oysa 50 yaþýndan sonra baþlayan baþaðrýlarý öncelikle sekonder
nedenleri (kitle lezyonu veya temporal arterit gibi) akla getirmelidir.
Migrenlilerin sadece %2sinde aðrýnýn baþlangýcý 50 yaþýn üzerindedir. Küme
tipi baþaðrýsý 3050 yaþ civarýnda baþlar. Gerilim tipi baþaðrýsý ise genelde
20-40 yaþlarýnda ortaya çýkar. Hipnik baþaðrýsý <span class=GramE>sendromu</span>
genellikle 50 yaþýndan sonra ortaya çýkar. Gençlik yýllarýnda da görülebilen
ama genelde 40 yaþlarýn üzerinde rastlanan ÝAKB sýk karþýlaþýlan bir baþaðrýsý
nedeni olarak hatýrlanmalýdýr. Yaþlýlarda baþaðrýsý daha seyrek görülür, ancak
genellikle önemli bir soruna iþaret eder. Etyoloji yaþa göre farklýlýk
gösterir, ayrýca taný ve tedaviyi etkileyecek komorbid durumlarýn bulunma
olasýlýðý da yaþlý hasta grubunda daha fazladýr. Hastanýn&nbsp;<b
style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-style:italic'>cinsiyeti</span></i>&nbsp;</b>de önem
taþýyabilir. Migren için kadýnlarda erkeklere oranla 3-4 kat fazla bir
sýklýktan söz edilebilirken, gerilim tipi baþaðrýlarýnda böyle bir cinsiyet
ayýrýmý söz konusu deðildir. Küme baþaðrýlarýnda ise erkek egemenliði
çarpýcýdýr. <span style='mso-bidi-font-style:italic'>Gebelik sýrasýnda baþ</span>aðrýsýnýn
kaybolmasý migrenlilerde sýktýr veya (tersine) aðrýnýn gebelikte ortaya
çýkmasý, venöz tromboz gibi sekonder baþaðrýlarý açýsýndan önemlidir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>2. Baþaðrýsýnýn karakteri ve þiddeti</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;hasta
tarafýndan&nbsp;<span style='mso-bidi-font-style:italic'>zonklayýcý,
sýkýþtýrýcý, basýnç hissi, iðne batar gibi, patlayýcý, þimþek gibi, elektrik
çarpar gibi</span>&nbsp;þeklinde farklý ifadelerle tanýmlanabilir. Hasta
baþaðrýsýný tanýmlamakta zorlanýrsa, damar atar gibi, bir sargýyla sýkýlmýþ
gibi, býçak saplanýr gibi þeklinde örnekler verilip hangisine benzediði
sorulabilir. Aðrýnýn þiddeti de çok önemlidir. Migren baþaðrýlarýna kýyasla
gerilim tipi baþaðrýlarý çoðunlukla daha hafif þiddettedir. Migren aðrýsý
pulsatil&nbsp;bir aðrýdýr, hareketle artar, þiddetlidir ve genelde hastayý
günlük hayatýný devam ettiremez hale getirir. Hasta karanlýk ve hareketsiz bir
yer ister, ýþýk ve gürültüden kaçýnýr. Zonklayýcý veya basýnç hissi oluþturan
baþaðrýlarý migren için tipikken, sýkýþtýrýcý baþaðrýsý, en sýk gerilim tipi
baþaðrýsýnda ifade edilir. Hastalar gerilim tipi baþaðrýlarýný sýklýkla bant
gibi veya mengene ile sýkýlmýþ gibi olarak tanýmlarlar. Kronik gerilim tipi
baþaðrýsý kalýcý donuk ve doluluk hissi ile giden bir aðrýdýr. Migren
baþaðrýsýnýn küçük yaþlarda eriþkinlerdekinden farklý karakter taþýdýðý da
unutulmamalýdýr. Çocukluk yaþlarýnda, sýklýkla iki yanlý ve frontal yerleþimli
olmasý ve yarým-bir saat gibi kýsa süreler migren için tipiktir. Küme tipi baþaðrýsý
ise derinden gelen can sýkýcý ve rahatsýz edici bir aðrýdýr. Hasta yatamaz,
yerinde duramaz ve sürekli gezinmek durumundadýr. Otonomik sefalaljilerin
önemli ve çok ayýrt ettirici bir özelliði, her zaman çok þiddetli olmalarý ve
çeþitli otonom bulgularýn eþlik etmesidir. Ýdyopatik saplanýcý baþaðrýsýnda
deðiþen bölgelerde iðne veya býçak batar gibi aðrýlar tanýmlanýrken, trigeminal
nevralji gibi nevraljik aðrýlarda þimþekvari veya elektrik çarpar gibi aðrý
ifadesi kullanýlýr. Her tür aðrý tipi ve þiddeti sekonder nedenlere baðlý
olarak da görülebilir. Organik aðrýlarda, aðrýnýn þiddeti ve tabiatý genelde
deðiþken ve ilerleyicidir. Beyin tümörünün aðrýsý genelde gerilim tipi
baþaðrýsýný çaðrýþtýrýr. Bir anevrizmanýn veya arterio-venöz malformasyonun kanamasý
sýklýkla sürekli, þiddetli, künt veya zonklayýcý aðrý yaratýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>3. Baþaðrýsýnýn baþlangýcý</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;ile ilgili bilgiler
de taný için ipuçlarý saðlar. Kafa <span class=GramE>travmasýnýn</span>
ardýndan ortaya çýkan baþaðrýsý bir post-konküzyon baþaðrýsý bozukluðunu veya
kafaiçi bir patolojik süreç olasýlýðýný akla getirmelidir. Ancak kafa <span
class=GramE>travmasý</span> hem migreni, hem de küme baþaðrýlarýný
tetikleyebilir. Doðum öncesi veya sonrasý dönemde ortaya çýkan baþaðrýsý bir
kortikal ven veya dural sinüs trombozunu akla getirmelidir. Baþaðrýsýnýn ortaya
çýkýþýnýn ateþle birlikte olmasý infektif bir nedeni düþündürür. Efor (örneðin
aðýrlýk kaldýrma, spor sonrasý) subaraknoid kanamayý veya selim bir tablo olan <span
class=GramE>efor</span> ile iliþkili baþaðrýsýný ortaya çýkarabilir.&nbsp;<i
style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:bold'>Baþaðrýsýnýn
zamansal gidiþi</span></i>&nbsp;de çok yol göstericidir. <span class=GramE>Örneðin
migren özelliklerine sahip baþaðrýlarý çeken bir hastada belirli bir süredir
(çoðunlukla bir yýl veya daha fazla) bu tip baþaðrýlarýnýn tekrarlýyor olmasý,
aðrý aralarýnda tümüyle normale dönmesi veya kronik baþaðrýlý durumlarda yine
belirli bir süredir devam ediyor olmasý (3 ay veya daha fazla) ve aðrý
þiddetinde kuþku duyuracak bir progresyon veya baþka nörolojik belirtilerin
olmamasý beklenir. Bununla birlikte epizodik migren ataklarýna sahip
hastalarýn, aþýrý derecede sýk aðrý kesici kullanýmý (analjezik,
antiromatizmal, ergotamin, triptan, narkotik ilaçlar gibi) ardýndan ataklarýnda
sýklaþma ve aðrý karakterinin deðiþmesi ve baþaðrýlarýnýn sürekli bir hal
almasý sýk karþýlaþýlan bir durum olup, <i style='mso-bidi-font-style:normal'>ilaç
aþýrý kullanýmý baþaðrýsý</i> (ÝAKB) olarak adlandýrýlan sekonder bir
baþaðrýsýnýn klinik gösterisidir.<b><i>&nbsp;</i></b></span></span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>4. Baþaðrýsýnýn yerleþimi</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;de klinisyen için
önemlidir. Sadece yüzde ve hep ayný yanda ise aðrý tipi de dikkate alýndýðýnda
nevraljik aðrýlar veya nöropatik aðrýlar öncelikle düþünülebilir ancak gözü ve
baþýn diðer bölümlerini (þakak, alýn gibi) içermesi ön tanýlarý
deðiþtirmelidir. Bu tür aðrýlar eðer hep tek yanlý ve ayný tarafta ise,
özellikle otonomik belirtilerin varlýðýnda, otonomik sefalaljileri akla daha
önce getirmelidir. Migrenlilerin çoðu aðrý tarafýnýn ataktan ataða
deðiþebildiðini söylese de, %20yi aþan hastada aðrýnýn hep ayný yanda olduðu
unutulmamalýdýr. Migrenin aksine, küme baþaðrýsýnda hastalarýn sadece %10-15i
ataktan ataða aðrýnýn taraf deðiþtirdiðini söyler. Temporal arter bölgesine <span
class=GramE>lokalize</span> bir aðrý, hastanýn yaþý ve aðrýnýn baþlangýç yaþý
ileri olduðunda, temporal arteriti öncelikle düþündürmelidir. Boyundan baþlayan
veya boyna da yayýlan aðrýlar servikal bir kökeni akla getirebilirse de, migren
ataklarýna büyük sýklýkla servikal spazmýn eþlik ettiði unutulmamalýdýr.
Gerilim tipi baþaðrýsý ise tipik olarak iki yanlýdýr. Ýki yanlý veya bir yanda
daha baskýn olmakla birlikte diðer yanda da hissedilen baþaðrýlarý, otonomik
sefalaljiler ve nevraljik aðrýlar için dýþlayýcý bir özelliktir. Bu tür
aðrýlarda migren veya gerilim tipi baþaðrýlarý en sýk olmakla birlikte ÝAKB
gibi sekonder nedenler de düþünülmelidir. Supratentoryal alanda aðrý oluþturan
yapýlarýn baþlýca innervasyonu trigeminal sinirden kaynaklanýr. Ýnfratentoryal
aðrý oluþturan yapýlarýn innervasyonu ise üst servikal sinirlerden,
glossofaringeus ve vagus sinirlerinden kaynaklanýr. Supratentoryal lezyonlar
genellikle frontal baþaðrýlarýna yol açarken, infratentoryal lezyonlar sýklýkla
oksipital bölgede aðrý oluþturur. Ancak, trigemino-servikal <span class=GramE>komplekse</span>
farklý yapýlardan yönelen nöronlarýn örtüþmesi nedeni ile bu paternin dýþýna
çýkan yayýlmalar da söz konusu olabilir. Baþaðrýsý net bir biçimde göz
çevresine sýnýrlý ise, göz hastalýðý veya döküntü öncesi oftalmik zoster akla
gelmelidir. Trigeminal nevralji maksiller ve mandibüler alanlarda daha sýktýr.
Beyin tümörü saptanan hastalarýn yarýsýndan biraz fazlasý baþaðrýsýndan
yakýnýr; bunlarýn da %80inde aðrý tümörün bulunduðu taraftadýr. Serebrovasküler
hastalýklarla iliþkili baþaðrýlarý yaygýn veya <span class=GramE>lokalize</span>
olabilir. </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>5. Baþaðrýsýný tetikleyen nedenler:</span></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:13.5pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'>&nbsp;</span></b><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Presipite edici faktörler tanýya yardýmcý
olduðu gibi baþaðrýsýnýn önlenmesinde ve koruyucu tedavisinde de önemlidir.</span><span
style='mso-ansi-language:TR'> </span><span style='font-size:13.5pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'>Migrende yaþam stili düzenlenmesinde en önemli unsur
düzensiz beslenme ve uzun süreli açlýðýn önüne geçilmesidir. Biyolojik yolaðý
tam bilinmemekle birlikte migren ataklarýnýn tetikleyicileri arasýnda
hipogliseminin önemli olduðu düþünülmektedir. Migrenli hastalarýn en az
1/3ünde de yetersiz sývý alýmýnýn baþaðrýsýný tetiklediði bildirilmiþtir.
Hastalarýn %30 ile %70inde açlýk hem migren hem de gerilim tipi baþaðrýsýný
tetiklemektedir. </span><span style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=ColorfulList-Accent11CxSpFirst style='margin-left:0cm;mso-add-space:
auto;text-align:justify'><span class=GramE><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Migreni ortaya çýkaran sebepler arasýnda
uykusuzluk, aþýrý uyku, stres, stres sonrasý rahatlama, özel bazý yiyecekler
(en sýk olarak çikolata, peynirler, alkollü içecekler, özellikle kýrmýzý þarap,
turunçgiller, monosodyum glutamat, nitrat ve aspartat içeren yiyecekler),
yorgunluk, menstrüasyon, lodos hava durumu, yükseklik ve basýnç deðiþiklikleri,
fiziksel bazý uyaranlar (parlak ýþýk, yüksek ses, parfüm, kimyasallar), bazý
ilaçlar (nitrogliserin, sildenafil, dipridamol gibi) yer almaktadýr. </span></span><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Tetikleyici yiyecekleri
kýsaca gözden geçirecek olursak; alkolün hangi mekanizma ile baþaðrýsýna neden
olduðu tam bilinmese de hayvan modelinde etanolün meningeal damarlarda
vazodilatasyona yol açtýðý gösterilmiþtir. Peynirin içindeki biyojenik <span
class=GramE>aminlerin</span> baþaðrýsýný tetiklediði düþünülmektedir.
Migrenlilerde serotonin içerdiði bilinen çikolata yeme isteðinin migren prodromunun
bir parçasý olduðu da düþünülmektedir. Histaminin intravenöz verildiðinde ve
inhalasyon yoluyla alýndýðýnda baþaðrýsýný tetiklediði bilinmektedir. Kokain
kullanýmý ve kokain yoksunluðu da migren benzeri baþaðrýlarýný tetikleyebilir.
Diðer yandan, stres, açlýk, uyku deðiþikliði (yetersiz uyku veya aþýrý uyku ya
da öðlen uykusu gibi zamaný kaymýþ uyku) gibi tetikleyici nedenlerin migren
kadar gerilim tipi baþaðrýsý için de söz konusu olduðunu unutmamak gerekir.
Oysa koku (keskin parfüm kokusu, sigara kokusu), parlak ýþýk, <span
class=GramE>rüzgar</span> (lodos), sigara dumaný, mayalý içkiler (kýrmýzý
þarap) özellikle migrene özgü tetikleyicilerdir. Gerilim tipi baþaðrýlarýnýn
koku ile tetiklenmediði, koku tetiðinin migren ve gerilim tipi baþaðrýsý için
ayýrt edici özellik olarak sayýlabileceði bilinmektedir. Gürültü, her tür
baþaðrýsýnda kötü etki gösterirken aðrý sýrasýnda ýþýk ve koku, özellikle
migren aðrýsýnda yüksek oranda rahatsýz edicidir.&nbsp;Küme tipi baþaðrýsýnda
alkol akut ataðý ortaya çýkarýr. Egzersizler genelde organik/sekonder
baþaðrýlarýný tetikler ama egzersizle tetiklenen primer baþaðrýlarý da vardýr.
Akut baþlayan fakat daha öncesinde olmayan baþaðrýsýnda tetikleyen neden
özellikle önemlidir. Örneðin öksürmek, ýkýnmak gibi kafaiçi basýncý arttýran
veya güçlü bir <span class=GramE>efor</span> ya da cinsel iliþki gibi
etkinlikleri takiben geliþen akut baþaðrýsý akla ilk olarak subaraknoid
kanamayý getirmelidir. Nörolojik ve fizik muayenenin normal olmasý halinde,
özellikle de yineleyen bir durum söz konusuysa, öksürük baþaðrýsý, orgazm baþaðrýsý,
<span class=GramE>efor</span> baþaðrýsý, gökgörültüsü baþaðrýsý gibi
idyopatik durumlar da akla gelmelidir. Bu tür seyrek rastlanan primer
baþaðrýlarýnýn özelliði, baþka durumlarda ortaya çýkmamasý, sadece tanýmlanan
bu özel durumlarda ortaya çýkmasý ve tekrarlayýcý olmasýdýr. Kas kökenli
aðrýlar, duyarlý bölgenin palpasyonu veya zorlanmasý ile tetiklenebilir.
Trigeminal nevralji, tetik noktaya dokunmakla ortaya çýkarýlabilir. Bu
noktalarýn yemek yeme, konuþma, soðuða maruz kalma, diþleri fýrçalama, dokunma,
týraþ olma veya yüz yýkama gibi basit uyaranlarla uyarýlmasý bir ataðý
tetikleyebilir. Baþaðrýsýný attýran nedenlerden boyun spazmýnýn migrene de
sýklýkla eþlik ettiði unutulmamalýdýr. Baþ ve beden hareketleri (merdiven
çýkma, eðilip kalkma gibi) migren için özellikle arttýrýcý rol oynarken,
gerilim tipi baþaðrýsýnda etkili olmasý beklenmez.</span><span
style='font-family:"Times","serif";mso-ansi-language:TR'> </span><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migrenli hastalarýn
yaklaþýk yarýsýnda fiziksel aktivite baþaðrýsýný tetiklemektedir. Stresin
migren ataklarýný tetiklediðini bildiren yayýnlar olmasýna karþýn, bazý
çalýþmalar stresin gerilim tipi baþaðrýsýnda migrenden daha etkili olduðunu
göstermektedir. <o:p></o:p></span></p>

<p class=ColorfulList-Accent11CxSpLast style='margin-left:0cm;mso-add-space:
auto;text-align:justify'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýsýný&nbsp;<i
style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:bold'>iyileþtiren
nedenler</span></i>&nbsp;içinde uyumak, karanlýk ve sessiz ortam migren için
çoðu kez iyileþtirici bir role sahiptir. Küme baþaðrýsýnda yüksek yoðunluklu oksijen
soluma (15 lt/dakika) saniyeler veya dakikalar içinde aðrýyý geçirebilir. Baþa
soðuk uygulamak yine migren için iyileþtirici bir uygulama olabilir. Gebelik ve
menopoz dönemleri de migrenli kadýnlarda rahatlama dönemleri olarak
hatýrlanabilir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>5. Baþaðrýsýnýn sýklýðý ve süresi</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;tanýda önemli
ipuçlarý verir ve tedavimizi yönlendirir. Sekonder nedenlerle ortaya çýkan
baþaðrýsý genelde özel bir patern göstermez, sýklýðý ve þiddeti progresiftir.
Primer baþaðrýlarýnda aðrý sýklýðý kritik öneme sahiptir. Migren ataklarý belli
bir düzende gelir, genelde ayda 2-8 kez olur. Bir gün içinde birden fazla atak
alýþýlmýþ deðildir. Eðer ilaç aþýrý kullanýmý söz konusu deðilse, günlük veya
gün aþýrý migren ataðý (<span style='mso-bidi-font-style:italic'>kronik migren</span>)
oldukça seyrek karþýlaþýlan bir durumdur. Migren ataðýnýn analjezik ilaç
kullanýlmadýðýnda 4 saat ile 3 gün arasý bir süre devam etmesi beklenir. Yetmiþ
iki saatten uzun sürmesi durumunda, <i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-style:italic'>migren statusu</span></i>&nbsp;terimi
kullanýlýr. Oysa epizodik gerilim tipi baþaðrýlarýnda bir ritim söz konusu deðildir
ve atak süreleri dakikalardan günlere hatta haftalara dek oldukça deðiþkendir,
bir gün içinde birkaç kez de ortaya çýkabilir. Otonomik sefalaljiler süre
konusunda daha tutarlý bir gruptur. Bunlar içinde en uzun süreli ve görece en
seyrek olaný küme baþaðrýsýdýr. Küme baþaðrýsý çoðunlukla 15 dakika ile 3 saat
arasý bir süreye sahiptir, bununla birlikte daha uzun sürmesi de tanýyý
dýþlamaz. Ýlk baþlangýç günleri ve sonlanýþ günleri dýþýnda, sýklýðý iki günde
birden günde 8e dek deðiþir. Paroksizmal hemikranya ise daha kýsa süreli (2-30
dakika) ve gün içinde çok daha fazla sayýda gelmesi ile (günde 10dan fazla)
küme baþaðrýsýndan ayrýlabilir. Otonomik sefalaljiler içinde en kýsa süreli
olaný ise SUNCT ve SUNA olup süre 1-600 saniye arasýnda deðiþir ve günde
yüzlerce kez&nbsp;bile olabilir. Nevraljik aðrýlar bundan da daha kýsa
sürelidir (saniyelik), seyrek veya gün içinde çok sayýda olabilir. Hemikranya
kontinuada ise aðrýnýn hiç kesilmeden aylardýr sürüyor olmasý ve arada migrenöz
þiddetlenmeler kuraldýr.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>6. Baþaðrýsýna eþlik edenler</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;de taný için ipuçlarý
vermektedir. Migrende gastrointestinal <span class=GramE>semptomlar</span>
olarak bulantý ve kusma görülür. Ayrýca dizziness, fotofobi, fonofobi,
tinnitus ve bulanýk görme eþlik edebilir, hastalarýn yaklaþýk %10unda pitozis,
hafif göz yaþarmasý, göz kanlanmasý gibi otonomik bulgular bulunabilir. Küme
tipi baþaðrýsýnda ve diðer otonomik sefalaljilerde ise göz yaþarmasý, yüz
kýzarmasý, burun týkanýklýðý veya akýntýsý gibi çeþitli otonomik belirtiler ve
parsiyel Horner Sendromu tek yanlý ve belirgin olarak görülür ve taný <span
class=GramE>kriterleri</span> için de bu bulgularýn eþlik etmesi
gereklidir.&nbsp;Kronik gerilim tipi baþaðrýsýnda ise genellikle hastanýn
elinde somatik, emosyonel ve fizik <span class=GramE>semptomlarý</span>
gösteren uzun bir liste vardýr. Gerilim tipi baþaðrýsýna hemen hiç birþey eþlik
etmez.&nbsp;<i style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:
bold'>Aura</span></i>&nbsp;varlýðýnda artýk baþaðrýsýnýn özellikleri önem
taþýmaz, hatta aurayý baþaðrýsý izlemeyebilir (aðrýsýz aura). Auralý
migrenlilerin týkayýcý damar hastalýklarý yönünden artmýþ bir riske sahip
olduklarý ve özellikle sigara veya östrojen kullanýmýnýn bu riski genel topluma
göre daha da arttýrdýðý bilinmeli ve hastalar bu konuda uyarýlmalýdýr. Ayrýca,
hemipleji ve beyinsapý bulgularý þeklinde aura varlýðýnda triptanlarýn
kullanýlmasýnýn sakýncalý olabileceði unutulmamalýdýr. Migrenlilerin %70inde
ve daha nadiren diðer baþaðrýlý olgularda <i style='mso-bidi-font-style:normal'>allodini</i>
saptanýr. Bu durum aðrý uyandýrmasý beklenmeyen dokunma, saç tarama, gözlük
takma gibi normal bir uyaran ile aðrý ve aþýrý duyarlýlýk hissedilmesi olarak
tanýmlanýr. Patofizyolojisinde santral duyarlýlaþma rol oynamaktadýr. Bu
bulgunun varlýðý triptan grubu ilaçlara yanýtsýzlýk ve kronik migrene dönüþüm
açýsýndan önem taþýmaktadýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sekonder
baþaðrýsý bozukluklarýna sýklýkla çift görme, epileptik nöbetler, tinnitus ve
fokal nörolojik bulgu gibi özellikler eþlik eder. Sekonder baþaðrýlarýnda,
lezyonun yerleþimine göre sýklýkla nörolojik bulgular mevcuttur. Kafaiçi
kitleleri hastalarýn yarýsýnda bulantý ile veya bulantýsýz (projektil) kusma
ile birlikte görülür. Temporal arterit kafa derisinde sýnýrlý bir hassasiyet,
halsizlik, polimiyaljia romatika, subfebril ateþ veya baþka bir sistemik
belirti ile ya da görme kaybý veya inme ile iliþkili olabilir. Eðer mevcutsa
çene klodikasyosu temporal arterit için patognomoniktir. Ateþ ve ense sertliði
menenjite iþaret eder.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>7. Emosyon ve sosyal faktörler:</span></b><b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Öykü alýnýrken hastaya
aile, evlilik ve iþ iliþkileri sorulmalý ve stres faktörleri varsa ortaya
çýkarýlmalýdýr. Bu tür sorularýn sorulmasý için uygun ortam, zaman ve hastanýn
doktora güveni saðlanmalýdýr. Bu sýrada tedaviyi <span class=GramE>yönlendirebilecek<span
style='mso-spacerun:yes'>  </span>gebelik</span> isteði, kendini þiþman bulmasý
gibi bazý bilgiler de elde edilir. Ayrýca ÝAKB tedavisi gibi bazý durumlarda
hastanýn tedavisi sýrasýnda aile desteði almasý çok önemlidir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>8. Özgeçmiþ ve uyku paterni:</span></b><b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Hekim hastanýn geçirmiþ
olduðu tüm medikal ve cerrahi hastalýklarý ve durumlarý (doðum, menopoz gibi)
ve varsa kafa <span class=GramE>travmasýný</span> bilmelidir. Herhangi yeni bir
hastalýk veya tedavi baþaðrýsýnýn nedeni olabilir, ya da tedavi stratejisinde
önem taþýr. Hastaya önceden lomber ponksiyon ya da beyin cerrahisi giriþimi
yapýldýysa bilinmesi, intrakranyal hipotansiyona baðlý postüral baþaðrýlarýný
deðerlendirmek için önem taþýr. Bazý <span class=GramE>spesifik</span> allerjik
etkenler veya yiyecekler baþaðrýsýna sebep olabilir. Glokom, yeni saptanan
hipertansiyon, diyaliz, hipotirodi, sinüzit gibi hastalýklar ve yeni baþlanmýþ
oral kontraseptif <span class=GramE>dahil</span> tüm tedaviler&nbsp;mutlaka
bilinmelidir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Kronik
baþaðrýlý hastanýn özgeçmiþindeki baþarýlý ve baþarýsýz tedaviler baþaðrýsý
tanýsýnýn ortaya konulmasýna ve uygun tedavi seçimine yardýmcý olur. Hastanýn
daha önce denediði ve yan etki görmeyip fayda gördüðü tedavinin devamý genelde
doðru bir yaklaþýmdýr. Ayrýca baþaðrýsý ile eþ zamanlý baþlanmýþ herhangi bir
ilacýn baþaðrýsýný tetiklemiþ olma olasýlýðý mutlaka akýlda tutulmalýdýr.
Nitratlar, amantadin, sildenafil, dipridamol, simetidin, reserpin, indometazin,
hormonal tedaviler, bazý antibiyotikler baþta olmak üzere çeþitli ilaçlar
baþaðrýsýný baþlatabilir. Kadýnlarda oral kontraseptif kullanýmý veya
postmenopozal hormon tedavisi aðrýnýn þiddetini, sýklýðýný, süresini
deðiþtirebilir ve <span class=GramE>komplikasyonlarýný</span> arttýrabilir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Küme
tipi baþaðrýsý sýk olarak,&nbsp;<span style='mso-bidi-font-style:italic'>hipnik
baþaðrýsý</span>&nbsp;ise tipik olarak her gece ayný zamanda uyandýrýr.
Migrenlilerde baþaðrýsý genellikle uyanýkken baþlar, migren aðrýsý genelde uyku
ile düzelme eðilimindedir, ancak uzun ataklarda ertesi sabah da aðrý devam
edebilir. Kronik gerilim tipi baþaðrýsý olan hasta sýk sýk ve erken uyanýr.
Uyku bozukluðu ayný zamanda bir depresyon belirtisi olabilir.&nbsp;<span
style='mso-bidi-font-style:italic'>Depresyon</span>&nbsp;uykuya dalmada güçlük,
uykuyu sürdürmede güçlük veya sabah erken uyanma ile gidebilir. Anksiyete ile
iliþkili baþaðrýsýnda hasta uykuya dalmakta zorluk çeker. Hipertansiyon aðrýsý
uyanýrken olur ve gün ilerledikçe azalýr.&nbsp;<span style='mso-bidi-font-style:
italic'>Uyku apnesi</span>&nbsp;sýk rastlanan bir durumdur, özellikle kilolu
kiþilerde sabah baþaðrýlarýna yol açabilir. Bu açýdan hastalar sorgulanmalý,
kuþkulu durumlarda da polisomnografi incelemesi yapýlmalýdýr. Uyku sorunlarý
ayrýca profilatik tedavide ilaç seçiminde de önem taþýr.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><i><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></i><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>9. Aile öyküsü:</span></b><b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migren kalýtsal bir
hastalýktýr ve ailede genelde migrenli baþka hastalar vardýr. Özellikle auralý
migren olgularýnda bu yatkýnlýk daha belirgindir, genetik kökeni ortaya ilk
konan ciddi bir auralý migren formu olan&nbsp;<i style='mso-bidi-font-style:
normal'><span style='mso-bidi-font-weight:bold'>ailesel hemiplejik migrende</span></i>&nbsp;ailede
etkilenmiþ bir baþka bireyin varlýðý taný için gereklidir. Eðer aile öyküsü
yoksa ayný tablo <i style='mso-bidi-font-style:normal'>sporadik hemiplejik
migren</i> olarak adlandýrýlýr. Küme tipi baþaðrýsýnda aile öyküsü nadirdir.
Kronik gerilim tipi baþaðrýsýnda ise ailede depresyon öyküsü bildirilmiþtir.
Ailesel baþaðrýlarýnda ortak çevresel faktörler de rol oynayabilir, bütün
ailede karbon monoksit ile iliþkili baþaðrýsýna yol açabilir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<b>&nbsp;</b></span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýlý
Hastanýn Muayenesi</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýlý
hastanýn muayenesinde ayrýntýlý fizik muayene ve nörolojik muayene yapýlmasý
temeldir. Baþaðrýsý ile baþvuran hastada öncelikle vital bulgular
deðerlendirilmelidir. Hipertansiyona baðlý baþaðrýsýnda diastolik&nbsp; basýnç
110 mmHg ve üstüdür. Hipertansiyon tedavi ile kontrol altýna alýnýnca baþaðrýsý
da genellikle takip eden günler içinde düzelir. Baþaðrýsý hipertansiyon veya
hipertansiyon nedeniyle kullanýlan ilaçlarýn yan etkisi olarak ortaya
çýkabileceði gibi, migren gibi baþaðrýlý durumlarýn atak sýrasýnda kan
basýncýnda sýklýkla geçici yükselmeye yol açabileceði de akýlda tutulmalýdýr.
Ateþ varlýðý sistemik bir infeksiyonu, ense sertliðinin olmasý menenjit
tanýsýný düþündürür. </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>Baþaðrýsýndan yakýnan bir hastada, baþ ve boyun bölgesinin
muayenesi öncelikli olarak yapýlmalýdýr. </span><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Temporal arterlerde belirginleþme,
boðumlanma, geniþleme ve hassasiyet bulunmasý, klinik uyumluysa temporal
arteriti düþündürmelidir, ancak bu bulgular akut migren ataðýna da eþlik
edebilir. Bazý hastalarda göz bulgularý da eþlik eder. Örneðin küme tipi
baþaðrýsý için karakteristik özellikler; konjunktival kýzarýklýk, tek taraflý
pitoz, kýsmi Horner <span class=GramE>sendromu</span> gibi bulgulardýr. Ayrýca
baþaðrýlý olguda göz çevresinde aðrý da eþlik ediyorsa glokomu dýþlamak gereklidir.
Kafaiçi basýnç artýþýnda ise göz dibinde papilödem saptanýr.&nbsp;<span
style='mso-bidi-font-style:italic'>Bu nedenle baþaðrýsý olan bir hastanýn göz
dibi bakýlmadan muayenesi tamamlanmýþ kabul edilmemelidir. Yüz bölgesinde </span>tetik
nokta varlýðý trigeminal nevralji için karakteristiktir, SUNCT gibi bazý otonom
sefalaljilerde de görülebilir. <span style='mso-bidi-font-style:italic'>Bunun
yanýsýra kulak-burun-boðaz infeksiyonlarýný dýþlamak için bu bölgelerin
ayrýntýlý muayenesi yapýlmalý; boyun bölgesinin muayenesinde h</span>areket
kýsýtlýlýðý, spazm ve gerginlik deðerlendirilmelidir. Ayrýca temporomandibüler
eklemler hassasiyet, hareket kýsýtlýlýðý, asimetri ve týkýrdama açýsýndan
incelenmelidir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýsýnda
Yardýmcý Taný Yöntemleri</span></b><span style='font-size:13.5pt;font-family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>1. Radyolojik incelemeler</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Akut
sinüzit varlýðýnda sinüs grafileri anlamlýdýr, kronik sinüzitin baþaðrýsý
nedeni olmadýðý bilinmelidir. Artýk çok seyrek kullanýlan diðer direkt filmler;
fraktürleri, ayrýk sütürleri, pineal gland itilmesini, dövme bakýr görünümü ile
kafaiçi basýnç artýþýný gösterebilir; intrakranyal kalsifikasyonlar, sella
büyüklüðü ve erozyonlarý konusunda bilgi verir. Ayrýca litik lezyonlar ile
hiperosteozis ve metastazlarý gösterebilir. Baziler invajinasyon konusunda
yardýmcý olur.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bilgisayarlý
<span class=GramE>tomografi</span> (BT) ve manyetik rezonans görüntüleme (MRG)
daha önce belirtilmiþ olan sekonder baþaðrýsý kuþkusu olan durumlarda istenir,
primer baþaðrýlarýnda gerekli deðildir. BT akut baþaðrýsýnda en kolay, hýzlý ve
en çok kullanýlan yöntemdir. Ayrýca, BT kronik baþaðrýsýnda, subakut/kronik
subdural hematom ve hidrosefaliyi dýþlamak&nbsp;konusunda yardýmcý olur, beyin
ödemini gösterebilir. Diðer yandan öykü ve&nbsp;muayene KÝBAS düþündürüyorsa,
lomber ponksiyon (LP) yapýlmadan önce kitle etkisinin dýþlanmasý amacýyla, kafa
<span class=GramE>travmasý</span> söz konusuyla ve açýk-kapalý kýrýklar varsa
hýzla BT yapýlmasý uygun olabilir. MRG günümüzde birçok açýdan BT incelemesinin
önüne geçmiþtir. MRG çeþitli sekanslarda farklý deðerlendirmelere olanak
saðlayarak baþlýca demiyelinizan lezyonlar, primer maligniteler ya da metastazlar,
özellikle arka çukur tümörleri ve inmeleri BTye kýyasla daha iyi gösterir.</span><span
style='font-size:7.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>2. Lomber ponksiyon,</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;kafaiçi&nbsp;
infeksiyon ve SAK tanýlarýný koymak amacýyla klinik þüphe varsa ense sertliði
ve ateþ mevcudiyetinde yapýlmalýdýr. Post-LP baþaðrýsý riski vardýr. Görece
yeni tanýmlanan bir tablo olan HaNDL (headache and neurological deficits with
cerebrospinal fluid lymphocytosis) <span class=GramE>sendromunda</span> da
baþaðrýsý ile birlikte geçici nörolojik defisitleri olan hastalarda LP
lenfositozu göstermek ve tanýyý desteklemek amacýyla yapýlýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>3. Diðer taný testleri: </span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kan sayýmý, sedimentasyon
hýzý, elektrokardiyografi, tiroid fonksiyon testleri, B12 düzeyi gibi rutin
biyokimya araþtýrmalarý baþaðrýsýnýn sekonder nedenlerini ve hastanýn genel
durumunu araþtýrmak için yapýlmalýdýr.&nbsp;Elektroensefalografiye baþaðrýsýnda
çok baþvurulmaz. Eðer baþaðrýsý epileptik ataklarla birlikte ise yapýlabilir.
Pozitron <span class=GramE>emisyon</span> tomografisi, fonksiyonel MRG gibi
çalýþmalar ise migrenin patofizyolojisini açýklama yönünden araþtýrmalarda
kullanýlan yöntemlerdir. Transkranyal magnetik stimülasyon ve diðer
elektrofizyolojik yöntemler de araþtýrma amaçlý uygulanmaktadýr.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýsýnýn
þiddetinin ortaya konmasýnda daha net bir yaklaþýmýn kullanýlmasý yararlýdýr ve
kiþinin kendi kendine doldurduðu <i style='mso-bidi-font-style:normal'>Migren
Kýsýtlýlýðý Deðerlendirme (MIDAS) Sorgulama Formu</i> Türkçeye adapte
edilmiþtir. Bu formla kiþinin günlük yaþamýnda kaybettiði gün sayýsý (iþe/okula
gitmediði günler ve yüksek oranda kýsýtlanmanýn yaþandýðý günler)
ölçülmektedir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baþaðrýlý
bir hastanýn takibinde&nbsp;<i>baþaðrýsý günlüðü</i>&nbsp;kullanýlmasý çok
önemlidir, bu günlükten tedavi sürecinin objektif olarak izlenmesinin dýþýnda
taný için de önemli ipuçlarý ve tetikleyici faktörlerin saptanmasý saðlanabilir
(Þekil 2). Hastaya bir baþaðrýsý günlüðü verilerek atak sayýsý, süresi,
kullanýlan ilaç ve aðrýnýn tedaviye cevap verip vermediðinin yazýlmasý ve
þiddeti hafif, orta, þiddetli þeklinde kaydetmesi istenir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
35.4pt;line-height:16.3pt'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
35.4pt;line-height:16.3pt'><b><u><span style='font-size:10.0pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:blue;
mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi2.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>Þekil 2</span><span
style='mso-bidi-font-size:11.0pt;color:purple;font-weight:normal'>.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Örnek bir baþaðrýsý günlüðü</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><b><span
style='font-size:14.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>SIK RASTLANAN PRÝMER
BAÞAÐRILARI</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>MÝGREN</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren,
tüm baþaðrýsý tipleri içinde doktora en fazla baþvuru nedeni olan durumdur. Migren
tanýsý için özel bir laboratuvar testi veya radyolojik inceleme yoktur.
Ýnsanlýk tarihi kadar eski bir hastalýk olan migren toplum için oldukça önemli
bir saðlýk sorunudur, Dünya Saðlýk Örgütü tarafýndan en çok kýsýtlýlýk yapan
hastalýklar arasýnda ele alýnmýþtýr. Kadýnlarýn yaklaþýk %20'sinin, erkeklerin
ise %8'inin migrenli olduðu bilinmektedir. Atak sýrasýndaki olumsuz etkileri
dýþýnda okul ve iþ performansýnda düþme ve sosyal problemler gibi kronik
etkileri vardýr.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Karakteristik
özellikleri tekrarlayýcý olmasý, ataðýn ilaçsýz olarak 4 saatten fazla sürmesi
(ve 3 günden az), tek yanlý oluþu (%80 hastada), zonklayýcý olmasý, atak
sýrasýnda sýklýkla ýþýktan ve sesten rahatsýzlýk, merdiven çýkma gibi fiziksel
eylemlerle aðrýda artýþ, aðrýya sýklýkla bulantý veya kusmanýn eþlik etmesi,
aðrýnýn orta þiddette veya þiddetli olmasýdýr. Migren çoðu kez öncesinde bir
nörolojik defisit olmaksýzýn ortaya çýkarken <i style='mso-bidi-font-style:
normal'>(<span style='mso-bidi-font-weight:bold'>aurasýz migren</span>)</i>,
migrenli hastalarýn %1015 kadarýnda aðrýlarýn hemen öncesinde 560 dakika arasý
süren, geçici nörolojik belirtiler görülebilir <i style='mso-bidi-font-style:
normal'>(<span style='mso-bidi-font-weight:bold'>auralý migren</span>)</i>. En
sýk görsel (hemianopsi, beyaz ýþýklar ya da kýrýk çizgiler görme gibi) veya
dilde, yüzde, kolda uyuþma, güçsüzlük, konuþmada bozulma gibi bulgularýn
birkaçý veya vertigo gibi diðer arka sistem bulgularý, hatta uyanýklýk kusuru
þeklinde&nbsp;<span style='mso-bidi-font-weight:bold'>aura</span>&nbsp;olabilir.
Hemen ardýndan veya 1 saat içinde aðrý ortaya çýkabilir ya da nadiren aurayý
baþaðrýsý izlemeyebilir. Migren ataklarý çoklukla epizodik ataklar þeklinde
gelirken, en az 3 aydýr her gün veya günaþýrý olacak þekilde kronikleþmiþ
olarak da görülebilir. Bu durumda ayýrýcý tanýda ÝAKB de düþünülmelidir. Böyle
bir durumda aðrý kesicilere en az 2 ay gibi bir süre ara verilmeden aðrýlarýn
kontrolü mümkün deðildir ve aðrý kesiciler aþýrý kullanýldýðý sürede yapýlan
profilaktik tedavi çabalarý da çoðu kez baþarýsýzlýkla sonuçlanýr.&nbsp;<b>Tablo
3</b>te IHS sýnýflamasýndaki ilgili bölümler özetlenmiþtir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all style='mso-special-character:line-break'>
</span></b><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;mso-outline-level:1'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-font-kerning:18.0pt;
mso-ansi-language:TR'>Tablo 3.&nbsp;</span></b><span style='font-size:12.0pt;
font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Uluslararasý Baþaðrýsý
Derneði: Migren Kriterleri (2018)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 36.0pt'><span style='font-size:12.0pt;line-height:115%;mso-ansi-language:
TR'><span style='mso-tab-count:2'>            </span><o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l8 level2 lfo5;
tab-stops:18.0pt 40.5pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Aurasýz Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 81.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Taným: 4-72 saat süren ataklarla
kendini gösteren tekrarlayan baþaðrýsý. Baþaðrýsýnýn tipik özellikleri: Tek
taraflý zonklayýcý tarzda, orta þiddetli veya þiddetli olmasý, rutin fiziksel
aktiviteyle kötüleþme ve mide bulantýsý ve/veya fotofobi ve fonofobinin eþlik
etmesidir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 81.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 81.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tanýsal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>A.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>B-D <span class=GramE>kriterlerine</span>
uyan en az 5 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>B.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>4-72 saat arasý süren baþaðrýsý
ataklarý (tedavi edilmeden ya da tedavisi baþarýsýz olan)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt 36.0pt 81.0pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Baþaðrýsý aþaðýdakilerden en az iki özelliði taþýmalýdýr:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Tek taraflý yerleþim<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Zonklayýcý karakter<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Orta þiddetli ya da þiddetli aðrý <o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Rutin fiziksel aktiviteyle kötüleþme ya da rutin fiziksel
aktiviteden kaçýnmaya neden olma (örneðin: yürüme ya da merdiven çýkma)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt 36.0pt 81.0pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>D.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Baþaðrýsý sýrasýnda aþaðýdakilerden en az biri görülür:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -18.0pt -13.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Mide bulantýsý ve/veya kusma<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -18.0pt -13.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Fotofobi ve fonofobi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>E.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Sýnýflamada yer alan baþka bir baþaðrýsý tanýsý ile açýklanamamaktadýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span style='font-size:12.0pt;
background:yellow;mso-highlight:yellow;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l8 level2 lfo5;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-family:
Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>1.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span></b><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-ansi-language:
TR'>Auralý Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Taným: Tam düzelen tek yanlý,
görsel, duysal veya merkezi sinir sistemi ile iliþkili diðer belirtilerle kendini
gösteren, genellikle basamaksý þekilde geliþen dakikalar süren yineleyici
ataklar. Aura <span class=GramE>semptomlarýný</span> sýklýkla baþaðrýsý ve
migrenle iliþkili belirtiler izler. <o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-top:0cm;margin-right:0cm;margin-bottom:
0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:
0cm;line-height:normal;mso-list:l8 level3 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 49.5pt'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-family:
Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>1.2.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span></b><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-ansi-language:
TR'>Tipik Auralý Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tanýsal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l16 level1 lfo9;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l16 level1 lfo9;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'>. Tam düzelen aþaðýdaki aura semptomlarýndan en az biri görülür:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l3 level1 lfo10;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Görsel<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l3 level1 lfo10;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 36.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Duysal<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l3 level1 lfo10;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 36.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Konuþma ve/veya lisan bozukluðu<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:2'>           </span>ii.
Motor, beyinsapý ve retinal <span class=GramE>semptomlar</span> görülmez<o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l16 level1 lfo9;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aþaðýdaki özelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:67.5pt;margin-bottom:.0001pt;text-indent:-13.5pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>1. 5 dakika ya da daha uzun sürede basamaksý ilerleme
gösteren en az bir aura semptomu, ve/veya birbirini izleyen 2 veya daha fazla <span
class=GramE>semptom</span> görülür<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Her bir aura <span class=GramE>semptomu</span> 5 dakikadan uzun ve 60
dakikadan kýsa sürer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>En az bir aura <span class=GramE>semptomu</span> tek taraflýdýr<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aura sýrasýnda veya sonrasýndaki 60 dakika içinde baþaðrýsý baþlar<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>D. Sýnýflamada yer alan baþka bir
baþaðrýsý tanýsý ile açýklanamamaktadýr<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 36.0pt 40.5pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.2. Beyinsapý
Auralý Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 36.0pt 40.5pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>Daha önce kullanýlmýþ terimler: Baziler arter
migreni, baziler migren, baziler tip migren.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tanýsal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l17 level1 lfo11;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l17 level1 lfo11;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'>. Tam düzelen aþaðýdaki beyinsapý semptomlarýndan en az ikisi görülür:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:54.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1. Dizartri<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:54.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2. Vertigo<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Tinnitus<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hipoakuzi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Diplopi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Duysal defisitle iliþkilendirilmeyen ataksi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Uyanýklýk düzeyinde azalma (GKS </span><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'>&#8804;</span><span
style='font-size:12.0pt;mso-ansi-language:TR'>13)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:2'>           </span>ii.
Motor ve retinal <span class=GramE>semptomlar</span> görülmez<o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l17 level1 lfo11;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aþaðýdaki özelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>1. 5 dakika ya da daha uzun sürede basamaksý
ilerleme gösteren en az bir aura semptomu, ve/veya birbirini izleyen 2 veya
daha fazla <span class=GramE>semptom</span> görülür<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l7 level1 lfo12;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Her bir aura <span class=GramE>semptomu</span> 5 dakikadan uzun ve 60
dakikadan kýsa sürer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l7 level1 lfo12;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>En az bir aura <span class=GramE>semptomu</span> tek taraflýdýr<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l7 level1 lfo12;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Aura sýrasýnda veya sonrasýndaki 60 dakika içinde
baþaðrýsý baþlar<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>D. Sýnýflamada yer alan baþka bir
baþaðrýsý tanýsý ile açýklanamamaktadýr<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 36.0pt 40.5pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.3. Hemiplejik
Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tanýsal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l10 level1 lfo13;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l10 level1 lfo13;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'>. Tam düzelen motor güçsüzlük görülür<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:63.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-31.5pt;line-height:normal;mso-list:l9 level1 lfo14;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 36.0pt 45.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>ii.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Tam düzelen görsel, duysal bulgular ve/veya konuþma/lisan bozukluðu görülür<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>C.
Aþaðýdaki özelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:67.5pt;margin-bottom:.0001pt;text-indent:-13.5pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>1. 5 dakika ya da daha uzun sürede basamaksý
ilerleme gösteren en az bir aura semptomu, ve/veya birbirini izleyen 2 veya
daha fazla <span class=GramE>semptom</span> görülür<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Her bir aura <span class=GramE>semptomu</span> 5 dakikadan uzun ve 60
dakikadan kýsa sürer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>En az bir aura <span class=GramE>semptomu</span> tek taraflýdýr.<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aura sýrasýnda veya sonrasýndaki 60 dakika içinde baþaðrýsý baþlar<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 40.5pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>      </span>D.
Sýnýflamada yer alan baþka bir baþaðrýsý tanýsý ile açýklanamamaktadýr<s><o:p></o:p></s></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1.2.4. Retinal Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tanýsal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l21 level1 lfo15;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l21 level1 lfo15;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:1'> </span>. Tam düzelen mono-oküler, pozitif
ve/veya negatif görsel belirtiler (sintilasyonlar, skotom veya körlük), atak
sýrasýnda aþaðýdakilerden en az biri ile doðrulanmýþ olmalý:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l15 level1 lfo16;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Klinik görme alaný muayenesi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l15 level1 lfo16;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hastanýn çizerek ifade ettiði mono-oküler görme alaný bozukluðu<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 67.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:2'>           </span>ii.
Aþaðýdaki özelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l25 level1 lfo17;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>5 dakika ya da daha uzun sürede basamaksý ilerleme görülür<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l25 level1 lfo17;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Semptomlar 5 dakikadan uzun ve 60 dakikadan kýsa sürer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l25 level1 lfo17;tab-stops:
-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aura sýrasýnda veya sonrasýndaki 60 dakika içinde baþaðrýsý baþlar<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:31.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l21 level1 lfo15;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 40.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Sýnýflamada yer alan baþka bir baþaðrýsý tanýsý ile açýklanamamaktadýr ve
diðer amarozis fugaks nedenleri dýþlanmýþtýr<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1.3. Kronik Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Taným: Üç aydan daha fazla süre
boyunca ve ayda 15 veya daha çok gün olan; ayda en az 8 gün migren
özelliklerini taþýyan baþaðrýsý.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tanýsal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l1 level1 lfo18;
tab-stops:18.0pt 31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>A.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Migren veya gerilim tipi
baþaðrýsý benzeri, 3 aydan uzun süre boyunca ayda 15 veya daha çok gün olan, B
ve C <span class=GramE>kriterlerine</span> uyan baþaðrýsý<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l1 level1 lfo18;
tab-stops:18.0pt 31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>B.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Aurasýz migren <span class=GramE>kriterlerine</span>
uyan en az 5 veya auralý migren kriterlerine uyan en az 2 atak geçirmiþ hastada
geliþmesi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l1 level1 lfo18;
tab-stops:18.0pt 31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>C.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>3 aydan uzun süreyle, ayda en az
8 gün aþaðýdaki özelliklerden herhangi birine uymasý:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo19;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aurasýz migren <span class=GramE>kriterleri</span><o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo19;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Auralý migren <span class=GramE>kriterleri</span><o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo19;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hasta tarafýndan baþlangýçta migren olduðunun düþünülmesi ve triptan veya
ergot türevleri ile iyileþmesi<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;mso-list:l1 level1 lfo18;
tab-stops:31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>D.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>Sýnýflamada yer
alan baþka bir baþaðrýsý tanýsý ile açýklanamamaktadýr<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
54.0pt'><span style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenden
söz edildiði zaman çoðunlukla baþaðrýsý sadece þiddetli aðrý boyutu ile
deðerlendirilmektedir. Oysa aðrý, migrenin sadece bir dönemi olup,&nbsp;<span
style='mso-bidi-font-style:italic'>migreni serebral disfonksiyona baðlý olarak
þekillenen ve farklý dönemler içinde ortaya çýkan bir <span class=GramE>semptomlar</span>
kompleksi olarak ele almak daha uygundur</span>. Migrenin bu dönemlerini, aðrý
öncesinde ortaya çýkan ve kiþinin duygu durumunda veya kognitif iþlevlerinde
deðiþikliklerle þekillenen, kimi zaman da otonom ve sistemik belirtilerinin
eþlik ettiði&nbsp;<span style='mso-bidi-font-weight:bold'>premonitör <span
class=GramE>semptomlarý</span> içeren <i style='mso-bidi-font-style:normal'>prodrom
dönemi</i></span>, varsa <i style='mso-bidi-font-style:normal'>aura dönemi</i>,
ardýndan aðrýnýn baþlamasý, aðrýnýn yaþandýðý dönem ve aðrýnýn sonlanmasý ile
þekillenen <i style='mso-bidi-font-style:normal'>aðrý dönemi</i> ve son
olarak da&nbsp;<i style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:
bold'>postdrom</span>&nbsp;dönemi</i> olarak sýralayabiliriz (<b>Tablo 4</b>).
Hastadan iyi bir öykü alýndýðýnda migrenlilerin yaklaþýk %50-60ýnda prodrom
belirtilerinin bir ya da daha fazlasýyla karþýlaþýldýðý görülecektir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
4. </span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenin
Prodrom Döneminde Rastlanabilen Semptomlar</span><span style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;padding:
  0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nöropsikolojik
  <span class=GramE>semptomlar</span></span></b><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;height:84.5pt'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt;height:84.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Aþýrý
  duyarlýlýk-tepkisellik, depresif duygu durumu</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Öfori,
  nadiren hiperaktive</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Durgunluk/donukluk,
  <span class=GramE>konsantrasyon</span> ve dikkatte azalma, düþüncede
  yavaþlama</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Kelime bulma
  güçlüðü, konuþurken takýlma</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Artmýþ ýþýk,
  ses, koku duyarlýlýðý</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Esneme, uyuma
  isteði</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sistemik/otonom
  <span class=GramE>semptomlar</span></span></b><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes;height:70.25pt'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt;height:70.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ense sertliði</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Halsizlik</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Açlýk, tatlý yeme
  isteði, iþtah artýþý veya iþtahsýzlýk</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Aþýrý su
  içme, vücutta su tutulmasý, sýk idrara çýkma</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Karýnda
  þiþlik hissi, kabýzlýk veya ishal hali<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Göz yaþarmasý</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
Patofizyolojisi <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-weight:bold'>Migren patofizyolojisi</span><span style='font-size:
10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>&nbsp;genellikle santral serotoninerjik ve
adrenerjik aðrý <span class=GramE>modüle</span> eden sistemleri içine alan
nörovasküler teoriye göre açýklanmaya çalýþýlýr. Nörojenik inflamasyonun migren
aðrýsýndan sorumlu olduðu ve trigeminovasküler sistemin aktive olduðu
düþünülmektedir. Eskiden patofizyolojik açýklama olarak vasküler baþaðrýsýnýn
damarlarýn dilatasyonu ile ortaya çýktýðý düþünülüyordu. Wolfun ilk
çalýþmalarý aðrýya duyarlý intrakranyal yapýlarý göstermiþtir.&nbsp; Bu yapýlar
venöz sinusler, dural, meningeal ve diðer arter ve venler, Willis polligonu
yapan büyük arterlerin proksimal kýsýmlarý, 5<span class=GramE>.,</span> 7., 9.
ve 10. kranyal sinirler ve üst servikal sinirlerin aðrýya duyarlý lifleri, kafa
tabanýndaki dura-materin damarlara komþu parçalarý, paranazal sinus mukozalarý,
diþler, kaslar, deri ve deri altý dokusudur. Beyin parankiminin aðrýya duyarlý
olmadýðý, cerrahlarýn yaptýðý araþtýrmalar sonucunda bildirilmiþtir.
Hipotalamusun oreksin sisteminin migren ve küme baþaðrýsýndaki otonom
belirtilerin geliþmesinde potansiyel rolü üzerinde de durulmaktadýr. Premonitor
döneme iliþkin PET çalýþmalarý bu fazda, limbik sistemle merkezi iliþkisi
bilinen posterior ve lateral hipotalamus ile komþu mezensefalonun ventral
tegmentum bölgesinde aktivasyon göstermiþtir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;line-height:normal'><b><u><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi3.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>Þekil 3.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;Baþaðrýsý
patofizyolojisinde önem taþýyan yapýlar þekilde gösterilmiþtir. Korteks,
talamus (Tal), hipotalamus (Ht), limbik sistem ve periakuaduktal gri madde
(PAG) baþta olmak üzere beyinsapý yapýlarý arasýnda yoðun baðlantýlar
bulunmaktadýr ve bu yapýlar trigeminoservikal <span class=GramE>kompleks</span>
ile baðlantýlýdýr.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
oluþumunda kortikal aktivite varlýðý bugün kabul gören bir görüþtür. Migrene
baðlý kan akýmý deðiþiklikleri ve fonksiyonel MRG sinyali <b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'>kortikal yayýlan depresyon</i></b>
olarak bilinen, Leao tarafýndan tanýmlanmýþ tabloyla benzer zamansal (26
mm/dakika hýzýyla yayýlma) ve yerleþimsel özellikler göstermektedir. Kortikal
yayýlan depresyon glial ve nöronal membranlarda aþýrý bir depolarizasyon ile
iyonik akýmlarýn bozulmasý, hücre dýþý potasyumun artmasý, glutamat salýnýmý ve
bunu izleyen geçici artýþý izleyen serebral kan akýmý azalmasý ile
karakterizedir. Kortikal yayýlan depresyonun auranýn altýnda yatan temel
mekanizma olduðu kanýtlanmýþtýr, ancak hala tam açýklýða kavuþmamýþ sorular
vardýr. Anahtar rolü olan glutamat salýnýmýnýn hücre içine Ca<sup>2+</sup>
giriþine neden olmasý voltaj kapýlý Ca<sup>2+</sup> kanallarý ile iliþkili
mutasyonlarýn rol oynadýðýný gösterirken, sinaptik aralýktan transporter
aracýlý taþýnma için ise sodyumpotasyum-ATPaz (Na+K+-ATPaz) pompasýnýn
devreye girdiði bilinmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenli
olgularda normallerle kýyaslandýðýnda transkranyal magnetik stimülasyonla
fosfen oluþma eþiðinin düþük veya deðiþken olmasý altta yatan bilinmeyen
yatkýnlýk faktörlerine iþaret etmektedir. Migren patofizyolojisinde beyinsapý
mekanizmalarýnýn da katkýsý olduðu kesindir. &nbsp;Bulantý, otonom <span
class=GramE>semptomlar</span> gibi eþlikçiler bu yapýlardaki deðiþik
sinyallerden kaynaklanmaktadýr. Dorsolateral pons ve mezensefalon, PET
çalýþmalarýnda aktivite görülen yapýlardýr ve periakuaduktal gri madde (PAG) de
önem taþýmaktadýr. </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Trigeminal
yolak ya da trigeminovasküler sistem burada tutulan ana yapýdýr. Kalsitonin
geni ile iliþkili peptid (CGRP) denen serebral otoregülasyonda önemli rolü olan
nöropeptidin migren ataðý sýrasýnda arttýðý ve bu sistemin aktivasyonunda rol
oynadýðýnýn gösterilmesi son yýllardaki önemli geliþmelerdendir ve erenumab,
fremanezumab gibi yeni tedavi stratejilerine yön vermiþtir. Periferik
trigeminal duysal yapýlardan ikincil nöronlara nosiseptif duysal iletim, baþta
CGRP olmak üzere pituiter adenilat siklaz aktivatör polipeptid-38 (PACAP-38),
glutamat ve nitrik oksid yoluyla olmaktadýr. Trigeminal nosiseptif nöronlarýn
dýþýnda astrositlerin etkisiz elemanlar olmayýp dalgalar yoluyla migren
mekanizmalarýnda katkýsý olduðu da bazý çalýþmalarda savunulmuþtur. Trigeminal
duysal nöronlarý etkileyenin, mekanik basýn ve iyonik deðiþimlerin (artmýþ K,
artmýþ osmolarite, azalmýþ pH gibi) yaný sýra substans P, bradikinin, endotelin
ve CGRP gibi peptidler ve glutamat, serotonin, histamin, ATP, adenozin gibi
nörotransmitterler olduðuna inanýlmaktadýr. CGRP düzeyi kronik migrenlilerde
ataklar arasýnda da yüksek olmaya devam etmektedir. Nitrik oksit vasküler
hücrelerden konstriksiyon sýrasýnda salýnan ve önemli rol oynayan maddelerden
biridir. Ýnen ve çýkan aðrý kontrol sistemleri, beyinsapý kan damarlarýný
inerve eden çýkan serotoninerjik sistemi (midbrain raphe) içerir ve talamusa,
hipotalamus ve kortekse doðru yayýlýr. Bu sistem hem uyku hem de nöroendokrin
kontrolü saðlar. Ýnen aðrýyý <span class=GramE>modüle</span> eden
serotoninerjik sistem, beyinsapýnýn PAG kýsmýndan baþlar, medullanýn rafe
magnusuna ulaþýr ve medulla spinalisin dorsal boynuzunda sonlanýr. PAGnýn
stimülasyonu insanda potent analjeziyi ortaya çýkarýr. Noradrenerjik aðrý
kontrol sistemi ponsun lokus seruleusundan kaynaklanýr. Ýnen nöronlar medulla
spinaliste sonlanýr. Çýkan noradrenerjik sistem, lokus seruleustan baþlar,
mikrosirkülasyonu inerve eder ve serebral kortekse yayýlýr. Merkezi sinir
sistemi periferik aðrý reseptörlerinden gelen aðrýyý <span class=GramE>modüle</span>
eden sistemler yoluyla gelen uyarýlarý kontrol eder. Serotoninerjik sistemde
5-HT (5-hidroksi triptamin) adrenerjik sistemde olduðu gibi, enkafalin
nöronlarýyla etkileþir. Norepinefrini, GABA içeren internöronlar kullanýlýr.
Primer duysal nöronlardan uyarýlar yalnýzca MSSne deðil perifere de gider.
Periferik trigeminal nöronlar da sensitizasyon <span class=GramE>fenomeni</span>
gösterirler, aljezik bir uyarana maruz kalýnca ayný veya farklý uyaran için
cevap eþiði düþmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><span
style='mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Çeþitli
yöntemlerle yapýlan elektrofizyolojik çalýþmalar, uyarýlmýþ potansiyellerin
kullanýldýðý araþtýrmalar migrende MSS uyarýlabilirliðinin arttýðýný
kanýtlamaktadýr. Migrenlilerde kontrollere kýyasla habituasyon yanýtýnýn yani
tekrarlanan uyarýlara verilmesi beklenen azalmýþ yanýtýn kaybolduðu hatta
yanýtlýlýðýn arttýðý görülmektedir. Bu habituasyon kaybý ataklar arasýnda
saptanýrken hemen atak öncesinde ve atak sýrasýnda normale dönmektedir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Fonksiyonel
görüntüleme çalýþmalarý da migrenli beynin interiktal dönemde bile aþýrý
yanýtlý olduðunu göstermiþtir. Ayrýca devamlý hale gelmiþ sensitizasyon
sonrasý, benzer tetiklerle daha düþük eþiklerde aðrý geliþimi yani bir çeþit
aðrý belleðinin oluþmasý da nöral plastisite olarak yorumlanmaktadýr.
Fonksiyonel MRG çalýþmalarýnda aðrý sýklýðý arttýkça aðrýyý kolaylaþtýran
matrikste dinlenim durumu aðýnda artmýþ konnektivite saptanmaktadýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bugün
için araþtýrýlan önemli bir soru genetik olarak belirlenen iyonik
dengesizliklerle iliþkili aura fazý sonrasýnda hangi mekanizmalarýn
trigeminovasküler sistemi aktive ettiðidir. Son yýllarda kortikal yayýlan
depresyonun inflamatuar bir yolaðý aktive ederek ve pannexin-1 megakanallarýný
açarak meningeal nosiseptörleri uyardýðý gösterilmiþtir. Pannexin-1 aktivasyonu
(high mobility group B1 (HMGB1)) yoluyla parenkimal inflamasyonu uyarmaktadýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bir
diðer önemli soru da, kan beyin bariyeri bozulmadýðý halde perfierik
mekanizmalarýn nasýl etkili olduðudur. Bununla birlikte anti-CGRP monoklonal
antikorlarýn etkisi periferik mekanizmalarý desteklemektedir; fremanezumab ve
diðer antikorlar A&#948; liflerini dolayýsýyla santral yüksek eþikli nöronlarý
etkilemektedir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
Genetiði</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Son
yýllarda baþaðrýsý, özellikle de migren genetiði konusunda önemli geliþmeler olmuþtur.
Bugün için migren, genetik faktörlerin çevresel faktörlerle etkileþim
gösterdiði <span class=GramE>kompleks</span> çok genli (poligenik) bir hastalýk
olarak kabul edilmektedir. Auralý migrende genetik faktörlerin aurasýz migrene
göre daha fazla rolü olduðu konusunda çeþitli bulgular vardýr. Sorumlu lokuslar
ve yatkýnlýk genlerinin tam olarak hangileri olduðu ve sayýsý henüz
bilinmemektedir. Migrenin ailesel özellik gösterdiði uzun zamandýr bilinmekte
ve deneyimli klinisyenler tarafýndan tanýya yardým amacýyla bile kullanýlmaktaydý.
Buna karþýn yoðun araþtýrmalara raðmen þu an için sadece migrenlilerin çok
küçük bir oranýný oluþturan ve karakteristik bir klinik tablo olan <i
style='mso-bidi-font-style:normal'>ailesel&nbsp;<span style='mso-bidi-font-style:
italic'>hemiplejik migren</span>in (familyal hemiplejik migren (FHM))</i>
genleri bulunabilmiþ, ancak çok daha sýk görülen aurasýz migren formlarýnýn
genlerine henüz ulaþýlamamýþtýr. Otozomal dominant tipte genetik geçiþ gösteren
tek genli (monogenik) bu auralý migren formunun kalsiyum kanalý (<i
style='mso-bidi-font-style:normal'>CACNA1A</i>), Na-K-ATPaz pompasý (<i
style='mso-bidi-font-style:normal'>ATP1A2</i>) ve sodyum kanalý (<i
style='mso-bidi-font-style:normal'>SCN1A</i>) ile iliþkili bazý genlerdeki
mutasyonlardan kaynakladýðý kesin olarak kanýtlanmýþtýr. Bu veriler de migrenin
bir kanalopati, yani iyon kanal hastalýðý olduðu görüþünü desteklemektedir. Bu
mutasyonlarý taþýyan bazý aile bireylerinde aurasýz migren ya da tamamen normal
fenotip bulunabilmesi olayýn diðer ilginç bir boyutudur. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Notch3</span></i><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> mutasyonu saptanan
serebral otozomal dominant arteryopati, subkortikal infarktlar ve
lökoensefalopati ile giden CADASIL gibi bazý nadir genetik tablolarda da migren
çok sýk rastlanan ve bazen ilk dikkati çeken yakýnmadýr.</span><span
style='font-size:6.5pt;font-family:"Arial","sans-serif";color:#222222;
background:white'> </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Öte
yandan bu genlerin sýk rastlanan diðer migren fenotipleri için birkaç olgu
dýþýnda anlamlý bir <span class=GramE>yatkýnlýk<span style='mso-spacerun:yes'> 
</span>oluþturmadýklarý</span> görülmüþtür. Yapýlan baðlantý analizi
çalýþmalarýnda çok farklý kromozomlar üzerinde birbirinden baðýmsýz baðlantý
bölgeleri gösterilmiþtir. Saptanan 44 baðýmsýz tek nükleotid polimorfizminin
migrenle iliþkili olduðu gösterilmiþtir ve bunlar 38 farklý genomik lokusde yer
almaktadýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><span
style='mso-spacerun:yes'>  </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bazý
çalýþmalarda elde edilen sonuçlar izleyen diðer çalýþmalar tarafýndan,
metodolojik nedenlerle ve daha da önemlisi etnik farklýlýklar nedeniyle
doðrulanamamýþtýr. Aday olarak kabul edilebilen genlerde çok sayýda yapýlmýþ
olan polimorfizmlerle iliþkilendirme çalýþmalarý mevcuttur, ancak bunlarýn da
önemi net deðildir. Son genetik veriler, CSNK1D, MEF2D, TGFBR2, PHACTR1, ASTN1,
TRPM8, LRP1 gibi birçok farklý genle iliþkinin bulunduðu yönündedir. Bu
genlerin çoðu glutamaterjik iletimde görevlidir ve migrende saptanmýþ olan
artmýþ kortikal eksitabiliteyle baðlantýlý olabilir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
genetiði araþtýrmalarýnýn gelecekte sýk rastlanan ve aðýr formlarýn genlerini
aydýnlatmasý, <span class=GramE>spesifik</span> taný ve tedavi beklentisi
açýsýndan önem taþýmaktadýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Bazý Özel Migren Tipleri <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kronik Migren<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararasý
Baþaðrýsý Derneði baþaðrýsý sýnýflama komitesinin 2018 yýlýnda yayýnladýðý taný
kriterlerine göre kronik migren; aurasýz ve auralý migrenden sonra <span
class=GramE>1.3</span> kodlamasýyla üçüncü migren tipi olarak sýnýflamada
yerini almýþtýr. Hastanýn en az 3 ay süreyle, ayda 15 veya daha fazla gün
baþaðrýsý yaþamasý ve bu baþaðrýlarýndan en az 8 gününün migren özellikleri
taþýmasý kronik migren olarak tanýmlanmaktadýr (Tablo 3). Auralý ya da aurasýz
ataklar olabilir ve baþaðrýsýna baðlý kýsýtlýlýðý en yoðun yaþayan
gruplardandýr. Baþaðrýsý migren veya gerilim tipi özelliklerini gösterebilir.
Genellikle yoðun olarak aðrý kesici kullanýmý söz konusudur. Hemen hergün
baþaðrýsýndan yakýnan bu hastalarýn klinik tablolarýný anlayabilmek ve ayýrýcý
taný yapabilmek için baþaðrýsý günlüðü mutlaka gereklidir. Ayýrýcý tanýda
sekonder baþaðrýlarýnýn yaný sýra kronik gerilim tipi baþaðrýsý, yeni
baþlangýçlý günlük ýsrarcý baþaðrýsý ve ÝAKB de dikkatle sorgulanmalýdýr.
Kronik migrenli hastalarýn bir kýsmýnda hem kronik migren hem de ÝAKB birlikte
olabilir. Ama ilaç aþýrý alýmý engellendiðinde epizodik migren ataklarý geri
dönüyorsa esas tanýnýn ÝAKB olduðu düþünülmelidir. Oysa ilaçlarýn
düzenlenmesine raðmen kronik süreç devam ediyorsa altta yatan nedenin kronik
migren olduðu anlaþýlýr. Kronik migren tanýlý hastalar genellikle analjezik
tedavilere dirençlidirler. Kronik migren grubunda botulinum toksin uygulama
endikasyonu olan olgular yer alýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Vestibüler Migren (Migrenöz
Vertigo)<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Son
sýnýflamada apendiks bölümünde yer alan ve henüz bir migren alt tipi olarak
yayýnlanmayan bu taný gün geçtikçe klinisyenlerin dikkatini çekmeye devam
etmektedir. Migren tanýlý hastalarýn yaklaþýk %10unda vestibüler migren tanýsý
için yeterli bulgular olduðu bildirilmektedir. Baþ dönmesinin özelliklerini
gözden geçirdiðimizde gerçek vertigo olabileceði gibi, dizzines þeklinde
nonspesifik ya da sadece pozisyonel olarak ortaya çýkabilmektedir. Vertigo
süresi ise oldukça deðiþkendir, dakikalar ya da günler boyunca sürebilir.
Migren ile iliþkili <span class=GramE>semptomlarýn</span> vertigo ile iliþkisi
de deðiþkendir. Bu <span class=GramE>semptomlar</span> vertigodan önce, sonra
ya da eþ zamanlý olarak ortaya çýkabilir. Migren tanýlý bir olguda vestibüler
migren tanýsý için vertigo ataklarýna baþaðrýsýnýn eþlik etmesi zorunlu
deðildir. Geçici iþitsel <span class=GramE>semptomlar</span>, bulantý, kusma ve
araç tutmasý sýklýkla vestibüler semptomlara eþlik eder.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><span
style='mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bu
klinik tablonun tanýsýnýn anlaþýlmasý kadar olasý eþlik edebilecek santral ve
periferik vestibüler sistem hastalýklarýnýn dýþlanmasý da önemlidir. Vestibüler
migren tanýsý ile hastaya tedavi seçeneklerini sunmadan önce ayrýntýlý olarak
kulak burun boðaz muayenesi ve iþitme testlerinin yapýlmýþ olmasý gereklidir
(Bakýnýz: <b style='mso-bidi-font-weight:normal'>vertigo</b>).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;background:yellow;
mso-highlight:yellow;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Menstrüel Migren<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Kesin
tanýmlamalar deðiþmekle birlikte menstrüel migren tanýmý perimenstrüel dönemde
oluþan migren ataklarýný tanýmlamaktadýr. Klinik gözlemler, migren
baþaðrýlarýnýn menstrüel dönem öncesinde daha sýk ve daha þiddetli olduðunu
ortaya çýkarmýþtýr. Bu baþaðrýlarý diðer migren baþaðrýlarýnýn cevap verdiði
tedavilere dirençli kalabilir, uzayabilir ve çok daha þiddetli olabilir.
Menstrüasyon&nbsp; sýrasýnda migren ataklarý sýk görülmesine karþýn, eðer
ataklarýn %90ý menstrüasyon sýrasýnda oluyorsa bu menstrüel migren adýný alýr.
Baþaðrýsýnýn menstrüel migren olarak tanýmlanabilmesi için ataklarýn %90ýnýn
adetten önceki 2 gün ve <span class=GramE>adetin</span> son günü arasýnda
olmasý gerekmektedir. Migren riski <span class=GramE>adetin</span> ilk 3 günü
daha fazladýr. Bu tablonun altýnda östrojene iliþkin döngülerin yattýðý
düþünülmekle birlikte net olarak kanýtlanmýþ bir mekanizma yoktur.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migren ve Komorbiditeler <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Depresyon:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren prodromu, atak
dönemi ve ikisi arasýndaki dönemlerde psikiyatrik <span class=GramE>semptomlarýn</span>
sýk görüldüðü bildirilmiþtir. Liveing 1873 yýlýnda depresyon ve yorgunluðu
migrenin tipik özellikleri olarak tanýmlamýþtýr. Wolf migrenli hastalarda,
karakteristik özellik olarak, aþýrý fiziksel yorgunluk ve apatinin bulunduðunu
kaydetmiþtir.&nbsp;Migren ile depresyon arasýndaki iliþki gözden geçirildiðinde
dikkate deðer bir benzerlik olduðu görülmektedir. Her iki bozukluk da kadýn ve
genç eriþkinlerde daha sýktýr, ýrk ve sosyal sýnýf açýsýndan benzer bir daðýlým
gösterir. Farklý incelemelerde, her iki bozukluk için de benzer prevalans
görülmektedir. Bu bulgularýn ve yapýlan az sayýdaki çalýþmalarýn ýþýðýnda
migren ve depresyon etyolojik olarak iliþkili bulunmuþtur. Bu nedenle ya ortak
bilinmeyen patolojik mekanizmalarý paylaþmaktadýrlar ya da bozukluklardan
birisinin diðerine yol açmasý veya onun geliþmesine neden olmasý þeklinde bir
sebep-sonuç iliþkisi söz konusudur. Migren hastalarýnda depresyonu tanýmak ve
tedavi etmek önemlidir. Çünkü depresyon, migrenin kronikleþmesi olasýlýðý için
önemli bir göstergedir ve bu hastalarda migren ilaçlarýna direnç, ilaç aþýrý
kullanýmý geliþmesi ve artmýþ özürlülük ile ilintilidir. Ayrýca migrenlilerde
bipolar bozukluk, anksiyete ve posttravmatik stres bozukluðu da daha sýk
bildirilmektedir. Psikiyatrik bozukluklarýn eþlik ettiði migren olgularýnda
tedavi baþarýsýnýn da daha kötü olduðu gözlenmiþtir. Bunun dýþýnda da kronik
aðrý, baþaðrýsý ve depresyon arasýndaki iliþki, psikiyatrik ve psikososyal
açýdan&nbsp;ayrýca gözden geçirilmesi gereken bir konudur.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Ýnflamatuar Barsak
Hastalýklarý:</span></i><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>
Temel olarak gastrointestinal sistemi etkileyerek karýn aðrýsýna yol açabilen
kronik sistemik inflamatuar bir hastalýk grubudur. Toplum geneliyle
karþýlaþtýrýldýðýnda migren sýklýðýnýn bu hastalarda daha fazla olduðu
görülmüþtür ve prevalansýn iki kat artýþ gösterebildiðini bildiren çalýþmalar
vardýr. Bu iki hastalýk grubunun birlikteliði, inflamatuar barsak hastalýðýnda
oluþan inflamasyonun migren aðrýlarýný kolaylaþtýrýcý etkisi olduðu görüþü ile
açýklanmaktadýr. Hastalýk alevlenmesi riski nedeniyle bu hastalardaki akut
migren ataðý tedavisinde nonsteroidal anti-inflamatuar (NSAÝ) analjezikler
kullanýlmamalý, birinci basamak tedavide triptanlar tercih edilmelidir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Fibromiyalji:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren hastalarýnýn
yaklaþýk üçte birine fibromiyalji de eþlik etmekte olup, bu iki aðrýlý durumun
birlikteliði bazý patofizyolojik süreçlerin ortak olduðu görüþünü
desteklemektedir. Üstelik bu iki hastalýðýn birlikte olduðu bireylerde diðer
medikal ve psikiyatrik komorbiditelerin de çok daha fazla görüldüðü
bildirilmiþtir. Klinik pratikte migren ve fibromiyalji birlikteliði akýlda tutularak,
tedavi planlamasýnda buna uygun yaklaþýlmalýdýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Epilepsi:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren ve epilepsi de bazý
ortak patofizyolojik mekanizmalarý paylaþan hastalýklardýr ve genetik
çalýþmalarla aralarýndaki baðlantý gösterilmiþtir. Her ikisi de beyin
fonksiyonlarýnda geçici deðiþimlere yol açarlar ve zamansal açýdan birliktelik
gösterebilirler. Özellikle çocukluk çaðýnda görülen abdominal migren ile
abdominal epilepsi arasýnda bir iliþkinin bulunduðu belirtilerek ayýrýcý tanýda
bu olasýlýðýn akla gelmesi önerilmektedir.<span style='mso-spacerun:yes'> 
</span>Bunun yaný sýra oksipital paroksizmli selim çocukluk çaðý
epilepsilerinde de baþaðrýsý görülebilmekte ve görsel aura ile birlikte iktal
EEG deðiþiklikleri kaydedilmektedir (Bkz: <i style='mso-bidi-font-style:normal'>Epilepsi</i>).
Önceden auralý migren tanýsý almýþ hastalarda, baþaðrýsý sýrasýnda EEGde
epileptiform bulgularýn görülmesi durumunda ise <i style='mso-bidi-font-style:
normal'>migren aurasýyla tetiklenen nöbet</i> düþünülmelidir. Migren tipi
baþaðrýsý, epileptik bir belirti olarak ortaya çýkar ve EEGde epileptik bir
nöbet paterni ile birliktelik gösterirse <u>iktal epileptik baþaðrýsý</u>
olarak taný almaktadýr. <i style='mso-bidi-font-style:normal'>Postiktal
baþaðrýsý </i>ise epilepsi hastalarýnda en sýk görülen peri-iktal baþaðrýsýdýr.
Burada aðrý epileptik nöbetten sonra en geç 3 saat içinde baþlamakta ve nöbet
bittikten sonraki 72 saat içinde iyileþmektedir. Epilepsi ile birliktelik
durumunda migren baþaðrýsýnda profilaksi endikasyonu da varsa, teratojeniteleri
baþta olmak üzere yan etki <span class=GramE>profilleri</span> göz önüne
alýnarak, benzer þekilde valproat ve topiramat seçenekleri kullanýlabilir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Ýnme:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren hastalarý arasýnda
özellikle auralý migreni olanlarda vasküler olaylar daha sýk görülmektedir.
Migren, özellikle inme ve miyokard infarktüsü gibi vasküler patolojiler için
bir risk faktörü olarak kabul edilmekte, altta yatan olasý mekanizmalar
arasýnda endotelyal iþlev bozukluðu, hiperkoagülabilite, vazospazm, yayýlan
kortikal depresyon, genetik özellikler veya immobilizasyon gibi faktörler
sýralanmaktadýr. Auralý migrende, özellikle kadýn hastalarda, ak madde
lezyonlarý daha sýk görülmekte olup sessiz infarkt geliþimi riski de yüksek
bulunmuþtur. Bunun yaný sýra, bu hastalarda geliþebilen bir diðer patolojik
durum olan <i style='mso-bidi-font-style:normal'>migrenöz infarkt</i>, auralý
migren ataðýnýn bir <span class=GramE>komplikasyonu</span> olarak kabul
edilmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararasý
Baþaðrýsý Derneðinin (IHS) 2018 Sýnýflamasýnda tipik bir auralý migren ataðý
sýrasýnda baþlayan, nörogörüntüleme ile uygun vasküler alanda gösterilen
iskemik beyin lezyonuyla iliþkili bulunan bir veya daha fazla migren aurasýnýn
varlýðý migrenöz infarkt olarak tanýmlanmaktadýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Taný
<span class=GramE>kriterleri</span> aþaðýdaki gibidir: <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>B
ve C <span class=GramE>kriterlerine</span> uyan migren ataðý<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bir
veya daha fazla aura <span class=GramE>semptomunun</span> 60 dakikadan uzun
sürmesi dýþýnda önceki ataklarý tipik olan auralý migreni olan bir hastada
geliþmiþtir<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Nörogörüntüleme
incelemeleri ilgili alanda iskemik infarkt göstermektedir<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sýnýflamada
yer alan baþka bir baþaðrýsý tanýsý ile açýklanamamaktadýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
Tedavisi </span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
nedeniyle hastalarýn hayat kalitesi belirgin derecede düþer, ataklarýn tedavi
edilmesi çoðunlukla gereklidir.<span style='mso-spacerun:yes'>  </span>Ayrýca tablonun
sýklýðý ile birlikte düþünüldüðünde migren ataðý sýrasýnda hastanýn iþini
yapamaz duruma gelmesi toplumsal anlamda da kayýplara yol açmaktadýr. Migren
tanýsý koyulduktan sonra hastaya migrenin hayatý tehdit eden bir beyin
hastalýðý olmadýðý ve tedavisinin belli bir düzene göre ve hekimle iþbirliði
içinde yapýlmasý gerektiði açýklanmalýdýr. Son yýllarda yapýlan epidemiyolojik
çalýþmalar özellikle auralý migrenin 45 yaþ altý kadýnlarda artmýþ bir iskemi
riski (3,8-6,2 kat) yarattýðýný göstermiþtir. Bu durum sigara ve diðer risk
faktörleri bulunduðunda artmaktadýr ve bu nedenle hastalar
bilgilendirilmelidir. Migrenli olgularda sessiz infarktlarýn ve sessiz ak
akmadde lezyonlarýnýn da artmýþ olduðu gösterilmiþtir (<b>Þekil 4</b>).</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.25pt;margin-bottom:.0001pt;line-height:normal'><b><u><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi4.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>Þekil 4.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migrenli olgularda
normallere göre daha sýk rastlandýðý bildirilmiþ olan ve tam olarak önemi
bilinmeyen beyaz madde lezyonlarý bazen ciddi boyutlara ulaþabilmektedir.
Auralý migreni olan bu olguda hatalý olarak multipl skleroz tanýsý ile
araþtýrmalar yapýlmýþtý.</span><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Karanlýk
ve sakin bir odada, buz paketi koyarak dinlenmek aðrýnýn giderilmesini
kolaylaþtýrýr. Eðer uyunabilirse genellikle hasta aðrýdan kurtulmuþ olarak
uyanýr. Hastalýðý tetikleyen faktörlerden kaçýnma, öðün atlamama, uyku
saatlerinin düzenli olmasýnýn saðlamasý gibi bazý basit tedbirlerle aðrýnýn
sýklýðý azaltýlabilir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><i><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenin
Ýlaçla Tedavisi </span></i></b><span style='font-size:13.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrende
ilaç tedavisi ataklardan korunmaya yönelik <i>profilaktik</i> veya önleyici/koruyucu
tedavi ve ataðýn aðrý, bulantý, kusma gibi yakýnmalarýnýn giderilmesine yönelik
<i>atak (akut/aðrý) tedavisi</i> olarak iki þekilde yapýlýr. Profilaktik
tedavi belirli bir süre boyunca düzenli ilaç kullanarak aðrý sýklýðýný ve
þiddetini azaltýlmaya yöneliktir. Migren tedavisi herkese ayný þablonun
uygulanmadýðý, her hastaya özel olarak karar verilmesi gereken bir tedavi
þeklidir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
Tedavisi&nbsp;</span></i><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>(<b>Tablo
5a ve b</b>) </span><span lang=IT style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:IT'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
tedavisinde hafif ve orta þiddetli ataklarda aspirin, asetaminofen, naproksen,
etodolak veya ibuprofen gibi aðýz yolu ile alýnan basit ve NSAÝ analjezikler
veya kafein ile kombine edilmiþ analjezikler etkilidir. Ancak kombine
ilaçlardan kaçýnmak tercih edilmelidir. Sýk ataklý olgularda (ayda beþden
fazla) analjezik kullaným sýnýrlarý belirlenmeli ve hasta ÝAKB konusunda
uyarýlmalýdýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
için özel olan atak tedavisinde <i style='mso-bidi-font-style:normal'>ergot
preparatlarý</i> ve <i style='mso-bidi-font-style:normal'>triptan grubu</i>
(sumatriptan, eletriptan, rizatriptan, frovatriptan gibi) gibi tedaviler önemli
bir yer tutmaktadýr. Ergo türevi ilaçlarýn uzun süreli kullanýmda daha da
belirginleþen genel damar daraltýcý riskleri, çok daha ucuz olmalarýna karþýn,
bu tip yan etkileri taþýmayan seçici serotoninerjik ilaçlar olan triptanlarýn
günümüzde migren <span class=GramE>spesifik</span> ilaçlar olarak ergo
türevlerine tercih edilmelerine neden olmuþtur. Triptanlar 5HT1B ve1D reseptör
agonistidir. Þiddetli bir atak için NSAÝ ilaç kullanmadan doðrudan triptanlar
tercih edilebilir. Bulantýsý çok belirgin olduðu için oral alamayan hastalarda
kas içi ve damardan <span class=GramE>enjeksiyonlar</span> dýþýnda hastanýn
kendine uygulayabileceði deri altý injeksiyon þeklinde ve nazal sprey þeklinde
de triptan grubu ilaçlar üretilmiþtir. Bu ilaçlar hastanýn her atakta doktor
baþvurusu yapmaktan kurtulmasý açýsýndan çok önem taþýmaktadýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
tedavisinde opiodlerin ve kortikosteroidlerin yeri yoktur. <i style='mso-bidi-font-style:
normal'>Anti-emetikler</i> ise yararlý kabul edilmektedir, NSAÝden 20 dakika
önce alýnmalarý hem bulantýyý giderir, hem de mideden emilimi arttýrýr, ayrýca
hafif aðrý giderici etkileri de olduðu ileri sürülmektedir. Metoklopramid (10-20
mg oral veya ÝV, ÝM) ve domperidon (20-30 mg) kullanýlabilir; QT uzamasý,
distoni ve diskinezi riski açýsýndan dikkatli olunmalýdýr.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
tedavisinde ilaçlarýn baþaðrýsý baþlangýcýnda mümkün olduðunca erken alýnmasý
önerilmektedir. Migren tedavisinin hastanýn yaþam kalitesini yükseltmeye
yönelik olduðu unutulmamalý ve tedavi her hastanýn durumuna ve özel
gereksinimlerine göre yönlendirilmelidir. Örneðin uyuyarak ataðýný geçirebilen
ve ilaç almayý sevmeyen ya da yan etki gören bir hastaya diðerlerine iyi gelen
bir analjeziði almasý için ýsrar etmek uygun deðildir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
5A.&nbsp;</span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
atak tedavisinde günümüzde sýk kullanýlan bazý özgül olmayan ilaçlar</span><span
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ýlaç</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Önerilen Doz</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Etkinlik
  Düzeyi</span></b><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Olasý veya
  Sýk Yan Etki</span></b><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Tercih
  edileceði Komorbid Durum</span></b><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Olumsuz
  Komorbid Durum veya Kontrendikasyon</span></b><span lang=DE style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Asetil
  salisilik asit</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1000 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri, kanama eðilimi</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Koroner arter
  hastalýðý, geçici iskemik atak</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Böbrek
  hastalýðý, karaciðer hastalýðý, peptik ülser, gastrit, kanamalý durumlar</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Parasetamol (<u>+</u>Kafein)</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>500-1000 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>?+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nadir
  (karaciðer, kan ve deri)</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gebelik</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Karaciðer
  hastalýðý</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Naproksen</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>550-1100 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Artrit ve diðer
  aðrýlý durumlar</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ülser,
  gastrit</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Metamizol
  oral ve Ý.V.</span><span lang=IT style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:IT'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1000mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Hipotansiyon
  Agranülositoz,</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Porfiri, kan
  diskrazileri, glikoz 6P dehidrogenaz eksikliði</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Diklofenak </span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>50-100 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Artrit ve
  diðer aðrýlý durumlar</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ülser,
  gastrit, ürtiker, kolit, karaciðer ve böbrek yetmezliði</span><span lang=DE
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Flurbiprofen</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>100-300 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Romatizmal
  hastalýklar, dismenore</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Renal ve
  hepatik fonksiyon bozukluðu, sývý retansiyonu, ödem</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ýbuprofen</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>200-8000</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Romatizmal
  hastalýklar, dismenore</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Renal ve
  hepatik fonksiyon bozukluðu, sývý retansiyonu, ödem</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
35.4pt;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all style='mso-special-character:line-break'>
</span></b><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
5B.&nbsp;</span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
atak tedavisinde günümüzde sýk kullanýlan bazý özgül ilaçlar</span><span
lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Ýlaç</span></b><b style='mso-bidi-font-weight:normal'><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Önerilen Doz</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Etkinlik Düzeyi</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=108 valign=top style='width:80.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Olasý veya Sýk Yan Etki</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=104 valign=top style='width:77.95pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Tercih edileceði Komorbid Durum</span></b><b
  style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=130 valign=top style='width:97.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Olumsuz Komorbid Durum veya Kontrendikasyon</span></b><b
  style='mso-bidi-font-weight:normal'><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Eletriptan
  (Oral)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>40 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=108 rowspan=6 valign=top style='width:80.9pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ateþ basmasý,
  kýrgýnlýk,&nbsp; halsizlik, asteni, sersemlik hali, baþ dönmesi, bulantý,
  göðüste basýnç, sýkýntý hissi ve aðrý</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=104 rowspan=6 valign=top style='width:77.95pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Yok</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=130 rowspan=6 valign=top style='width:97.75pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Baziler tip
  migren, hemiplejik migren, periferik arter hastalýðý, Prinzmetal anjinasý,
  kontrol edilemeyen hipertansiyon</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Naratriptan
  (Oral)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2,5 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sumatriptan
  (Oral)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sumatriptan
  (Subkütan)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sumatriptan
  (Nazal)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>50-100mg<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6 mg<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>20mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Zolmitriptan
  (Oral, nazal)</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2,5 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Rizatriptan</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Frovatriptan*</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2,5 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>*Frovatriptan
daha uzun etkilidir ve perimenstrüel migrende koruyucu tedavide
kullanýlabilmektedir.</span><span lang=DE style='font-size:13.5pt;font-family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:DE'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=DE style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:DE'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>Özellikle hemiplejik migren, baziler migren ve
uzamýþ auralý migren hastalarýnda vazokonstriktör ilaçlar kullanýlmamalý veya
sýnýrlý tutulmalýdýr.</span><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<span
style='mso-bidi-font-style:italic'> Auralý migren olarak adlandýrýlan
ataklarda, aðrý baþlamadan önce aura döneminde verilen triptan grubu ilaçlarýn
etkisiz kalacaðýný bilmek önemlidir</span>. Bir diðer önemli bilgi de
migrenlilerde allodini durumu geliþtiðinde artýk triptana cevabýn
kaybolmasýdýr.&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><i><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></i><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Profilaktik
Tedavi</span></i><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Atak tedavisine yeterli cevap vermeyen ve/veya atak tedavilerinin yan
etkilerinin tolere edilemez düzeyde olduðu, ayda 5den fazla sayýda migren
ataðý geçiren hastalarda profilaktik tedavi indikedir. Ayrýca 48 saatten uzun
süren migren ataklarý, hasta tarafýndan subjektif olarak dayanýlmaz þiddette
bulunan migren aðrýlarý ve <span class=GramE>komplike</span> migren ataklarý
(hemiplejik migren, baziler migren, uzamýþ auralý migren, migrenle iliþkili
infarkt gibi nadir durumlar) yüksek oranda profilaksi gerektirir. Migrene baðlý
kayýplarýn (iþgücü, sosyal yaþam) yani kýsýtlýlýðýn düzeltilmesi ve yaþam
kalitesinin yükseltilmesi de tek baþýna profilaksi indikasyonu kabul
edilmelidir.</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><i><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>&nbsp;</span></i><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Koruyucu tedavide kullanýlan ilaçlar migren atak sýklýðýný ve þiddetini
azaltýrlar ve migren sýklýðýnýn yüzde ellinin üstünde azalmasý tedavinin
etkinliðini gösterir. Profilaktik ilaçlar düþük dozlarda baþlanarak yavaþ yavaþ
arttýrýlýr ve etkinliði deðerlendirebilmek için iki üç ay beklemek ve etkin
dozda en az 6 ay tedaviye devam etmek gerekir. Profilakside kullanýlan ilaçlar
çeþitli gruplardandýr, örneðin <i style='mso-bidi-font-style:normal'>hipertansiyon
kontrolü amaçlý ilaçlar </i>(<i style='mso-bidi-font-style:normal'>beta-blokerler:</i></span><i><span
style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span></i><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>propranolol, metoprolol, nöbivolol veya verapamil gibi), <i
style='mso-bidi-font-style:normal'>epilepsi ilaçlarý</i> (valproik asid,
topiramat, gabapentin, pregabalin gibi) <i style='mso-bidi-font-style:normal'>depresyon
ilaçlarý</i> (amitriptilin, venlafaksin, duloksetin gibi) ve flunarizin
sayýlabilir. Profilaksi altýndaki bir hastanýn kullandýðý ilacýn olasý yan
etkileri konusunda önceden bilgi sahibi olmasý ve hekim kontrolünde kalmasý
önemlidir. Bu ilaçlarýn büyük kýsmý migren indikasyonu olmayan ilaçlar
olduðundan hastaya yan etkileri konusunda ayrýntýlý bilgi verilmeli ve
bilgilendirilmiþ olur imzalatýlmalýdýr. Ýlaç seçerken hastanýn durumuna ve
diðer hastalýklarýna göre olumlu (</span><span style='font-size:13.5pt;
line-height:115%;font-family:Wingdings;color:black;mso-ansi-language:TR'>J</span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>) veya olumsuz durumlar (</span><span
style='font-size:13.5pt;line-height:115%;font-family:Wingdings;color:black;
mso-ansi-language:TR'>L</span><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>) dikkatle
ele alýnmalýdýr (<b>Tablo 6</b>). Önümüzdeki yýllarda <i style='mso-bidi-font-style:
normal'>CGRP ile iliþkili monoklonal antikorlarýn</i> profilakside kullanýmý
devreye girecektir. <i style='mso-bidi-font-style:normal'>Botulinum toksin</i>
tedavisi de profilaktik amaçlý olup sadece kronik migrende indikedir.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kontrollü çalýþmalarýn
güvenli ve etkin olduklarýný göstermesine raðmen, auralý migrende
beta-blokerlerin kullanýmý tartýþmalýdýr. Ca kanal blokerleri, valproat,
topiramat, gabapentin ve lamotrijin auralý migrenlilerde diðer seçenekler
arasýnda sayýlabilir.&nbsp;</span><span style='font-size:13.5pt;line-height:
115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<h2 style='margin-top:0cm;text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:TR;mso-fareast-language:EN-US;font-weight:
normal'>Migren profilaksisinde ilaç günde 1 veya en fazla 2 dozda alýnmalýdýr
ve bir baþaðrýsý günlüðünün kullanýmý saðlanmalýdýr. Hasta bir sorunla
karþýlaþtýðýnda doktora ulaþabilmeli ve 3 ayda bir kontrolleri
yapýlmalýdýr.&nbsp; Profilaksiye yanýtsýz olguda günlüðü dikkatle ele alýnmalý,
hastanýn beklenti düzeyi ve atak tedavisi, dozu, ilacý gerektiði gibi kullanýp
kullanmadýðý, yan etkiler gözden geçirilmelidir.<o:p></o:p></span></h2>

<p class=MsoNormal><span style='mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Hastanýn iyi uyku düzeni, beslenme ve spor gibi, yaþam <span class=GramE>hijyenine</span>
dikkat etmesi, tetikleyicilerden uzak durmasý öðütlenmelidir.
Profilaksinin&nbsp;endike olduðu olgularda en sýk yapýlan hatalar arasýnda
tedavide gecikme, düþük doz ve kýsa süre kullaným ve ilaç seçerken
komorbiditeye dikkat edilmemesi sayýlabilir.</span><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;<b>Tablo&nbsp; 6.</b>&nbsp;Migren
profilaksisinde ilaç seçiminde kormorbitenin rolü</span><span lang=DE
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:DE'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Komorbid durum</span></b><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><b><span style='font-size:10.0pt;line-height:115%;
  font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Etki</span></b><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Profilaksi seçimi</span></b><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + hipertansiyon</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker, kalsiyum kanal blokeri</span><span
  lang=DA style='font-size:12.0pt;line-height:115%;mso-ansi-language:DA'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + anjina</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Kalsiyum kanal blokeri</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + stres</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + depresyon</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, SNRI</span><span lang=NO-BOK
  style='mso-ansi-language:NO-BOK'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=NO-BOK style='font-size:
  12.0pt;line-height:115%;mso-ansi-language:NO-BOK'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + insomni</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + epilepsi</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, valproat*</span><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + tremor<o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L<o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker, gabapentin<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Valproat<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + parkinsonizm<o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L<o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Kalsiyum kanal blokeri<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + obezite</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Valproat, flunarizin, amitriptilin</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +astým</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +Raynaud <span class=GramE>fenomeni</span></span><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +yaþlý hasta</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, kalsiyum kanal blokeri</span><span
  lang=DE style='font-size:12.0pt;line-height:115%;mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +zayýf beden</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat, beta-bloker</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +dikkat gerektiren iþ</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, topiramat</span><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +karaciðer hastalýðý</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Valproat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +glokom</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17;mso-yfti-lastrow:yes'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +böbrek taþý</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;* </span><span style='mso-bidi-font-size:
13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>valproat doðurganlýk çaðýnda kadýn olgularda kesinlikle
kullanýlmamalýdýr </span><span lang=EN-US style='font-size:13.5pt;line-height:
115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><i><span style='font-size:10.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='text-align:justify'><i><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Migren statusu</span></i><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;72
saatten uzun süren ataklar veya 4 saatten kýsa süren aðrýsýz dönemlerin dýþýnda
devam eden ataklar veya standart atak tedavisine cevapsýz uzamýþ migren
þeklinde tanýmlanabilir. Hastanýn hýzla kortikosteroidler (deksametazon 16 mg
ÝV gibi), antiemetik (ÝV), antiepileptik (ÝV), magnezyum (1 gr ÝV), ketodolak
veya gereðinde opioidler gibi seçeneklerle tedavisi saðlanmalýdýr. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><i><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Yeni
Geliþtirilen Tedaviler <o:p></o:p></span></i></b></p>

<p class=MsoNormal style='text-align:justify'><i style='mso-bidi-font-style:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>5HT1F reseptör agonistleri,</span></i><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'> triptanlardan farklý olarak kan damarlarý
üzerindeki serotonin reseptörlerine etki etmediði için koroner ve serebral
vazokonstriksiyona neden olmaz. Bu grupta yer alan lasmiditan (100-200mg, oral)
migren atak tedavisinde etkili bulunmuþtur. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>CGRP ve reseptörlerinin trigeminal ganglion, trigeminal sinirde
sonlanmalarý ve dural arterler çevresindeki daðýlýmý migren baþaðrýsýnda ana
hedefi oluþturmaktadýr. <i style='mso-bidi-font-style:normal'>Küçük molekül
CGRP <span class=GramE>antagonisti</span></i> olan <i style='mso-bidi-font-style:
normal'>gepantlar, </i>atak kontrolünde oldukça etkili; triptanlar gibi
vasküler hemodinami üzerinde etki göstermediðinden de koroner ve periferik
arter hastalýklarýnda güvenli bulunmuþtur. Ancak ilk geliþtirilen gepant grubu
moleküller kullaným zorluðu ya da sistemik yan etkiler gibi çeþitli olumsuz
yönleri nedeniyle klinik pratiðe geçememiþtir. Bu grupta, hem atak hem
profilaksi tedavisinde kullanýlmasý amacýyla yeni moleküller
geliþtirilmektedir. CGRP molekülüne veya reseptörüne baðlanarak <span
class=GramE>nötralize</span> eden <i style='mso-bidi-font-style:normal'>anti-CGRP
monoklonal antikorlarý</i> ise, migren proflaksisinde öne çýkan yeni seçenekler
arasýndadýr. Bunlar kan-beyin bariyerini geçmeyen, karaciðer veya böbrekten
atýlmayan, peptid doðasý nedeniyle oral kullanýlamayan ve yarý ömrü haftalar
olan büyük moleküllerdir. Erenumab (70-140mg, aylýk deri altý injeksiyon)
Amerika ve bazý Avrupa ülkelerinde gereken bilimsel ve idari onaylarý almýþtýr,
fremanezumab onu izlemiþtir, galcanezumab ve eptinezumab gibi moleküllerin
çalýþmalarý da baþarýlý þekilde devam etmektedir. Bu maliyeti yüksek ve uzun
dönem yan etkileri henüz iyi bilinmeyen ilaçlarýn diðer profilaksi tedavilerine
yanýt vermeyen migren hastalarýnda kullanýlmasý önerilebilir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><i><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Giriþimsel
Tedaviler<o:p></o:p></span></i></b></p>

<p class=MsoNormal style='text-align:justify'><i style='mso-bidi-font-style:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Botulinum nörotoksini, </span></i><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>kronik migren profilaksisinde
kullanýlmaktadýr, epizodik migren tedavisinde etkinliðini gösteren yeterli
kanýt yoktur. Deriyi inerve eden trigeminal sinir uçlarýndan retrograd
transport ile santrale taþýndýðý ve CGRP ve P-maddesi gibi nöropeptidlerin
salýnýmýný baskýlayarak etki oluþturduðu düþünülmektedir. Kranyal ve servikal
bölgede 31 farklý noktaya, 3 ay aralýklarla uygulanýr. Pahalý ve giriþimsel bir
tedavi seçeneðidir, eðitimli ellerde yüksek bir riski yoktur, geçici felçler
olabilir. Kozmetik amaçlý kullanýmý da olmasý bazý hastalarda sempati
yaratmaktadýr.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Sýk ataklý migrende, özellikle kronik migrende <span class=GramE>lokal</span>
anestetikler ile <i style='mso-bidi-font-style:normal'>büyük oksipital sinir
(GON: great occipital nerve) blokajý</i> güvenli ve etkili giriþimsel tedaviler
arasýnda görülmektedir. Ancak bu ucuz yöntem ile ilgili henüz bir
standardizasyon geliþtirilmemiþtir; tek taraflý <span class=GramE>blokaj</span>
yeterlidir; kranyal defekti, injeksiyon yeri infeksiyonu ve lokal anestetiklere
alerjisi olanlara yapýlmamalýdýr. <i style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Son yýllarda, özellikle medikal tedaviye yanýt alýnamayan migren
hastalarýnda <i style='mso-bidi-font-style:normal'>nörostimülasyon uygulamalarý</i>
gündeme gelmiþtir. Non-invazif yöntemler arasýnda transkranyal manyetik
stimülasyon, transkranyal doðru akým uyarýmý ve non-invazif vagal sinir
stimülasyonu (VSS); invazif yöntemler arasýnda ise oksipital sinir stimülasyonu
ve implante VSS yer almaktadýr. Henüz rutin klinik kullanýmlarý yoktur.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Son yýllarda özellikle kronik dirençli migren olgularýnda baþarýlý olduðu
öne sürülen cerrahi bazý giriþimler ise, ulusal ve uluslararasý düzeyde idari
olarak kabul edilmeyen ve tedavi kýlavuzlarýnda yer almayan uygulamalardýr.
Üstelik bu yöntemler, geri dönüþümsüz <span class=GramE>komplikasyonlara</span>
yol açabilmekte ve izlemde tedaviye dirençli nöropatik aðrý geliþimine neden
olabilmektedir. Migren cerrahisi adýyla duyurulmaya çalýþýlan bu yöntemlerin
kullanýmlarý bilimsel kanýtlar ve bilimsel onaylarý olmadýðýndan sakýncalýdýr.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><i><span
style='font-size:12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Migren tedavisinde baþarýsýzlýðýn nedenleri</span></i></b><span
style='font-size:12.0pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Taný eksik veya yanlýþtýr</span><span style='font-size:12.0pt;
     mso-ansi-language:TR'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Taný konmamýþ baþka bir hastalýða baðlý sekonder baþaðrýsý bozukluðu
     mevcuttur</span><span lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Yanlýþ taný konmuþ baþka bir primer baþaðrýsý bozukluðu mevcuttur</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Ýki veya daha fazla farklý baþaðrýsý bozukluðu mevcuttur</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Önemli tetikleyici faktörler gözden kaçýrýlmýþtýr</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Hormonal tetikler, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Psikososyal faktörler (depresyon ve madde baðýmlýlýðý), <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Baþaðrýlarýný tetikleyen diðer ilaçlar, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Yaþam þeklinin baþaðrýsýný tetiklemesi (stres, uykusuzluk,
alkol kullanýmý vb.)<o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l13 level1 lfo21;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Ýlaç aþýrý kullanýmý vardýr</span><span lang=EN-US style='font-size:
     12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l13 level1 lfo21;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Kafein aþýrý kullanýmý vardýr</span><span lang=EN-US style='font-size:
     12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l13 level1 lfo21;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Tedavi dozlarý ve yaklaþým yetersizdir</span><span lang=EN-US
     style='font-size:12.0pt'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Etkisiz ilaç, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Yüksek baþlangýç dozu, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Yetersiz devam dozu, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Yetersiz tedavi süresi</span><span style='font-size:12.0pt;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Hastanýn gerçekçi olmayan yüksek beklenti düzeyi</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Tedaviyi zorlaþtýran diðer komorbid hastalýklarýn varlýðý</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Atak tedavisinde kusma olduðu halde oral yolla uygulama</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Bulantý ve gastrik staz olan olgularda önce anti-emetik verilmemesi</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Ýþ verimi çok düþtüðü halde basit analjeziklerle yetinilmeye
     çalýþýlmasý</span><span lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Kombine analjeziklerin ve Ergo preparatlarýnýn yoðun kullanýmý</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:12.0pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>GERÝLÝM
TÝPÝ BAÞAÐRILARI </span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Primer baþaðrýlarý içinde en sýk karþýlaþýlan tip gerilim tipi
baþaðrýlarýdýr (GTB). Türkiyede yýllýk prevalansý yaklaþýk %32dir. GTBler
migrenden daha sýk görülmekle birlikte, görece daha hafif baþaðrýlarýna neden
olduklarýndan hekime baþvuruda daha geri plandadýr. Sýklýkla 20 yaþ civarýnda
baþlar, her yaþta görülebilir. Kadýnlarda biraz daha sýk görülmekle birlikte
aradaki fark migrende olduðu kadar çarpýcý deðildir. GTBnin lokalizasyonu
deðiþkendir ve <span class=GramE>semptomlarý</span> ayný hastada bile tek tip
deðildir. Bu nedenle bir çöp sepeti tanýsý gibi ele alan yazarlar vardýr.
Bazý araþtýrmacýlar ise migren ile ayný spektrumun diðer ucu olduðu
görüþündedir. GTBli olgularýn %10 kadarýnda baþaðrýsý zonklayýcý gibi
hissedilebilir ve baþka olgularda tek yanlý aðrý olabilir. Kaslarda gerginlik
%80 olguda palpasyonla saptanýr ve hastalar sýklýkla dikkat eksikliðinden
yakýnýrlar. Depresif ruh durumu, anksiyete bozukluðu, somatoform bozukluklar ve
diðer yakýnmalar eþlik edebilir. Bazý hastalarda fibromiyalji ve miyofasyal
aðrý <span class=GramE>sendromu</span> birlikteliði vardýr.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span style='font-size:13.5pt;line-height:
115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Aðrýnýn,
ataklar þeklinde gelebildiði gibi, kronikleþmiþ halde de görülmesi seyrek
deðildir. GTB, IHS sýnýflamasýnda&nbsp;<b>Tablo 7</b>de görüldüðü gibi seyrek,
sýk ve kronik olarak gruplandýrýlmýþtýr ve bu hasta için sorun olma boyutu ve
tedaviyi yönlendirmek açýsýndan anlamlýdýr.&nbsp;<b><i> Kronik gerilim tipi
baþaðrýsý</i></b>&nbsp;günlük olarak veya çok sýk görülen epizodik GTBden
geliþen bir&nbsp;durumdur. Baþka bir&nbsp;hastalýkla&nbsp;iliþkili olmadýðýnýn
gösterilmesi önem taþýr. Yurdumuzda oldukça sýk rastlanan (%5in üstünde) ve
polikliniklere sýk baþvuran grubu oluþturmaktadýr. Yaþam kalitesi üzerine
olumsuz etkisi olan bir durumdur. Ýlaç aþýrý kullanýmýna yol açabilir ve bazý
olgularda kronik migrenden ayrýmý sorun yaratabilir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span style='font-size:
12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 54.0pt'><b><span style='font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'>Tablo 7.&nbsp;</span></b><span style='font-size:12.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Uluslararasý
Baþaðrýsý Derneði (IHS) 2018 Sýnýflama Sistemine Göre Gerilim Tipi Baþaðrýsý</span><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;line-height:
115%;mso-ansi-language:TR'><span style='mso-spacerun:yes'>     </span><o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><i style='mso-bidi-font-style:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>Seyrek epizodik
gerilim tipi baþaðrýsý </span></i><span style='font-size:12.0pt;line-height:
115%;mso-ansi-language:TR'>tanýsý için:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A-C <span class=GramE>kriterlerine</span> uyan, 30
dakikadan uzun ve 7 günden kýsa süreyle, ayda ortalama 1 günden (yýlda 12
günden) az olan, en az 10 baþaðrýsý ataðý gereklidir.<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><i style='mso-bidi-font-style:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>Sýk epizodik
gerilim tipi baþaðrýsý </span></i><span style='font-size:12.0pt;line-height:
115%;mso-ansi-language:TR'>tanýsý için:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A-C kriterlerine uyan, 30 dakikadan uzun ve 7 günden kýsa
süreyle, 3 aydan uzun süredir ayda ortalama 1-<span class=GramE>14<span
style='mso-spacerun:yes'>  </span>gün</span> olan,<span
style='mso-spacerun:yes'>  </span>en az 10 baþaðrýsý ataðý gereklidir.<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><i style='mso-bidi-font-style:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>Kronik gerilim
tipi baþaðrýsý </span></i><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>tanýsý için:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A-C <span class=GramE>kriterlerine</span> uyan, saatler
ya da günler süren ya da hiç geçmeyen baþaðrýsýnýn, 3 aydan uzun süredir ayda
15 gün veya daha fazla olmasý gereklidir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span style='font-size:
12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;mso-list:l23 level1 lfo23;tab-stops:
18.0pt 31.5pt 54.0pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Aþaðýdaki özelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Bilateral lokalizasyonda<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Baskýlý veya sýkýþtýrýcý karakterde<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Hafif veya orta þiddette<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Rutin fiziksel aktivite ile kötüleþme yok<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;mso-list:l23 level1 lfo23;tab-stops:
18.0pt 31.5pt 67.5pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Aþadaki özelliklerden ikisi:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l11 level1 lfo25;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Bulantý veya kusma yok<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l11 level1 lfo25;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Fotofobi veya fonofobi bulgularýndan en fazla biri var<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;mso-list:l23 level1 lfo23;tab-stops:
18.0pt 31.5pt 54.0pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Sýnýflamada yer alan baþka bir baþaðrýsý tanýsýna
uymamaktadýr<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm'><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm'><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;mso-bidi-font-style:
italic'>Gerilim Tipi Baþaðrýsýnda Patofizyoloji </span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>GTBlerin
patofizyolojisi net deðildir, çok faktörlü olduðu öngörülmektedir. Muhtemelen
sadece anormal kas kasýlmasýnýn deðil, anormal nöron duyarlýlýðý ve aðrýnýn
kolaylaþmasýnýn bir klinik yansýmasýdýr. Nitrik oksitin (NO) gerilim tipi
baþaðrýsýnda <span class=GramE>lokal</span> bir aracý madde olduðu
savunulmaktadýr. Primer olarak kas kökenli bir baþaðrýsý olduðu iddia edilmiþse
de kanýt yoktur ve artmýþ EMG aktivitesi olmamasý, botulinum toksin
uygulamalarýnýn baþarýsýz olmasý buna ters düþmektedir. Trigeminal siniri motor
nöronlara baðlayan internöronlarda anormal bir modülasyon bulunduðu düþünülmektedir.
Bu anormallik bazal gangliadan, limbik sistemden veya dorsal raphe
nukleusundaki serotoninerjik nöronlardan kaynaklanabilir. Bir görüþe göre
kronik gerilim tipinde supraspinal fasilitasyon sonucu trigeminal kaudal
nukleus nöronlarý aþýrý duyarlý hale gelmektedir. Eðer migrende damarsal
nosiseptörün aþýrý duyarlýlýðý söz konusu ise, kronik GTBde de büyük
olasýlýkla perikranyal kaslarda miyofasyal nosiseptörün aþýrý duyarlýlýðý ile
giden bir bozukluk söz konusu olabilir. Sekonder segmental santral duyarlýlaþma,
uyarýlarýn supraspinal modülasyon bozukluðu ve miyofasyal dokudan doðan uzamýþ
aðrýlý uyarýlarýn kronik forma dönüþünün de önemli olduðu düþünülmektedir. Akut
atak fiziksel veya psikolojik stresle, ya da fizyolojik olmayan çalýþma
koþullarý sonucu ortaya çýkabilir. Geçmiþte GTBnin önemli bir psikolojik
boyutu olduðunu savunanlar olsa da bu konuda bir kanýt elde edilememiþtir,
stres faktörlerinin nörofizyolojik mekanizmalarý tetiklediði düþünülmektedir.
Zorlanan kaslardan gelen nosisepsiyon artýþý aðrý modülasyonu bozulmuþ bir
kiþide ataðý tetikleyebilir. Emosyonel mekanizmalar da endojen antinosiseptif
sistemi baskýlayabilir. Nosiseptif nöronlarýn uzun vadeli potansiyasyonu ve
antinosiseptif sistemin aktivitesinin azalmasý kronik GTBne yol açabilir.
Trigeminal kaudal nukleus nöronlarýnýn duyarlýlaþmasý normalde aðrýya yol
açmayacak uyaranlarýn aðrýlý olmasý ve tetik noktalarý oluþturarak migren ve
GTB belirtilerinin çakýþmasýna ve trigeminal vasküler sistemin de aktivasyonuna
yol açabilir. MSS kas tonusunu gama eferent nöronlar yoluyla kontrol etmekte ve
buradan hareketle kas iðlerine giden alfa-motor nöronlar etkilenmektedir.
Renshaw hücreleri GABA aracýlýðýyla sinaptik sisteme etki etmektedir.
Baþaðrýsýz dönemlerde de perikranyal kas hassasiyetinin varlýðý önemlidir ve
tek baþýna kas kasýlmasýnýn baþaðrýsýndan sorumlu olmadýðýný göstermektedir, bu
hassasiyetin nedeni tam bilinmemekle birlikte çizgili kastaki kan damarlarý
çevresindeki nosiseptörlerin rolü olabilir. Ayrýca kas yorgunluðuna yol açan
metabolik ve nörokimyasal deðiþiklikler önemlidir. Diðer kronik aðrýlý
durumlara benzer þekilde kronik GTB formunun voksel tabanlý morfometrik MRG
çalýþmalarýnda beyin yapýsýnda deðiþikliklerle seyrettiði, aðrý yollarýyla
iliþkili gri maddede anlamlý azalmalar olduðu son yýllarda gösterilmiþtir. GTB
patofizyolojisi alanýndaki çalýþmalarýn yetersizliði bu hastalýðýn sýklýðý ve
yarattýðý yük düþünüldüðünde çok dikkat çekicidir. Son yýllarda yapýlmýþ olan
ve henüz doðrulanma bekleyen bazý ufak boyutlu çalýþmalar interlökin-8,
adiponektin ve nörotrofik faktörlerin rolü üzerinde durmaktadýr.<span
style='mso-spacerun:yes'>  </span>GTB ve migrenin tamamen ayrý hastalýklar mý
yoksa primer baþaðrýsý spektrumunun iki ucu mu olduðu sorusunun yanýtý da henüz
tartýþmalýdýr. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;mso-bidi-font-style:
italic'>Gerilim Tipi Baþaðrýsýnda Tedavi </span></b><span style='font-size:
13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Gerilim tipi baþaðrýsýnýn tedavisi migrene benzer prensipler içermektedir
ve daha az seçeneklidir. Atak sýrasýnda genelde parasetamol gibi <i
style='mso-bidi-font-style:normal'>basit analjezikler veya NSAÝ ilaçlar </i>yeterlidir,
herhangi birinin diðerlerine üstünlüðü gösterilmemiþtir. Tedavide hasta temelli
bir yaklaþým uygundur. Kronik GTBde <i style='mso-bidi-font-style:normal'>antidepresan
ilaçlar</i> kullanýlýr. Profilaksisinde antidepresanlarýn antinosiseptif etkisi
antidepresan etkiden kaynaklanmamaktadýr. Profilakside amitriptilin en etkili
ilaçlardandýr. Sersemlik hissi, aðýz kuruluðu, taþikardi, kalpte ileti bloðu,
nöbet, görme bozukluðu, idrar retansiyonu gibi yan etkileri vardýr ve ileri
yaþta, obez hastalarda ve MAO inhibitörü kullanma öyküsü olanlarda
kullanýlmamalýdýr. SSRI grubunun da (Paroksetin 20 mg, Fluoksetin 20 mg,
Citalopram 10-20 mg, Sertralin&nbsp; 50-100 mg, Fluvoksamin 50-100 mg ve
diðerleri) etkinliði vardýr. Bulantý, uyuklama, terleme, aðýz kuruluðu,
impotans, ekstrapiramidal bozukluklar ve nöbet gibi yan etkiler oldukça
seyrektir. MAO inhibitörü kullanan, karaciðer yetmezliði ve renal yetmezlik
olan hastada verilmemelidir. Bazý olgular tizanidin 2-8 mg/gün kullanýmýndan
yarar görebilir. GTBde ilaç tedavisi ile birlikte gevþeme teknikleri, stresle
mücadele yöntemleri, çeþitli egzersizler ve masaj gibi uygulamalarýn yapýldýðý
ilaç dýþý tedaviler de baþarýlý sonuçlar vermektedir. Bazý merkezlerde
oksipital sinir <span class=GramE>blokajý</span> þeklinde teknikler ilaç
tedavisine yanýtsýz kronik olgularda denenmektedir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>TRÝGEMÝNAL
OTONOMÝK SEFALALJÝLER </span></b><span style='font-size:14.0pt;line-height:
115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>Trigeminal otonomik
sefalaljiler </span><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR;mso-bidi-font-weight:
bold'>(TOS)</span><b><span style='font-size:14.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;trigeminal sinir daðýlýmýna uyan
bölgede baþaðrýsý ve bununla birlikte kranyal otonomik aktivasyon ile
karakterize bir dizi baþaðrýsý <span class=GramE>sendromundan</span> oluþur. En
sýk görülen tipi küme baþaðrýsýdýr. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;text-align:justify'><span
class=GramE><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-bidi-font-style:italic'>TOS</span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;için ortak özellikler aðrýnýn çok þiddetli
oluþu, her zaman tek yanlý oluþu, otonomik belirtilerin ataða mutlaka eþlik
etmesi (gözde yaþarma, kýzarma, þiþme, burunda o yanda týkanma veya akýntý,
alýnda veya yüzde terleme gibi), hergün veya gün aþýrý oluþu ve önceki sayýlan
baþaðrýlý durumlara göre kýsa süreli oluþu ve ayný gün içinde
tekrarlayabilmeleridir (<b>Tablo 5</b>). </span></span><span style='font-size:
13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Aðrý yerleþimi ve karakteri tüm TOS için benzer
olabilmekle birlikte, aðrý süreleri ve tekrarlama sayýlarý en ayýrdedici
özellikleridir.&nbsp;<span style='mso-bidi-font-style:italic'>Küme baþaðrýsý</span>,
otonomik sefalaljiler içerisinde yukarýda da anlatýldýðý gibi en uzun süreli
olaný olup ataklar 15 dakika ile 3 saat arasý sürebilir ve gün aþýrý bir kez
ile günde 8 kez arasýnda deðiþen sýklýkta gelebilir.&nbsp;<span
style='mso-bidi-font-style:italic'>Paroksizmal hemikranya</span>&nbsp;ve&nbsp;<span
style='mso-bidi-font-style:italic'>SUNCT/SUNA&nbsp;</span>ise çok daha nadir
durumlar olup küme baþaðrýsýndan daha kýsa süreli oluþlarýyla ayrýlýrlar. </span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Küme (Demet, Cluster) Baþaðrýsý<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Küme baþaðrýsý, gerilim ve migren baþaðrýsýndan sonra en sýk görülen primer
baþaðrýsýdýr. Her yaþta rastlanmakla birlikte daha yaygýn olarak 20-40 yaþ
arasý ortaya çýkmaktadýr. Çocuklarda ve yaþlýlarda çok seyrek görülür,
erkeklerde ve sigara içenlerde daha sýktýr. Aðrýnýn tipik özellikleri tek
taraflý, çok þiddetli ve migrene göre kýsa süreli olmasýdýr. Küme baþaðrýsý
olarak adlandýrýlmasýnýn en belirgin nedeni periyodik þekilde ortaya
çýkmasýdýr. Bu baþaðrýsý primer olabileceði gibi, nadir de olsa, sekonder bir
nedenle de ortaya çýkabilir. Deneysel çalýþmalar ve insanda fonksiyonel
görüntüleme incelemeleri ile oluþan bilgi birikimi, bu baþaðrýsý tipinde
fizyolojik trigeminal parasempatik refleksin aktive olarak sekonder kranyal
sempatik disfonksiyona neden olduðunu düþündürmektedir ve hipotalamusun
nosiseptif ve otonom yollara modülatör rolü üzerinde durulmaktadýr.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>&nbsp;</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Orbital, supraorbital, temporal tek taraflý, 15-180 dakika süren ve gün
aþýrý bir kez ile günde 8 defaya kadar ortaya çýkan þiddetli
ataklardýr.&nbsp;Bilinmeyen nedenlerle erkeklerde kadýnlara göre 3-4 kez daha
sýktýr.&nbsp;Çoðu hasta atak sýrasýnda huzursuz ya da ajitedir. Baþaðrýsý ile
ayný tarafta olmak üzere, ataklara aþaðýdakilerden biri ya da daha fazlasý
eþlik edebilir:</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;
Parsiyel Horner <span class=GramE>sendromu</span> (miyoz, pitoz)<br>
&nbsp;&nbsp;&nbsp; Burun týkanýklýðý veya akýntýsý<br>
&nbsp;&nbsp;&nbsp; Göz yaþarmasý (nazolakrimal kanalýn blokajýna baðlý olarak)<br>
&nbsp;&nbsp;&nbsp; Konjuktival kanlanma<br>
&nbsp;&nbsp;&nbsp; Alýn ve yüzde terleme artýþý (nadir)<br>
&nbsp;&nbsp;&nbsp; Ateþ basmasý (nadir)<br>
&nbsp;&nbsp;&nbsp; Yüzü ve göz kapaðýný içeren ödem (çok seyrek)<br>
&nbsp;&nbsp;&nbsp; Supraorbital cold spot (termografi ile saptanmýþ)</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Sistemik belirtiler<br>
&nbsp;&nbsp;&nbsp; Bradikardi<br>
&nbsp;&nbsp;&nbsp; Hipertansiyon<br>
&nbsp;&nbsp;&nbsp; Gastrik salgý üretiminde artýþ</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Ataklar, alýþýldýk biçimde aylar ya da yýllar süren düzelme dönemleri ile
ayrýlmýþ olan, haftalarca ya da aylarca süren diziler (küme dönemleri)
biçiminde ortaya çýkar. Ancak hastalarýn yaklaþýk %10-15inde düzelme
olmaksýzýn kronik belirtiler olur ve bu durum kronik küme olarak
adlandýrýlýr. Bir küme dönemi sýrasýnda ve kronik tipte, ataklar düzenli olarak
ortaya çýkar ve alkol, histamin ya da nitrogliserin ile uyarýlabilir. Aðrý her
bir küme dönemi sýrasýnda hemen hemen deðiþmeksizin ayný yerde ortaya çýkar. Hastalar
genellikle uzanamazlar ve tipik olarak dolaþmak zorunda kalýrlar. Akut
ataklarda posterior hipotalamik gri maddenin aktivasyonu olur. Küme baþaðrýsý,
olgularýn yaklaþýk&nbsp; %5inde kalýtsal olabilir. Bazý hastalarda sadece bir
tek küme dönemi de olabilmektedir. Trigeminal nevralji ile birlikte olan küme
baþaðrýsý (<i>küme-tik <span class=GramE>sendromu</span></i>) da
tanýmlanmýþtýr.</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Klinik olarak, baþaðrýsý konusunda tecrübe kazanmamýþ hekimler sýklýkla
küme baþaðrýsý ile migreni karýþtýrmaktadýrlar. Küme baþaðrýsý tipik olarak 6-12
hafta süren senelik ataklar halinde orta yaþlý erkeklerde ortaya çýkar. Bu
küme dönemlerinde, sabah erkenden (çalar saat baþaðrýsý) ya da uyuduktan
sonra bir saat içinde aðrýyla uyanýrlar. Alkol aldýktan sonra 20-30 dakika
içinde kriz dönemi baþlar ve hastalar doktor tarafýndan sözü edilmeden önce
bile alkolden kaçýnmalarý gerektiðini bilirler. Periyodik olmasý ana
özelliðidir, epizodlarý en çok ilkbahar ve sonbaharda görülür. Atak dönemi 2-3
ay sürer ve remisyon devri 1-2 yýl (sýnýrlarý 2 ay-20 yýldýr) devam eder.
Atakta aura yoktur ve aðrý 10-15 dakikada en yüksek seviyeye ulaþýr. </span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-fareast-language:TR'>Aðrýnýn en önemli
özelliklerinden biri huzursuzluk hissi olarak da tarif edilen <span
class=GramE>ajitasyonun</span> eþlik etmesidir. Yeni taný kriterlerine göre
otonom bulgu olmadan <span class=GramE>ajitasyon</span> varlýðý ile ayný
þekilde küme baþaðrýsý tanýsý koyulabileceði unutulmamalýdýr. </span><span
style='font-size:13.5pt;line-height:115%;font-family:"Times New Roman","serif";
color:black;mso-ansi-language:TR;mso-fareast-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Tedavi</span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Akut atakta 5-8 litre/dakika oksijen inhalasyonu %70 oranýnda baþarýlý
olmaktadýr. Medikal tedavi olarak intramusküler dihidroergotamin, tercihen
subkütan veya oral triptanlar ve akut atakta kortikosteroidler kullanýlabilir.
Küme baþaðrýsýnýn tipik özelliði analjezik ilaçlara ve migrenin tipik
profilaksisine çoðu kez yanýtsýzlýklarýdýr. Verapamil, lityum ve steroidlerle
profilaksiye ise yanýt verirler.</span><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:10.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Patofizyoloji</span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kümenin baþaðrýsý da
trigeminal sinirin nosiseptif oftalmik dallarý yoluyla taþýnýr. CGRP insanda
bilinen en güçlü vazodilatatörlerdendir ve salýnýmý sonucunda nörojenik bir
inflamasyon tetiklenir ve dural kan damarlarý geniþler. Küme baþaðrýsýnda da
trigeminovasküler sistemin aktive olduðu hastalarýn küme ataðý sýrasýnda
eksternal jügüler venlerinde CGRP düzeylerinin arttýðýnýn gösterilmesi ile
kesinleþmiþtir. Otonom bulgular ise kranyal parasempatik liflerin aktivasyonuna
sekonderdir. Bu lifler superior salivator nukleustan kaynaklanýr ve trigeminal
nukleus kaudalis ile fonksiyonel bir beyinsapý baðlantýlarý vardýr. Bu lifler
7.sinir ile seyreder ve pterigopalatin ganglionda sinaps yaparlar.
Postganglionik lifler beyin damarlarýna ve nazal mukozaya vazomotor ve sekretomotor
inervasyon saðlarlar. Küme baþaðrýlý kiþilerde bu yolda aktivasyon olduðu, VIP
kan düzeylerinin atak sýrasýnda belirgin þekilde arttýðýnýn gösterilmesi ile
desteklenmiþtir. Horner <span class=GramE>sendromu</span> geliþmesi
postganglioniktir ve karotid sempatik pleksusunun tutulumu ile baðlantýlýdýr.
Karotis kavernöz parçasý, bu düzeyde parasempatik, sempatik ve trigeminal
lifler biraraya geldiðinden en uygun lokalizasyon gibi görünmektedir.
Görüntüleme çalýþmalarý da kavernöz sinüsde arteryel geniþleme ve venöz dönüþte
obstrüksüyon göstermiþtir. Sendromun periodisitesi ise henüz açýklýða kavuþmuþ
deðildir. Oreksinler gibi bazý genlerde mutasyon varlýðý speküle edilmektedir.
Verapamile yanýt, erkeklerde sýk olmasý ve sigara ile baðlantý da henüz yeterli
þekilde açýklanabilmiþ deðildir. Profilaktik tedavide güçlü bir
anti-inflamatuar olan steroide çok hýzlý ve iyi yanýt alýnmasý küme
baþaðrýsýnýn temelinde inflamasyonun yattýðýný akla getirmektedir ancak bu
alanda bir kanýt yoktur. Hastalýðýn anýlan þekilde sirkadyen ve dönemsel
özellikler göstermesi ve yeni görüntüleme verileri patofizyolojisinde
hipotalamusun rolünü desteklemektedir. Patofizyolojisi henüz net anlaþýlamamýþ
olan bu tablonun nöronal, vasküler, genetik ve immün mekanizmalarýn karþýlýklý
etkileþimi sonucu oluþtuðu kanýsýna varýlmýþtýr. CGRP monoklonal antikorlarýnýn
bu tabloda da baþarýlý sonuçlar verdiði henüz yeni araþtýrmalarda dikkati
çekmektedir.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Paroksizmal
Hemikranya<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sjaastad
ve Dale tarafýndan 1974de tanýmlanmýþ olan paroksizmal hemikranya (PH), çok
seyrek görülen bir primer baþaðrýsýdýr. Kadýnlarda daha sýk görülür ve 25-40
yaþ arasýndaki kiþilerde rastlanmaktadýr. Aðrý kesinlikle hep ayný tarafta
þiddetli olarak ortaya çýkar, kýsa süren ve remisyonsuz baþaðrýlarýdýr.
Sýklýkla kroniktir, ancak epizodik formu da tanýmlanmýþtýr. Kiþi hemen bir yere
oturma ya da yatma ihtiyacý duyar. Aðrýnýn yapýsý zonklayýcý, damar atar gibi,
oyucu, delici olarak tanýmlanabilir. Ataklarýn ortalama günlük sýklýðý 5-20
arasýndadýr ve her seferinde aðrý </span><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:TR'>süresi 2-30 dakika<span style='color:black'> arasýndadýr.
Ýliþkili otonom deðiþiklikler küme baþaðrýsýndakine çok benzer ancak&nbsp;<i>tipik
özellik indometazinle 3 gün içinde tam kontrol edilebilmesidir</i>. Ýliþkili
otonom belirtilerin hemen hemen tamamý kranyal parasempatik aktivasyonla iliþkilidir.
Tek istisnasý muhtemelen kýsmi bir sempatik defisite baðlý olan Horner <span
class=GramE>sendromudur</span>. PH ayýrýcý tanýsýnda sekonder nedenler MRG ile
araþtýrýlmalýdýr. &nbsp;<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Tedavisi</span></i><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>, günde üç kez 25 mg
indometazindir. Eðer cevap alýnamazsa yavaþça 225 mga çýkarýlmasý
önerilmektedir. Ýndometazine cevapsýzlýk ancak 150 mg oral (100 mg IM) veya
üzeri dozlarda deðerlendirilebilir. Tüm hastalarda olasý gastrointestinal yan
etkilerine karþý önlem alýnmalýdýr. Epizodik formda indometazin genellikle
tahmin edilen atak süresinden daha uzun bir süre verilir ve azaltýlarak
kesilir. Remisyon dönemleri olsa da, kronik formda çok uzun süreli tedavi
gerekir. Ýndometazinin etki mekanizmasý bilinmemektedir ve NO üretimini
azaltýcý etkisi ve CGRP ve VIP üzerinden etkili olduðu sanýlmaktadýr.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>Hemikranya Kontinua<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><i><span style='font-size:13.5pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sjaastad
ve Spierings tarafýnda 1984de tanýmlanmýþtýr. Unilateral, otonom bulgu ve </span><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'>migrenöz bulgularýn eklendiði,
þiddetlenmelerle giden 3 aydan uzun bir süredir varolan devamlý bir
baþaðrýsýdýr. Otonom bulgular diðer TOSlara göre geri plandadýr. Saplanýcý
komponenti de vardýr. Aslýnda çok nadir olmadýðý ve kronik günlük aðrýlarýn
içinde tanýnmadýðý düþünülmektedir. Ayýrýcý tanýsýnda diðer TOSlar dýþýnda
kronik migren, kronik GTB ve&nbsp;<i>yeni günlük süreðen baþaðrýsý</i>&nbsp;vardýr.
Patofizyolojisi tam bilinmemektedir; migren ve TOS arasý geçiþ formu olarak
kabul edilmektedir. Fonksiyonel MRG kontralateral posterior hipotalamus
aktivasyonu ve ipsilateral mezensefalona uzanan dorsal pons aktivasyonu
göstermiþtir. Ýndometazine yanýtlý bir aðrýdýr. <span style='color:black'>Çapraz
bir çalýþmada oksipital sinir stimülasyonu 6 hasta üzerinde baþarýlý
bulunmuþtur.<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>SUNCT
Sendromu</span></b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;(Tek
taraflý göz yaþarmasý ve kýzarmasýnýn eþlik ettiði kýsa süreli nevraljiform
aðrýlar)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sjaastadýn
1978de tanýmladýðý bu tablo primer baþaðrýlarýnýn en seyrek
görülenlerindendir. Patofizyolojisinde trigeminohipotalamik yolaðýn rol aldýðý
öne sürülmektedir. Diðer aðrýlardan farklý olarak ileri yaþlarda ortaya çýkar,
ortalama görülme yaþý 50dir. Erkeklerde </span><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:TR'>daha sýk görülür. Aðrýnýn yapýsý þiddetli, yakýcý, oyucu,
elektrik çarpmýþ gibidir, 1-600 saniye süren paroksizmler halinde gelir. Taný
için günde en az bir kez olmasý gerektiði kabul edilmektedir. Öte yandan<sup>&nbsp;</sup>bir
saatte 5-6 atak ve günde 200 atak gibi bir sýklýða ulaþabilir. Status formu da
bildirilmiþtir. Baþaðrýsýna ayrý tarafta, göz kýzarmasý veya yaþarmasý; burun
týkanýklýðý veya burun akýntýsý, göz ödemi, alýn ve yüzde terleme, miyoz veya
pitoz gibi otonom belirtilerden en az biri eþlik etmelidir. Ataklar genelde
gündüz olur, bazý olgularda ataklar trigeminal veya boyun gibi bölgelerde
basýnç, çiðneme veya hareketle tetiklenebilir. Tedavide denenen ilaçlarýn çoðu
baþarýsýzdýr. En çok antiepileptik ilaçlardan (Lamotrijin 200-400mg,&nbsp;
topiramat 50-300mg, gabapentin eklenmesi) yararlanabilir. Sekonder SUNCT <span
class=GramE>sendromu</span> gösteren birçok olgu sunumu vardýr ve sýklýkla arka
çukur lezyonlarý ile iliþkilidir; bu durum hastalara MRG incelemesi
yapýlmasýnýn gerekliliðini ortaya koymaktadýr.<b>&nbsp;</b>Fonksiyonel MRG ile
bir hastada ipsilateral hipotalamik aktivasyon bildirilmiþtir. Dirençli
olgularda&nbsp; kortikostreoidler, azotioprin ve çeþitli invazif <span
class=GramE>prosedürler</span> önerilmiþtir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Göz kýzarmasý
ya da yaþarmasýndan yalnýz birinin olduðu ya da ikisinin de görülmediði
baþaðrýsý formuna ise </span><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-ansi-language:TR'>kranyal otonomik <span class=GramE>semptomlarýn</span>
eþlik ettiði kýsa süreli tek yanlý nevraljiform baþaðrýsý (SUNA)
denilmektedir.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:12.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Tablo
8.&nbsp;</span></b><span style='font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Kýsa süreli bazý
baþaðrýlarýnda ayýrýcý taný <o:p></o:p></span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=541
 style='width:405.8pt;mso-cellspacing:0cm;margin-left:-.05pt;border:solid white 1.0pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;height:25.7pt'>
  <td width=96 valign=top style='width:72.0pt;border:solid windowtext 1.0pt;
  border-right:none;padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Özellik</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Küme</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>KPH</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>EPH</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>SUNCT/SUNA</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Saplanýcý</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>baþaðrýsý</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Trigeminal nevralji</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;height:19.6pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Cinsiyet
  (E:K)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>3-<span
  class=GramE>4:1</span></span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1:2</span></span><span
  style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>-3</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1:1</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2.3:1</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>K&gt;E</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>K&gt;E</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2;height:28.4pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Atak Süresi</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>15-180 dakika</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2-45 dak</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2-30 dak</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1-600saniye</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&lt;1s</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&lt;1s</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;height:28.4pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Atak sýklýðý</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1-8/gün</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1-40/g</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>3-30/g</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1/gün-30/saat</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>deðiþken</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>deðiþken</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;height:28.4pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Otonom
  bulgular</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5;height:21.6pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Tedavi</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>özgül</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";background:yellow;mso-highlight:
  yellow'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>zor</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>CBZ</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes;height:21.6pt'>
  <td width=96 valign=top style='width:72.0pt;border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:solid windowtext 1.0pt;border-right:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ýndometazin
  etkisi</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+/-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span style='font-size:9.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>KPH: kronik paroksizmal
hemikranya EPH: epizodik paroksizmal hemikranya</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:9.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>SUNCT: Tek taraflý göz yaþarmasý
ve kýzarmasýnýn eþlik ettiði kýsa süreli nevraljiform aðrýlar</span><span
lang=EN-US style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:9.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>SUNA: </span><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
mso-ansi-language:TR'>kranyal otonomik <span class=GramE>semptomlarýn</span>
eþlik ettiði kýsa süreli tek yanlý nevraljiform baþaðrýsý<span
style='color:black'>&nbsp;</span></span><span lang=EN-US style='font-size:9.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:14.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>ÝLAÇ AÞIRI KULLANIM BAÞAÐRISI (ÝAKB)</span></b><span style='font-size:14.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Aþýrý
analjezik ilaç kullanmaya baðlý baþaðrýsý, ergotamin, triptan, basit
analjezikler, opioidler veya kombine analjeziklerin ayda 10-15 günden fazla
alýnmasýna baðlý olarak geliþen sekonder nitelikte baþaðrýsýdýr (Tablo 1B).
Tipik bir klinik tablosu yoktur, genelde altta migren gibi primer bir baþaðrýsý
vardýr. Tüm baþa <span class=GramE>lokalize</span>, künt, sýkýþtýrýcý veya
zonklayýcý olabilir. Genelde hafif, eþlikçi <span class=GramE>semptomu</span>
olmayan devamlý bir aðrýdýr, zaman zaman þiddetlenebilir. IHS tarafýndan
belirlenen <span class=GramE>kriterler</span>; öncesinde primer bir baþaðrýsý
olmasý, günlük veya çok sýk aðrý (&gt; 15 gün/ay); analjezik ilaçlarýn uygunsuz
kullanýmý (ilaç kullanýmý &gt; 10 gün/ay ve &gt; 3 ayý aþan zamandan
beri)&nbsp; ve ilaçlarýn býrakýlmasý ile düzelme þeklinde özetlenebilir.
Kadýnlarda erkeklerden 3-4 kat fazla rastlanmaktadýr, ortalama 40 yaþlarýnda
taný konulur. Bazý hastalarda primer baþaðrýsýnýn devam süresi 20 yýl, kötü
kullanýmýn süresi 10 yýl gibi süreleri aþabilmektedir. Migren ve GTBAdan sonra
3. en sýk tip baþaðrýsýdýr ve kronik günlük baþaðrýsý olgularýnýn 1/3ü bu
tanýyý almaktadýr. Ergenlik çaðýnda ve hatta çocuklarda artan oranlar
bildirilmesi endiþe vericidir. Genel <span class=GramE>popülasyonda</span> %3
sýklýkta hatta daha sýk olduðu bildirilmektedir. Ýlginç bir durum, devamlý NSAÝ
kullanmak durumunda olan artritlilerde seyrek geliþmesi ve sadece migreni olan
artritlilerde ortaya çýkmasýdýr. Bu durum genetik yatkýnlýk ile açýklanabilir.
Ýlaç baðýmlýlýðý (psikolojik ve fiziksel) ile benzer mekanizmalar içerdiði,
santral sensitizasyonun ve reseptör <span class=GramE>regülasyonunun</span>
(serotonin vs siklooksijenaz sistemleri) rolü olduðu ileri sürülmektedir.
Kronik suma- ve zolmitriptan tedavisi ile hayvan modellerinde korteks ve
beyinsapý serotonin reseptörlerinde anlamlý azalma gösterilmiþtir. Arka kök
nöronlarýnda artmýþ uyarýlabilirliðin yaný sýra nöroplastik kalýcý deðiþiklikler
olduðu ileri sürülmüþtür.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Yurdumuzda ÝAKBye en sýk yol açan ilaç grubu hala ergo bileþikleridir.
Triptanlarýn daha kýsa sürede ÝAKBya yol açabildiði ama tedavisinin de daha
kolay olduðu bilinmektedir. Ancak basit analjeziklerle ortaya çýkmýþ çok sayýda
ÝAKB olgusu da vardýr. Tedavide esas olan bu ilaçlarýn tamamen kesilmesi, bu
dönemdeki geri çekilme semptomlarýnýn tedavisi ve ileriye yönelik nüksü önlemek
için ve baþaðrýsý sýklýðýný kontrol için profilaksi <span class=GramE>dahil</span>
önlemlerin alýnmasýdýr. ÝAKBde nükslerin sýk olduðu bilinmektedir. Kombine
ilaçlar ve opioidlerle nüks daha sýktýr.&nbsp;&nbsp;<o:p></o:p></span></p>

<h2 style='margin-top:0cm;text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;font-weight:normal'>Hastaya yeterli þekilde durumu açýklamak ve <span
class=GramE>motivasyonu</span> saðlamak tedavide esastýr, ayaktan veya yatarak
ilaç kesme konusunda hasta ve hekim birlikte karar verebilir. Genelde aþýrý
ilaç kullanýmýný sýk poliklinik kontrolleri ile kesmek tercih edilmektedir.
Rutin aðrý tedavisinin býrakýlmasýný köprü tedavisi (genelde amitriptilin ve
anti-emetik; kortizon veya diðer) ve yoksunluk <span class=GramE>semptomlarýnýn</span>
giderilmesi (2-10 gün) izler. Hastalar özellikle ilk bir hafta içerisinde
karþýlaþacaklarý yoksunluk belirtileri (sinirlilik, huzursuzluk, baþaðrýsýnda
þiddetlenme, bulantý, kusma, uykusuzluk, diyare ve tremor gibi) açýsýndan
uyarýlmalý ve destek olunmalýdýr. Eþlik eden davranýþ modifikasyon tedavileri,
aylýk dozlarýn sýnýrlanmasý ve hastaya uygun profilaksi baþlanmasý önemlidir.<o:p></o:p></span></h2>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>ENDER
GÖRÜLEN&nbsp;DÝÐER </span></b><b><span style='font-size:14.0pt;line-height:
115%;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>PRÝMER BAÞAÐRILARI
<span style='color:red'><o:p></o:p></span></span></b></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Hipnik baþaðrýsý</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-bidi-font-style:italic'>:</span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Tipik olarak gece yalnýz uyku sýrasýnda
ve uykuya daldýktan birkaç saat sonra ortaya çýkan, uykudan uyandýran orta
þiddette baþaðrýlarýdýr. Çok seyrek rastlanýr ve genelde 50 yaþ üstünde
görülür. Aðrý genellikle zonklama þeklindedir, birden baþlar ve tüm baþa
yayýlýr. Birlikte görülen herhangi bir organik etken yoktur. Tartýþmalý olmakla
birlikte genellikle uykunun REM döneminde ortaya çýkar ve kiþiyi uyandýrýr.
Ataklar 15 dakika ile 4 saat arasýnda deðiþen sürelerde görülür, gecede birkaç
kez tekrarlayabilir. Tek taraflý olabilse de bu aðrýlar genellikle yaygýndýr.
Etkili tedavi için özellikle küme baþaðrýsýndan ayýrým önemlidir. Bu tür
baþaðrýlarý bulunan hastalar genellikle yatarken alýnan kafein, melatonin veya
200-600mg lityum karbonata cevaplýdýr.</span><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Primer saplanýcý baþaðrýsý:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Altta yatan organik bir bozukluk
olmaksýzýn, kendiliðinden ortaya çýkan geçici ve yerel/bölgesel saplanýcý
aðrýlardýr. Genelde trigeminal alandadýr ama baþka bölgelerde de olabilir ve
yer deðiþtirebilir. Saplanmalarýn birkaç saniye içinde (%80i 3 saniye veya
daha kýsa sürede) sonlanarak gün içinde pek çok kez deðiþen sýklýkta yeniden
ortaya çýkmasý olasýdýr. Seyrek olarak bazý olgularda býçak saplanýr tarzda
aðrýlar günler boyunca tekrarlar. Saplanmalar ayný baþ yarýsý veya karþý yarýda
bir alandan diðerine hareket edebilir. Saplanma aðrýlarý, genellikle aðrý
hissetmeye alýþýlmýþ olan baþ bölgesinde hissedilmek üzere, sýklýkla migren
(yaklaþýk %40) veya küme baþaðrýsý (yaklaþýk %30) tanýsý alan hastalar
tarafýndan bildirilmektedir. Tedavisi için kontrollü çalýþmalar olmasa da
indometazine olumlu yanýt alýnmýþ olgular bildirilmiþtir. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Numüler baþaðrýsý</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>: Para þeklinde baþaðrýsý olarak ifade
edilen bu aðrý altta yatan yapýsal bir lezyon olmaksýzýn ortaya çýkan, sýklýkla
kronikleþen, kafa derisinde 1-6cm çapýnda gibi küçük bir alanda ve süresi
oldukça deðiþken bir baþaðrýsý olarak tanýmlanmaktadýr. Bu tip baþaðrýsýnda
özellikle yapýsal ve dermatolojik lezyonlar; öykü, fizik muayene ve uygun
araþtýrmalarla dýþlanmalýdýr. Numüler baþaðrýsý nadir görülen primer
baþaðrýlarý arasýnda sýnýflandýrýlmaktadýr. Patogenezi tam olarak
aydýnlatýlamamýþ olan bu baþaðrýsýna sahip hastalar için net bir tedavi
algoritmasý yoktur. Aðrý þiddeti hafif olan olgular tedaviye ihtiyaç
duymayabilirler. Hastalarýn yarýsýndan çoðunun bilinen analjeziklere (NSAÝ,
parasetamol gibi) yanýtlý olduðu bildirilmektedir. Bu bilgilere raðmen,
þiddetli aðrýsý olan, aðrýsý süreklilik gösteren ve NSAÝye yanýt vermeyen
hastalarda gabapentin, trisiklik antidepresanlar gibi koruyucu tedavi
gerekebilir.<s><o:p></o:p></s></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Öksürük baþaðrýsý:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Öksürükle, hapþýrýkla ortaya çýkan,
eskiden Valsalva manevrasý baþaðrýsý denen nadir bir baþaðrýsýdýr.&nbsp;<span
style='mso-bidi-font-style:italic'>Selim öksürük baþaðrýsý&nbsp;</span>yani bu
tablonun primer þekli çok nadir bir durumdur. Kýrk yaþýn üstündeki bireylerde
ve erkeklerde daha sýk görülür. Baþaðrýsý öksürük, hapþýrýk veya bir Valsalva
manevrasýndan (aðýrlýk kaldýrma, zorlanma, dýþkýlarken ýkýnma, sümkürme, aðlama
veya þarký söyleme) hemen sonra veya birkaç saniye içinde ortaya çýkar.
Baþaðrýsý çok þiddetlidir ve patlayýcý bir nitelik gösterir, saniyeler veya
saatler (1 saniye-2 saat) sürer, genellikle iki yanlýdýr, en yoðun aðrý
vertekste veya diðer bölgelerde hissedilir. Öksürüðün önlenmesi ile baþaðrýsý
engellenebilir.<sup>&nbsp;</sup>Nörolojik muayene genellikle normaldir.
Kusmanýn bulunmasý, baþaðrýsýnýn altýnda organik bir neden olduðunu düþündürür.<sup>&nbsp;</sup>Öncül
bir solunum yolu infeksiyonu bazen bulunur. Hastalarýn çoðu atak aralarýnda
aðrýsýzdýr, ancak bazý olgularda ataklarýn ardýndan künt bir aðrý birkaç saat
boyunca sürebilir.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Öksürük baþaðrýlarýnýn yaklaþýk %40ý semptomatiktir ve bu olgularýn
çoðunluðunda Arnold Chiari Tip I malformasyonu bildirilmiþtir. Öksürük
baþaðrýsýnýn diðer bildirilen nedenleri arasýnda karotis veya vertebrobaziler
sistem hastalýklarý ve beyin anevrizmalarý yer almaktadýr. Baþlangýç yaþý&nbsp;<span
style='mso-bidi-font-style:italic'>semptomatik öksürük baþaðrýsý</span>&nbsp;hastalarýnda
selim öksürük baþaðrýsý hastalarýna oranla daha gençtir. &nbsp;<span
style='mso-bidi-font-style:italic'>Bu nedenle bu tip baþaðrýlarýnda MRG mutlaka
yapýlmalýdýr.&nbsp;</span>Semptomatik öksürük baþaðrýsý, selim öksürük
baþaðrýsýnýn aksine indometazine cevapsýz da olabilir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Egzersiz baþaðrýsý:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Egzersizin herhangi bir çeþidi ile
alevlenen baþaðrýlarýdýr. Genelde migren tipi baþaðrýsý görülür, zonklayýcýdýr,
5 dakika-48 saat sürer. Bu tipte baþaðrýsý ilk kez ortaya çýktýðýnda
subaraknoid kanama ve arteryel diseksiyonun dýþlanmasý zorunludur. Primer
egzersiz baþaðrýlarý özellikle sýcak hava veya yüksek irtifada ortaya çýkar.
Ergotamin alýmý ile bazý olgularda baþaðrýlarýnýn önlenebildiði bildirilmiþtir.
Olgularýn pek çoðunda indometazin etkili bulunmuþtur. Tedavide spordan yarým
saat önce NSAÝ verilmesi sorunu çözebilir. Öksürük baþaðrýsýndan daha erken
yaþta baþlayan bir tablodur.</span><span style='font-size:13.5pt;line-height:
115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>S<span style='mso-bidi-font-style:italic'>emptomatik <span class=GramE>efor</span>
baþaðrýsý</span>&nbsp;genellikle daha þiddetlidir, iki taraflýdýr ve baþlangýcý
patlayýcý niteliktedir. Çeþitli etyolojik nedenler arasýnda subaraknoid kanama,
sinüzit ve beyin kitleleri sayýlabilir. Diðer baþaðrýsý tipleri de <span
class=GramE>eforla</span> tetiklenebilir. Migren, LP sonrasý baþaðrýsý ve
intrakranyal hipertansiyona baðlý aðrý da öksürükle þiddetlenebilir. Ayrýca
Monro forameninden BOS akýmýný engelleyen III. ventrikül kolloid kisti bulunan
hastalarda da kafaiçi basýncýn ani yükselmelerine baðlý olarak paroksizmal
baþaðrýsý bulunabilir. Yan ventrikül tümörleri, kranyofaringioma, pinealoma,
serebral ve serebellar tümörleri bulunan hastalarda da benzer baþaðrýlarý
görülebilir. Feokromasitomalar da özellikle egzersiz sýrasýnda paroksizmal
baþaðrýlarýna yol açabilirler.<sup>&nbsp;</sup>&nbsp;Bu nedenle bu baþaðrýsý
tipinde de mutlaka ayrýntýlý incelemeler yapýlmalýdýr.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Cinsel iliþki ile iliþkili baþaðrýsý:</span></b><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span></b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Cinsel etkinlik sýrasýnda ortaya çýkan ve cinsel uyarýlma ile artan aðrý
genellikle iki yanlý çok þiddetli ve patlar gibi ortaya çýkar, nadiren
zonklayýcý veya saplanýcý özellik gösterebilir. Erkeklerde daha sýktýr ve
hastanýn yaþam kalitesini olumsuz etkiler. Süresi deðiþkendir, 1 dakikadan kýsa
sürebildiði gibi 3 saati aþabilir, 72 saate kadar uzayabildiði de
bildirilmiþtir. Sýklýðý doðrudan cinsel iliþki veya mastürbasyon sýklýðýna
baðlýdýr. Hastalarýn yaklaþýk üçte birinde fiziksel egzersizle benzer
baþaðrýlarý ortaya çýkar. Koitus sýrasýnda ortaya çýkan patlayýcý baþaðrýsý bir
subaraknoid kanamaya baðlý olabileceði gibi, primer bir baþaðrýsý da olabilir.
Bu hastalarýn uzun vadeli prognozu olumludur. Baþaðrýlarý sýk ve þiddetli ise,
ataklarýn kýsa süreli olmasý atak tedavisini anlamsýz kýlacaðýndan, profilaktik
tedavi gerekebilir. Bazý hastalar indometazine veya naproksene iyi cevap
verirler.</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Tanýmlanan farklý tipler arasýnda&nbsp;<span style='mso-bidi-font-style:
italic'>preorgazmik baþaðrýsý</span>&nbsp;boyun veya çene kasýlmalarýnýn eþlik
ettiði künt tipte, baþ ve boyunda yerleþen, cinsel heyecan düzeyi arttýkça
þiddetlenen bir baþaðrýsýdýr.&nbsp;<span style='mso-bidi-font-style:italic'>Orgazmik
baþaðrýsý,</span>&nbsp;orgazm sýrasýnda ortaya çýkan ani baþlangýçlý ve
þiddetli bir baþaðrýsýdýr.&nbsp;<span style='mso-bidi-font-style:italic'>Postüral
tip</span>&nbsp;ise koitus sonrasýnda düþük BOS basýncý baþaðrýsýný andýran
postüral deðiþkenlik gösteren baþaðrýsýdýr. Kafaiçi bozukluk olmaksýzýn cinsel
etkinlik ile tetiklenen baþaðrýsý, genellikle cinsel uyarýlma ile künt iki
yanlý aðrý olarak baþlar ve orgazm sýrasýnda aniden yoðun hale gelir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Yeni günlük süreðen baþaðrýsý:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;<span style='mso-spacerun:yes'> 
</span>Çok net olarak tanýmlanabilen baþlangýç anýndan itibaren aralýksýz devam
etmesi özelliði ile benzeri olmayan bir tablodur. Aðrý en az 3 aydýr devam
etmektedir ve migren veya GTB tipinde olabilir. Ancak ani ve net baþlangýç
özelliðinden dolayý kronik migren veya kronik GTB olarak sýnýflandýrýlmaz.
Düþük BOS hacmi baþaðrýsý, yüksek BOS basýncý baþaðrýsý, posttravmatik
baþaðrýsý, infeksiyonlara baðlý (özellikle viral) baþaðrýsý ve ÝAKB gibi
sekonder baþaðrýlarý uygun araþtýrma yöntemleri ile dýþlanmalýdýr. Tipik olarak
aylar içinde tedavisiz düzelen kendini sýnýrlayan bir formu ve yoðun tedavi
programýna raðmen devam eden dirençli þekli vardýr.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Atipik yüz aðrýsý:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Muayenede ve geniþ ayýrýcý taný
listesinin gözden geçirilmesini gerektiren incelemelerde bir bulgu saptanmayan
devamlý idyopatik yüz aðrýsýdýr. Derin veya yüzeyel, genelde tek yanlý
periferik nöroanatomik sýnýrlara uymayan, yayýlan ve hafif subjektif duyusal
yakýnmalarýn eklendiði ve patofizyolojisi iyi anlaþýlamamýþ bir durumdur. Altta
yatan bir nöropatik durum olduðu, hafif hasarlarýn tetiklediði uzun süreli
nöroplastik deðiþiklikler ve deaferantasyona baðlý olduðu düþünülmektedir. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Kranyal Nevraljiler</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;<b><span style='mso-bidi-font-style:
italic'><o:p></o:p></span></b></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Baþ ve boyun aðrýsý trigeminal, intermedyal, glossofaringeal, vagal,
oksipital sinirler aracýlýðý ile üst servikal köklerin afferent lifleri
tarafýndan taþýnýr. Bu sinirlerin basýya, distorsiyona, soðuk veya diðer
zararlý uyarýlara maruz kalmasý veya santral yollarda ortaya çýkan bir lezyonla
uyarýlmasý sonucunda semptomatik olarak ya da sýk olarak da idyopatik olarak
ilgili sinirin innerve ettiði alanda akut saplanýcý veya sabit bir aðrý ortaya
çýkar. Bu tablolar uluslararasý sýnýflamada farklý bir grup olarak ele
alýnmaktadýr.</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>En sýk görülen&nbsp;<b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-style:italic'>trigeminal nevralji</span></b><span
style='mso-bidi-font-style:italic'>&nbsp;</span>iyi tanýnan bir tablodur ve ayýrýcý
tanýda genelde problem yaratmaz. Trigeminal nevralji tek taraflý, kýsa
þimþekvari aðrýlar ile karakterize, ani baþlayýp ani sonlanan ve trigeminal
sinirin ikinci veya üçüncü dalýnýn daðýlým alaný ile sýnýrlý (birinci dalda %5)
bir durumdur. Aðrý genelde yüz yýkama, traþ olma, sigara içme, konuþma ve/veya
diþ fýrçalama (tetik faktörler) gibi uyaranlarla ortaya çýkabildiði gibi,
sýklýkla spontan da olabilir. Nazolabial oluk ve/veya çenedeki küçük alanlar
(tetik alanlarý) aðrýnýn tetiklenmesine eðilimli bölgelerdir. Tetik
noktalarýnýn daha çok idyopatik tipte olduðu düþünülmektedir. Aðrýlar deðiþik
dönemler boyunca durabilir. Bazen zeminde künt bir aðrý devam edebilir.
Nevraljiler idyopatik veya nadiren semptomatik&nbsp; (herpes zoster infeksiyonu
veya MRG ile gösterilmiþ yapýsal bir lezyon þeklinde) olabilir. Giderek artan
görüntüleme incelemeleri sonucunda bu tabloda yüksek oranda trigeminal sinir
kökünün geniþ ve kývrýmlý damarlar tarafýndan basýya uðradýðý gösterilmiþtir.
Olgularda ince kesitli bir MRG incelemesi mutlaka yapýlmalýdýr. Aðrý karþýya
geçmez, bilateral görüldüðünde multipl skleroz gibi bir tablodan
kuþkulanýlmalýdýr. Aðrý sýrasýnda o taraf yüz kaslarýnda spazm geliþebilir
(aðrýlý tik). Diðer sözü edilen sinir alanlarýna ait nevraljiler de tanýmlanmýþtýr
ama oldukça seyrektir.</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Tedavide analjezikler etkisizdir, altýn standart olarak kabul gören
karbamazepin (200-1200 mg yavaþça yanýt alýnana dek titre edilerek ve lökosit, elektrolit
ile transaminazlar izlenerek) veya benzer etkide olduðu bildirilen
okskarbazepin ilk seçenek ilaçlardýr. Gabapentin, pregabalin gibi diðer bazý
epilepsi ilaçlarý da yanýtsýz olgularda veya yan etki varlýðýnda ek olarak
kullanýlýr. Tedavi bazý hastalarda düþük dozlarla da saðlanabileceði için düþük
dozla baþlanýp klinik duruma göre yan etkiler açýsýndan takip edilerek
arttýrýlmalýdýr. Giriþimsel çeþitli sinir <span class=GramE>blokaj</span>
tedavileri deneyimli ellerde baþarýlý olarak bildirilmektedir; ilaç tedavisine
yanýtsýz olgularda denenebilir. Çok az sayýda dirençli olguda sinirin sýkýþtýðý
bölgeyi rahatlatmaya yönelik cerrahi giriþim yapýlabilir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Tolosa-Hunt <span class=GramE>sendromu</span>:&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Üçüncü, dördüncü ve/veya altýncý kranyal
sinirlerin paralizisi ile giden, genellikle kendiliðinden düzelen, ancak
alevlenme ve yatýþma eðilimleri sergileyen epizodik bir tablodur. Bazen
trigeminal birinci dal ve optik, fasyal veya akustik sinir tutulumu da
eklenebilir. Tedavi edilmezse haftalarca devam eden tek yanlý orbital aðrý söz
konusudur. Bu sendromda kavernöz sinüs, superior orbital fissür ve/veya
orbitada MR (<span class=GramE>kontrast</span> verilmesi genellikle
gerekmektedir) ve biyopsi ile granülomatöz bir lezyonun varlýðý gösterilebilir.
Kortikosteroidlerle genellikle 3 gün içinde düzelme gözlenir. Diðer aðrýlý
oftalmopleji nedenleri örneðin tümörler, vaskülit, bazal menenjit, sarkoidoz,
IgG 4 birikimi, diyabet ve oftalmoplejik migren uygun yöntemlerle
dýþlanmalýdýr.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><b
style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi5.jpg">Þekil 5.</a></span></b><span
style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'> Tolosa Hunt <span class=GramE>sendromu</span>
tanýsýyla izlenen bir olgunun koronal MR kesitinde kavernöz sinüste tutulum
dikkati çekmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>BAZI
SEKONDER BAÞAÐRILARI</span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Tekrarlayan Aðrýlý Oftalmoplejik Nöropati
(Oftalmoplejik migren)<i> </i></span></b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Eskiden migren alt grubu olarak sýnýflandýrýlmasýna raðmen artýk kranyal
nöropatiler grubunda yer almaktadýr ve tekrarlayan aðrýlý oftalmoplejik
nöropati olarak isimlendirilmektedir. Sýklýkla 3. kranyal sinir olmak üzere
bir ya da daha fazla oküler kranyal sinirde parezi ile birlikte ipsilateral
migren benzeri baþaðrýsý ile karakterizedir. Bu taný için hastanýn benzer
özellikleri gösteren en az iki atak geçirmiþ olmasý ve kranyal
görüntülemelerinde orbital, parasellar ve arka çukur lezyonlarýnýn dýþlanmýþ
olmasý gerekmektedir. Oldukça nadir bir tablodur. Baþaðrýsý ve kranyal
nöropatinin bir hafta ya da daha uzun süreli olabileceði bilinmektedir. Hatta
baþaðrýsýnýn oküler kranyal nöropatiden 2 hafta kadar önce baþlayabileceði de
bildirilmiþtir. Parezi saptanan oküler kranyal sinirin kranyal görüntülemelerde
<span class=GramE>kontrast</span> tutulumu <span class=GramE>göstermesi</span>
nedeniyle patofizyolojik sürecin demiyelinizasyonla seyreden bir durum
olabileceði öngörülmektedir. Ayrýca nadir görülen bir durum olsa da bu
hastalarýn steroid tedavisine iyi yanýt vermeleri de bu patofizyolojik sürece
ait düþünceleri desteklemektedir. Hastalarýn hem baþaðrýsý ataklarý, hem de
oftalmoparezileri steroide çok iyi cevap vermekte ve tam düzelme görülmektedir.
Tekrarlayan ataklarda ise steroid yanýtýnýn ilk atakta olduðu kadar iyi
olmayabileceði bildirilmiþ ancak tekrarlayan aðrýlý oftalmoplejik nöropati
tanýsý için henüz netleþmiþ bir tedavi algoritmasý oluþturulamamýþtýr.<b>&nbsp;</b></span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Hipertansif
Ensefalopati</span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Akut hipertansiyon, akut baþaðrýsýnda önemli ancak oldukça yanlýþ yorumlara
da yol açabilen bir ayýrýcý taný olasýlýðýdýr. MRG <span class=GramE>dahil</span>
birçok ileri inceleme ve çok sayýda tedavi uygulamasý ile kontrol edilemeyen
bir baþaðrýsýnýn nedeni hipertansiyon olabilir, bu nedenle her hastada mutlaka
arteryel tansiyon ölçülmelidir. Göz dibi bozukluðu, nöbetler, mental deðiþiklik
tabloya eþlik edebilir. Yeni baþlayan hipertansiyon veya malin hipertansiyonun
dekompansasyonlarý bu tabloya neden olabilir. Ancak hipertansiyonun tanýsý
konmuþ ve tedavisi düzenlenmiþ olduðu durumlarda baþaðrýsýný hipertansiyona
baðlamak yanlýþ bir yaklaþýmdýr. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:14.0pt;
mso-bidi-font-size:12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-bidi-font-weight:bold;mso-bidi-font-style:
italic'>Baþaðrýsý gerek artmýþ gerekse azalmýþ kafaiçi basýncýnýn sýk görülen
bir klinik belirtisidir</span><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'>&nbsp;(Bakýnýz:&nbsp;</span><u><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:blue;mso-ansi-language:TR;mso-bidi-font-weight:
bold'><a href="http://www.itfnoroloji.org/kibas/kibas.htm">Kafa içi basýnç
deðiþiklikleri</a></span></u><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'>).</span><span
style='font-size:16.0pt;mso-bidi-font-size:14.0pt;line-height:115%;color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Akut
Sinüzit</span></b><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Seyrek görülen bir baþaðrýsý nedeni olan akut sinüzit genellikle nazal yollarda
pürülan akýntý ve infeksiyon bölgesine göre deðiþen bir aðrý <span class=GramE>profili</span>
ile karakterizedir.&nbsp;<span style='mso-bidi-font-style:italic'>Sinüsler
üzerindeki aðrýnýn mutlaka sinüzite baðlý olmasý gerektiði þeklindeki yanlýþ
inanç nedeni ile baþaðrýsý nedeni olarak sinüzit tanýsý fazla sýk ve hatalý
olarak konmaktadýr.</span>&nbsp;Aslýnda frontal bölge yerleþimli ataklarla
giden baþaðrýsý en sýk migren ve GTB nedeniyle görülür. Burun týkanýklýðýnýn
baþaðrýsýna yol açýp açmadýðý da tartýþmalý bir konudur. Sfenoid sinüzit hem
klinik özellikler hem tedavi açýsýndan farklýlýklar gösterir ve sýk atlanýr.
Tüm sinüzit olgularýnýn sadece %3ünü sfenoid sinüzitler oluþturmasýna karþýn,
yaþamý tehdit edebilen bir durum olmasý nedeniyle önem taþýmaktadýr.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Temporal
Arterit</span></b><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Diðer adýyla&nbsp;<span style='mso-bidi-font-style:italic'>dev hücreli
arterit,&nbsp;</span>baþlýca orta boy arterleri etkileyen bir sistemik
vaskülittir. Belirti ve bulgularý arasýnda baþaðrýsý dýþýnda, görme kaybý,
halsizlik, kilo kaybý ve miyaljiler yer alýr. Elli yaþýndan önce görülmesi çok
nadirdir, kadýnlarda erkeklere göre üç kat daha sýk görülür.<sup>&nbsp;</sup>Yeni
ortaya çýkan baþaðrýsý bulunan veya baþaðrýsý paterninde belirgin bir
deðiþiklik tanýmlayan yaþlý bir hastada mutlaka bu taný akla gelmelidir. En
belirgin bulgusu olan baþaðrýsý, olgularýn %70-90ýnda mevcuttur ve üçte
birinde de ilk belirtidir. Aralýklý veya sürekli olabilir; tipik olarak
þakaklarda <span class=GramE>lokalize</span>, zonklayýcý bir aðrýdýr. Sýklýkla
beraberinde kafa derisi hassasiyeti ve tutulan damarlarýn üzerinde cilt
hassasiyeti bulunur. Kas aðrýsý ve eklem katýlýðý gibi belirtileri olan <i
style='mso-bidi-font-style:normal'><span style='mso-bidi-font-style:italic'>polimiyalji
romatika</span></i><span style='mso-bidi-font-style:italic'></span> ateþ, kilo
kaybý, gece terlemeleri, çene (masseter) klodikasyosu (özellikle çiðnerken
ortaya çýkan yorulma), amarozis fugaks (hastalarýn yarýsýnda iki yanlý
olabilir), kalýcý körlük (sýklýkla herhangi bir uyarý olmaksýzýn) veya kýsmi
görme kaybý (sýklýkla anterior iskemik optik nöropatiye baðlý olarak)
görülebilir. Diplopi ve kranyal sinir felci nadir görülür. Ayrýca seyrinde
koroner, mezenterik, hepatik ve renal arter iskemisi, aort rüptürü, inme ve
geçici iskemik ataklar da görülebilir. En tutarlý laboratuvar bulgusu eritrosit
sedimentasyon hýzýndaki artýþtýr. Bunun dýþýnda, C-reaktif protein artýþý ve
karaciðer enzimlerinde hafif bir yükselme ile hafif bir anemi de sýk görülür.
Çok nadiren eritrosit sedimentasyon hýzý normal bulunabilir. Bazý olgularda, baþlangýçta
normal olan eritrosit sedimentasyon hýzýnýn daha sonra yükselmesi, hastalýk
progresyonu ile iliþkili bulunmuþtur.<sup>&nbsp;</sup>Aspirin, NSAÝ veya
sistemik steroid kullanan hastalarda eritrosit sedimentasyon hýzý düþerek
yalancý negatif sonuç verebilir. Temporal arter biyopsisi tanýda altýn
standarttýr ve mümkünse steroid tedavisinin baþlanmasýndan sonra en geç 48 saat
içinde yapýlmalýdýr. Biyopside klinik olarak etkilenmiþ (hassasiyet, endurasyon
veya nabýz zayýflýðý bulunan) bir arter seçilir. Biyopsi negatifse (hastalýk
yama tarzý lezyonlar oluþturduðu için bu mümkündür), pozitiflik oranýný
arttýrmak için birden fazla kesit incelenmelidir. Biyopsi negatifse ve taný
olasýlýðý yüksekse, diðer temporal arterden tekrarlanmalýdýr. Bazen teknik
nedenlerle biyopsi tekrarý da negatif kalabilir, klinik þüphe netse ve
sedimentasyon yüksekse temporal arterit tanýsýndan vazgeçilmemelidir. Tipik
bulgular ve eritrosit sedimentasyon hýzýnda artýþ görülen bir hastada, temporal
arter biyopsi sonucu beklenirken hemen tedaviye baþlanmalýdýr. Tedavinin
baþlýca hedefi ani geliþen ve geri dönüþümsüz görme kaybýnýn önlenmesidir.
Baþlangýçtaki prednizon dozu günlük 60-80 mgdýr; bazý uzmanlar ilk dozlarý
intravenöz yolla vermeyi tercih etmektedir. Eðer hasta akut bir nörolojik <span
class=GramE>sendromla</span> veya hýzla kötüleþen bir nörolojik tabloyla
baþvurmuþsa, intravenöz pulse steroid (1000 mg/gün) ile veya çok yüksek doz
oral steroidle (120 mg/gün prednizon) tedaviye baþlanmalýdýr.<sup>&nbsp;</sup>Baþaðrýsý
ve sistemik belirtiler tipik olarak steroid baþlandýktan kýsa bir süre sonra
düzelme gösterir. Hasta belirtilerin kontrolü için en az 6 ay-1 yýl süre ile
bir idame dozu almalýdýr. Eldeki sýnýrlý veriler, steroidlerin dýþýnda en
tutarlý biçimde etkili immunsupresif ilacýn siklofosfamid olduðunu ve bir nüks
sonrasýnda verildiðinde steroidin daha hýzlý azaltýlarak kesilebilmesini
saðlayabildiðini düþündürmektedir. Ayrýca azatioprin kullanýmýný da savunan
klinisyenler vardýr.</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='line-height:21.75pt'><b><span style='font-size:12.0pt;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Tablo 9. </span></b><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'>Akut þiddetli baþaðrýsýnda
ayýrýcý taný listesi</span><span style='font-size:12.0pt;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Subaraknoidal kanama</span><span
style='font-size:12.0pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Diðer kanayýcý serebrovasküler hastalýklar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>subdural</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>ekstradural</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>intraserebral hematom</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Serebral venöz sinüs trombozu (Behçet
Hastalýðý veya diðer etyolojilere baðlý)</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Kafa <span class=GramE>travmasý</span>
sonrasý çeþitli sekonder nedenler</span><span style='color:black;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Geçici iskemik atak ve inmede ek bir <span
class=GramE>semptom</span> olarak</span><span style='color:black;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Hipofizer apopleksi</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Spontan intrakranyal hipotansiyon</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Ýntermittan hidrosefali</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Arnold-Chiari malformasyonu</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Ýdyopatik intrakranyal hipertansiyon</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Hipertansif ensefalopati</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Servikosefalik arteryel diseksiyon</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>MSS ve diðer akut infeksiyonlar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
menengoensefalit (bakteryel, viral, fungal)</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
serebral abse</span><span style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Optik nörit, akut glokom gibi göz
hastalýklarý</span><span style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Temporal arterit ve diðer vaskülitler</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Feokromasitoma</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Tiroid hastalýklarý</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Hiperkarbi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Preeklampsi</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Yer kaplayýcý lezyonlar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Ýntoksikasyon (örneðin karbonmonoksid)</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Ýlaç kötüye kullanýmý</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Ýdyopatik gökgürültüsü baþaðrýsý</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Küme baþaðrýsý ve benzer tablolar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Akut migren</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Selim <span class=GramE>efor</span>, öksürük
ve orgazm baþaðrýsý</span><span style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Akut sinüzit ve dental infeksiyonlar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;font-weight:
normal'><o:p>&nbsp;</o:p></span></h2>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;font-weight:
normal'><o:p>&nbsp;</o:p></span></h2>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:windowtext;mso-ansi-language:TR;
mso-bidi-font-weight:normal'>Gebelikte Baþaðrýsý ve Tedavi Yaklaþýmý <o:p></o:p></span></h2>

<h2 style='margin-top:0cm;text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:TR;mso-fareast-language:EN-US;font-weight:
normal'>Gebeliðin ilk trimesterinde artan östrojen seviyesi baþaðrýsýna neden
olabilirken, 2. ve 3. trimesterde östrojen seviyesinin <span class=GramE>stabilleþmesi</span>
ve artan endorfin seviyeleri ile baþaðrýlarý azalabilir. Gebelikle birlikte
migren baþaðrýlarýnda azalma olabilirse de %4-8 kadar hastada ataklar artarak
devam edebilir. Ýlk migren ataðýný gebelik döneminde yaþayan hastalar da
olabilir. Ýlk migren ataðýnda ya da ataklarý kötüleþen hastalarda taný
zorlayýcý olabilir ve öncelikle sekonder nedenlerin dýþlanmasý (preeklampsi, eklampsi,
sinüs ven trombozu gibi) gereklidir. Migren için koruyucu tedavi kullanan hasta
gebelik planlýyorsa, kullandýðý ilaç ya da ilaçlar azaltýlarak kesilmelidir.
Antiepileptikler, ergotamin preparatlarý, triptanlar gibi farklý tedavi
seçeneklerinden bu dönemde kaçýnýlmalýdýr. Gebelikte kullanýlabilecek ilaçlar
içerisinde A kategorisi bir seçenek olmamakla birlikte parasetamol, kafein,
metoklopromid, kodein, meperidin, ondansetron, hidrokodon ve siproheptadin
kategori B olmakla birlikte kullanýlabilir. Gebelik döneminde hastayý kadýn
doðum uzmanlarý ile birlikte takip ederek, tedavi seçeneklerini birlikte gözden
geçirmekte yarar vardýr. Tedaviye hastanýn durumuna ve atak özelliklerine göre
güvenli ilaçlarla devam etmek gereklidir. Etkinliði tartýþmalý olsa bile
parasetamol gebelik döneminde önerilebilecek tedavi seçeneklerinden biridir.
Yine bu dönemde ilaç dýþý tedavi yöntemleri (soðuk uygulama, pilates, masaj ve
uygun egzersiz gibi) önerilmelidir.<o:p></o:p></span></h2>

<p class=MsoNormal><span style='mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:Calibri;color:black;
mso-ansi-language:TR;mso-fareast-language:EN-US;mso-bidi-font-weight:normal'>Yaþlýlarda
Baþaðrýsý ve Tedavi Yaklaþýmý<o:p></o:p></span></h2>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Baþaðrýlarý yaþla birlikte deðiþiklikler gösterebilmektedir. Eriþkin yaþta
baþaðrýlarýnýn büyük çoðunluðunu (yaklaþýk %90) primer baþaðrýlarý
oluþtururken, ileri yaþlarda sekonder baþaðrýlarý ön plana geçmektedir. Yaþlý
hasta grubunda da baþaðrýsý kadýnlarda daha sýk bir <span class=GramE>semptomdur</span>.
<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Ýleri yaþtaki migren hastalarýnda ortaya çýkan geçici görme kaybý,
beyinsapý bulgularý, duysal <span class=GramE>semptomlar</span> gibi fokal
nörolojik bulgularý migren ile iliþkilendirmeden önce geçici iskemik atak ile
ayýrýcý tanýsýnýn yapýlmasý önemlidir. Vasküler risk faktörleri olan hastalarda
dikkat edilmesi gereken noktalardan biri triptan ve ergotamin preparatlarýndan
kaçýnýlmasýdýr. Yine ileri yaþ grubunda komorbidite olasýlýðý yüksek
olacaðýndan tedavi seçiminde diðer hastalýklarýn da göz önünde bulundurulmasý
gerekmektedir. Diðer önemli nokta ise hangi ilaç tercih edilecekse düþük doz
ile baþlanmasý ve yavaþ titre edilmesidir. Yaþlý migren hastalarýnýn atak
tedavisinde parasetamol, NSAÝ ya da bazen kombine analjezikler tercih
edilebilirken, koruyucu tedavi <span class=GramE>için<span
style='mso-spacerun:yes'>  </span>hastanýn</span> komorbiditesine göre
beta-blokerler, kalsiyum kanal blokerleri, antidepresanlar ya da antiepileptik
ilaçlar tercih edilebilir. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Çocuklarda baþaðrýsý<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Baþaðrýsý çocuk yaþ grubunda ve ergenlerde de sýk görülen yakýnmalarýn
baþýndadýr. Özellikle küçük çocuklar baþaðrýsýný tanýmlamada sýkýntý
çekebilirler. Bu dönemde de baþaðrýlarýnýn çoðu primer baþaðrýlarý ve iyi huylu
nedenlere baðlý olanlar olmakla birlikte, sekonder nedenlerin dýþlanmasý önem
taþýmaktadýr. Çocuk hastalarda öncelikle ilaç dýþý tedavilerin tercih edilmesi,
yaþam <span class=GramE>hijyeni</span> ve alýþkanlýklarýn gözden geçirilmesi ve
farmakolojik tedavi seçeneklerinin komorbid sorunlar göz önüne alýnarak
deðerlendirilmesi önerilmektedir. <o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";background:lime;mso-highlight:lime;mso-ansi-language:
TR'><span style='mso-spacerun:yes'> </span></span><b><span style='font-size:
13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'><br clear=all>
</span></b><b><span style='font-size:14.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>KAYNAKLAR </span></b><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Baykan B, Ertas M, Karli N, Akat-Aktas S, Uzunkaya O,
Zarifoglu M, Siva A,Saip S; MIRA-Neurology Study Group. The burden of headache
in neurology outpatient clinics in Turkey. Pain Pract 2007; <span class=GramE>7:313</span>-23.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Ertaþ M, Baykan B. Baþaðrýlarýna Yaklaþým ve Akut
Baþaðrýlarý. Ekspres Baský, Ýstanbul 2007.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Dodick DW. Migraine. Lancet 2018; 391: 131530. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Headache Classification Committee of the International
Headache Society (IHS). The International Classification of Headache Disorders,
3rd edition. Cephalalgia 2018;<span class=GramE>38:1</span>-211. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Bartleson JD, Black DF, Swanson JW. Cranial and facial
pain. (Chapter 20) Ýçinde: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL.
(editörler). Bradleys Neurology in Clinical Practice. 7th edition. 2016,
Elsevier Inc; <span class=GramE>London :197</span>-203.<span
style='mso-spacerun:yes'>  </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Garza I, Schwedt TJ, Robertson CE, Smith JH. Headache and
other craniofacial pain. Ýçinde: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy
SL. (editörler). Bradleys Neurology in Clinical Practice. 7th edition. 2016,
Elsevier Inc; <span class=GramE>London :1686</span>-1719.<o:p></o:p></span></p>

<pre style='margin-left:36.0pt;text-align:justify;text-indent:-18.0pt;
mso-list:l14 level1 lfo26'><![if !supportLists]><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:Tahoma;color:black;
mso-ansi-language:TR;mso-fareast-language:EN-US'><span style='mso-list:Ignore'>7.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:TR;mso-fareast-language:EN-US'>Holle D, Obermann M. Rare primary headaches. Curr Opin Neurol. 2014 Jun;27(3):332-6. <o:p></o:p></span></pre>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:Tahoma;color:black;mso-ansi-language:TR'><span
style='mso-list:Ignore'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Baþaðrýsý
Taný ve Tedavi Güncel Yaklaþýmlar, Türk Nöroloji Derneði Baþaðrýsý Çalýþma
Grubu Uygulamalarý. Galenos Yayýnevi, Ýstanbul. 2018<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><b><i><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Teþekkür:</span></i></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Prof Dr Mustafa Ertaþ ve Prof Dr Halil
Atilla Ýdrisoðluna geçmiþteki katkýlarýndan dolayý teþekkür ederiz.</span><span
lang=EN-US style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=EN-US><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
